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Synthetic biology is a research discipline which harnesses technological progress in 
de novo DNA synthesis as well as combining expertise of biological sciences and 
engineering research fields to facilitate construction of novel artificial biological 
systems. Since the past two decades, application of its methodologies has led to 
significant advances in metabolic engineering, providing alternative biochemical 
routes for the production of therapeutic products, cosmetics and biofuels. However, 
several challenges remain to be addressed to support development of synthetic 
biology applications, notably the demand for faster, cheaper and more reliable DNA 
manufacturing as well as efficient methods for genome-scale engineering of living 
organisms. This doctoral thesis proposes new interdisciplinary approaches to these 
problems, taking advantage of the latest laboratory automation technologies to 
improve efficiency of modern DNA assembly and genome editing methods. The first 
results chapter proposes application of a robotic platform for an acoustic liquid 
transfer for miniaturisation of DNA fabrication. This research, published in 2016, 
demonstrates the possibility to cost-efficiently assemble DNA in sub-microlitre 
assembly reactions. The second results chapter presents efforts to develop a method 
for genome-scale engineering of a model eukaryote, the budding yeast. This work 
capitalises on the recent progress in on-chip DNA synthesis and the next-generation 
sequencing (NGS) technology. Finally, the last results chapter demonstrates 
computational studies to predict and accelerate turnaround times of a commercial 
DNA supply chain using probabilistic simulations. The developed software is used to 
estimate sequence-specific DNA manufacturing turnaround times in order to help 
plan DNA manufacturing and guide decisions regarding further automation of 







All living organisms, from microbes to mammals, are equipped with thousands of 
genes which provide them with a range of capabilities needed to survive in their 
environment. To better understand how genes work and to re-purpose them for 
medicinal or industrial applications, researchers often create novel organisms, 
containing modified genes. Better methods for creating new DNA would therefore 
facilitate and accelerate research. This doctoral thesis shows how the latest progress 
in robotics can be used to make genetic engineering faster and cheaper. The work 
presented contributes to an emerging science discipline, called synthetic biology, 
which applies engineering methods to rationalise biology. First, this thesis 
demonstrates that it is possible to assemble DNA in volumes orders of magnitude 
smaller than previously, using technology originally developed for inkjet printers. 
Second, it presents application of a state of the art DNA modification method, called 
CRISPR, to delete any gene of baker’s yeast, a model organism which is easy to 
work with. Third, it shows results of computer simulation experiments, the objective 
of which was to help plan DNA manufacturing at one of the leading synthetic DNA 
production facilities. The work presented therefore further emphasises that a 
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1.1 Synthetic Biology – Current State 
 
1.1.1 Synthetic Biology Supports Innovation in a Range of Research Fields 
 
Synthetic biology is an interdisciplinary research field which harnesses engineering 
approaches as well as the latest de novo DNA fabrication technologies to address 
limitations of the classical genetic engineering methods (Cheng and Lu, 2012). 
Synthetic biologists thus do not rely on natural nucleic acid sequences, but instead 
choose to rationally design DNA in silico to then build it from “scratch”. This 
approach to genetic engineering helps circumventing issues which tend to hamper 
scientific progress (e.g., DNA material recovery from inaccessible environmental 
sources or its labor-intensive mutagenesis) and therefore is becoming increasingly 
popular among researchers (Gardner, 2013). 
 
Synthetic biology methods have been applied in a broad range of scientific projects, 
with several leading to significant research achievements (Cameron, Bashor and 
Collins, 2014). For instance, in order to support rational engineering of custom 
biological functions, various small synthetic biological circuits (Boolean logic gates, 
bistable switches, oscillators etc.) performing different logical operations have been 
built and led to construction of more complex functional biological devices (Elowitz 
and Leibler, 2000; Gardner, Cantor and Collins, 2000; Kobayashi et al., 2004; 
Stricker et al., 2008; Friedland et al., 2009; Purnick and Weiss, 2009). One notable 
example are whole-cell and cell-free biosensors, which demonstrate potential to 
address such challenges as the arsenic groundwater contamination in the regions of 
South and Southeast Asia or the need for efficient Ebola virus diagnostics (de Mora 
et al., 2011; Pardee et al., 2014). Metabolic engineering is yet another research 
discipline which has been applying synthetic biology methods. In the past years, this 
research collaboration has contributed to building different metabolically re-wired 
organisms able to produce diverse biochemical compounds (Smanski et al., 2016). 
For example, baker’s yeast, Saccharomyces cerevisae, was engineered to cost-
efficiently synthesise opioid drugs (thebaine and hydrocodone) and an antimalarial 
drug precursor (artemisinic acid), compounds which conventional manufacturing 
methods rely on expensive plant extraction and can be thus difficult to scale (Ro et 
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al., 2006; Galanie et al., 2015). Furthermore, a number of environment-friendly 
gasoline, diesel and jet fuel substitutes, belonging to diverse compound classes (e.g., 
alcohols, isoprenoids and fatty acid alkyl esters), have been thus far produced by 
genetically refactored microbes, with some of their biosyntheses utilizing an 
abundant and sustainable carbon source – plant biomass (Mendez-Perez et al., 2017; 
Peris et al., 2017; Ibrahim et al., 2018; Katre et al., 2018; Singh et al., 2018). Current 
biosynthesis methods are yet not limited to unicellular life nor living organisms. For 
instance, multicellular structures such as biofilms were also used to manufacture 
biofuels, while cell-free systems were applied in production of more green 
alternatives to such synthetic polymers as plastic (Wang and Chen, 2009; Kelwick et 
al., 2017; Tao et al., 2017). Synthetic biology approaches to bio-engineering are not 
limited to microorganism-based systems either. For example, plant and mammalian 
synthetic biology are two emerging research fields which hold promise for, e.g., crop 
improvement and development of precision medicine, respectively (Aubel and 
Fussenegger, 2010; Lienert et al., 2014; Liu and Stewart, 2015; Martella et al., 
2016). 
 
Synthetic biology is therefore supporting various applied research domains, with 
some of its applications being tangible in everyday life. One such example is 
Biofene®, a commercial isoprenoid compound produced by genetically engineered 
budding yeast, Saccharomyces cerevisiae, which at present is used as a “drop-in” 
diesel and jet fuel, powering public transportation in Brazil and jet engines of 
commercial airplanes, as well as a chemical additive in cosmetic products (Liebsch, 
2014; Beller, Lee and Katz, 2015). The scope of potential synthetic biology 
applications is broadening too and involves such unconventional ideas as “growing 
your own clothes”, using Kambucha tea microbial cultures, or manufacturing 
fragrances in bioreactors, even those which come from extinct flowers (Rutkin, 
2015; Florea et al., 2016). Such scientific creativity is possible thanks to synthetic 
biology’s efforts to simplify genetic engineering and as a consequence make it 
accessible to the youngest scientists, e.g., through such initiatives as the annual 




1.1.2 DNA “Reading” and “Writing” Technologies 
 
In 1976, one of the smallest (3,569 nucleotides-long) known genomes was sequenced 
– the viral MS2 bacteriophage genome (Fiers et al., 1976). In 1995, the first (1.8 
Mbp-long) prokaryotic genome was accomplished and belonged to a bacterial 
pathogen, Haemophilus influenzae (Fleischmann et al., 1995). Shortly after, in 1996, 
the first eukaryotic, budding yeast genome (12.1 Mbp-long), was read, and in 2001 
the first draft of the human genetic code (3.2 Gbp-long) was published (Goffeau et 
al., 1996; Lander et al., 2001). More recently, scientists have been embarking on 
more challenging projects, e.g., sequencing ~20 Gbp-long gymnosperm plant 
genomes or genetic material of unculturable microorganisms (i.e., metagenomics 
studies) (Zimin et al., 2014). 
 
Now, synthetic biologists are writing DNA to better understand the link between the 
genotype and phenotype as well as to discover the minimal set of genes required for 
life. Current state of the DNA manufacturing technology is one of the key factors 
which make this scientific approach feasible, with the improving de novo DNA 
fabrication methods promising an unconstrained DNA sequence customisation in the 
future (Clore, 2018; L. Wang et al., 2018; Palluk et al., 2018; Veneziano et al., 
2018). Back in 1970s, the first gene was made de novo (Agarwal et al., 1976). It was 
a 77 nucleotides-long yeast alanine tRNA gene DNA sequence enzymatically 
assembled from 17 DNA oligonucleotides, chemical synthesis of which took 5 years. 
Today, such oligonucleotides are available for a next-day delivery, while larger DNA 
fragments are likewise commercially available, affordable and ready within 
reasonable timescales (Kosuri and Church, 2014). Owing to this progress, synthetic 
biology projects are thus now entering genomic scales. 
 
Just like the DNA sequencing landmarks, the first genomes to be made de novo were 
the most compact viral and bacterial ones. In 2002, Cello et al. synthesised the first 
viral genome DNA - the poliovirus cDNA, which totaled ~7.5 kbp. In 2008, this 
work served as a stepping stone to construction of an attenuated version of this virus 
(a vaccine candidate) by re-coding its genetic material with underrepresented codon 
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variants (Cello, Paul and Wimmer, 2002; Coleman et al., 2008). The same year 
however yet another genome synthesis milestone was accomplished. The J. Craig 
Venter Institute announced re-fabrication of the first bacterial (Mycoplasma 
genitalium) genome, 583 kb-long (Gibson et al., 2008). Two years later, continuation 
of this work led to a successful re-synthesis of a nearly two times larger 1.08 Mbp 
Mycoplasma mycoides genome and its transplantation into a Mycoplasma 
capricolum recipient cell, which was “rebooted” with this foreign synthetic 
chromosome (Gibson et al., 2010). More recently, in 2016, the same research team 
has also managed to halve the re-synthesised M. mycoides genome (to 531 kbp), 
using an iterative “design, build, test and learn” synthetic biology methodology, 
giving rise to the smallest autonomously replicating cell (Hutchison et al., 2016).  
 
Eukaryotic chromosomes are a new research focus. In 2011, the International 
Synthetic Yeast Genome (“Sc2.0”) Project was launched (which our research team is 
a part of) and set itself a goal of custom S. cerevisiae yeast genome re-synthesis, 
incorporating a set of “designer” features into its native chromosomes (Dymond et 
al., 2011). For instance, a synthetic evolution system was added in the form of 
LoxPsym DNA recombinase recognition sites, inserted downstream of the non-
essential gene reading frames by design, which upon heterologous expression of the 
recombinase enzyme would serve as genomic rearrangement (i.e., deletion, 
duplication, inversion and translocation) foci, facilitating accelerated adaptation to a 
given environmental condition. A number of other custom chromosome 
modifications were also announced and included (1) deletion and relocation of DNA 
sequences, which are known to elicit genomic instability, i.e., of the Ty transposable 
elements and tRNA genes; (2) deletion of introns; (3) replacement of the native 
telomere sequences with much shorter synthetic alternatives; (4) replacement of all 
TAG stop codons with their TAA counterparts, to allow future expansion of the yeast 
genetic code with unnatural amino acids; and (5) incorporation of synthetic DNA 





To date, six synthetic yeast chromosomes have been published (synII, III, V, VI, X 
and XII) as a result of this international collaboration, totalling approximately 3.5 
Mbp of synthetic DNA, which constitutes more than one quarter of the native 12.1 
Mbp-long yeast genome (Annaluru et al., 2014; Mitchell et al., 2017; Shen et al., 
2017; Wu et al., 2017; Xie et al., 2017; Zhang et al., 2017). The rate at which 
consecutive yeast chromosomes are accomplished can be partially attributed to the 
DNA construction strategy adopted by the Sc2.0 Project consortium based on 
allocation of individual chromosome syntheses to different Sc2.0 Project research 
teams distributed worldwide. As a result however, each synthetic chromosome is 
built in a separate yeast strain. Therefore, the upcoming challenge is to combine all 
of them in a single yeast cell. To date, two viable yeast strains containing more than 
one synthetic chromosome have been reported (Mitchell et al., 2017). Future work 
on combining increasing amounts of synthetic DNA can be viewed both as a 
scientific challenge and an opportunity to discover unknown genetic interactions, 
which can give more insight into eukaryotic biology. Larger genome synthesis 
projects could benefit from this expertise. Recently, the international Human 
Genome Project-write consortium announced re-fabrication of human chromosomes. 
Synthetic human chromosomes are currently anticipated to assist in building novel 
cell lines of therapeutic importance and are a much larger scale undertaking, with 
chromosomal DNA sizes ranging from 48 to 249 Mbp (Boeke et al., 2016). 
 
Due to the fast-increasing pace of DNA reading and writing, DNA sequencing and 
fabrication technologies have been both benchmarked against Moore’s law, 
describing an exponential technological growth tendency previously observed in the 
computer industry. Both technologies exhibited such growth. Yet about a decade ago 
the DNA sequencing technology has readily surpassed it (Moore, 2006; Stein, 2010). 
The somewhat parallel technological progress in the reading and writing research 
domains facilitates efforts to engineer novel biological systems, which take 




1.1.3 Synthetic DNA as a Functional Biopolymer 
 
Application of nucleic acid manufacturing technologies is not limited to developing 
custom biological systems. As DNA is becoming a commodity product it is used by 
some researchers simply as a cheap biopolymer. For instance, scientists are now 
considering using DNA to store data, owing to its dense nanoscale four-bit (i.e., A, 
T, G, C) information encoding system (e.g., 1 cubic millimeter of DNA can encode a 
quintillion, or 10#$, bytes of data) as well as its longevity (i.e., a half-life of 521 
years at 13.1°C) (Allentoft et al., 2012; Church et al., 2012). As the amount of data 
generated daily continues to grow, DNA molecules can help to address the data 
storage demand (Church et al., 2012). To date, several different data objects have 
been stored in strings of DNA, including poems, entire books, images and GIFs 
(Church, Gao and Kosuri, 2012; Goldman et al., 2013; Shipman et al., 2017). Larger 
DNA data storage projects have been announced as well. For instance, in 2016 
Microsoft Corporation announced its ongoing research in this area and 
approximately 200 megabytes of data stored in its DNA data storage system 
(Extance, 2016).  
 
Aside from its capability to encode data, DNA can also spontaneously form various 
3D structures due to its biophysical properties. In vivo these properties allow the 
DNA strands to control access to genetic information. Ex vivo however, they can be 
harnessed to construct customised molecular structures, i.e., so-called “DNA 
origami”, which can perform various tasks. Design and assembly of DNA origami 
nanostructures can be considered as good examples of rational DNA engineering. 
First, dedicated pieces of computer-aided design software (e.g., the CADnano 2.0 
software) are used to determine the necessary set of DNA fragments required to 
build a certain nanostructure. Two types of single-stranded DNA are then used in the 
nanostructure assembly process, i.e., a longer, “scaffold”, DNA molecule and 
numerous shorter, “staple”, DNA oligonucleotides, which guide the nucleic acid 
scaffold towards the desired 3D shape during a thermal annealing step (Wang et al., 
2017). Many DNA origami constructs have been published, with drug delivery being 
one of their potential applications (Douglas et al., 2009; Rajendran et al., 2011; 
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Wickham et al., 2012). For example, in 2012 Jiang et al. demonstrated successful 
delivery of an anti-cancer drug, doxorubicin, into drug-sensitive and drug-resistant 
cancer cells and its significant cytotoxicity in both cell lines (Jiang et al., 2012). 
Following this work, further developments employing virus-like coating strategies 
have now also been applied and can help alleviating immune activation (Mikkilä et 
al., 2014). 
 
1.2 The Synthetic Biology Design, Build, Test and Learn Cycle 
 
Research projects and areas outlined above demonstrate efforts to forward engineer 
biological systems, which is one of the main ambitions of synthetic biology. Despite 
the scientific progress made so far, this goal however still proves vastly challenging, 
mainly due to our limited understanding of the way biology works (Kwok, 2010). 
Therefore, in order to tackle the complexities of forward engineering synthetic 
biologists try to systematise engineering workflows to avoid any ad hoc experimental 
work. These are thus typically organised into so-called “design, build, test and learn” 
(DBTL) optimisation cycles which aim at rationally designing and building a set of 
DNA constructs, which will provide sufficient experimental results to efficiently test 
a given experimental hypothesis and learn from the output data. Consecutive 
synthetic biology cycles capitalise on the knowledge gained throughout the 
preceding iterations and hence continuous progress towards the initially specified 




Each optimisation cycle starts with accurately specifying the intended nucleic 
acid/organism structure or function, e.g., by mathematically describing the desired 
biological system’s behavior. Once a formal specification is ready, suitable DNA 
constructs and edits have to be designed to satisfy the researcher’s requirements. 
Two kinds of DNA design methodologies are employed by synthetic biologists: 
rational and combinatorial. Rational methodologies are those which decide on a 
certain DNA design based on its predicted performance, as judged by an appropriate 
mathematical model. Combinatorial methods on the other hand seek to find a set of 
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design variants which will likely encompass the optimal one. In order to find the 
optimal design, these variants have to be screened or undergo selection under a 
suitable environmental pressure. Such search tactics are often labor-intensive and 
combinatorial approaches are typically used when there is a strong scientific belief 
that valuable DNA designs might not be considered by the rational approach due to a 
limited understanding of a particular biological system. Some common applications 
of the combinatorial DNA design methodology are identification of optimal 
metabolic pathway variants with, e.g., promoter, terminator, ribosome-binding site 
and enzyme libraries; or construction of genome-wide editing libraries to find the 
most favorable genotypes under a certain, e.g., chemical, condition (Smanski et al., 
2014; Kim, Moore and Yoon, 2015; Wong et al., 2015; Wong, Choi and Lu, 2016). 
 
Repositories of accurately characterised and standardised parts as well as various 
computer-aided design (CAD) software tools are two key resources necessary 
throughout the design process (Endy, 2005; Xia et al., 2011; Ham et al., 2012; 
Madsen et al., 2016; Appleton et al., 2017). Synthetic biologists thus aim at 
developing their own suite of CAD tools as well as implementing unified modular 
biological part standards (e.g., the BioBricks and PhytoBricks standards) and policies 
for in silico design representation (e.g., SBOL – Synthetic Biology Open Language), 
part characterisation and laboratory protocol documentation (i.e., SOPs – Standard 
Operating Procedures) (Knight, 2003; Shetty, Endy and Knight, 2008; Shetty et al., 
2011; Galdzicki et al., 2014; Patron et al., 2015). These efforts seek to simplify the 
design process and facilitate knowledge transfer in the synthetic biology community 
through centralised data repositories (e.g., Registry of Standard Biological Parts, 
SBOL Stack, ICE – Inventory of Composable Elements, or Clotho) (Endy, 2005; Xia 
et al., 2011; Ham et al., 2012; Madsen et al., 2016).  
 
The number of synthetic biology CAD tools is increasing and comprises 
computational solutions to different design challenges (Appleton et al., 2017). For 
instance, various CAD tools are available to rationally design DNA parts with the 
desired output. For example, the PromoterCAD software facilitates design of 
synthetic promoter sequences with tailored properties, whereas the online RBS 
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Calculator tool helps researchers build ribosome-binding sites with customised 
strengths (Salis, Mirsky and Voigt, 2009; Nishikata et al., 2014). Other pieces of 
software are dedicated to full DNA construct design and model-driven simulation of 
costruct’s behavior, with examples including the GenoCAD, BioJADE and iBioSim 
CAD tools, which are all equipped with access to public or their own DNA parts 
repositories (Goler, 2004; Czar, Cai and Peccoud, 2009; Watanabe et al., 2018). 
Synthetic biologists can hence use these design frameworks to conveniently evaluate 
performance of their designs and to then rationally choose the optimal DNA 
constructs. Even more convenient “hands-off” CAD solutions are now emerging and 
are there to completely automate DNA design. For example, Cello is a CAD tool 
which generates optimal DNA designs for synthetic biological circuits based on a 
formal specification of the circuit function. This tool applies a hardware description 
language, Verilog, which is used to describe the desired function as well as to specify 
various circuit components (i.e., sensors and actuators) and constraints, including the 
host organism context (Nielsen et al., 2016). Such rational and automated DNA 
design frameworks are no yet available for many other synthetic biology projects and 
so combinatorial approaches have to be employed instead. Standardised, modular 
and “one-pot” DNA assembly techniques allow easy construction of DNA sequence 
variants by swapping various DNA parts in their designated DNA assembly slots. 
However, swapping DNA parts at multiple such positions leads to a rapid expansion 
of the combinatorial space, which can prove challenging to screen (Wong, Choi and 
Lu, 2016). Synthetic biologists therefore take advantage of mathematical methods 
such as the design of experiments (DOE) method to rationally manage the scale of 
combinatorial experiments, so that these can efficiently elucidate the relationship 
between the DNA parts and a given function as well as between the DNA parts 
themselves. Such analyses are complex to tackle manually and therefore a number of 
CAD tools are available to perform these more easily (e.g., the Double Dutch and 
RedLibs CAD software) (Jeschek, Gerngross and Panke, 2016; Roehner et al., 2016). 
 
Determining a suitable DNA sequence, or a set of them, to elicit the desired function 
marks a near completion of the Design phase. DNA sequences now require further 
attention to plan the synthesis and assembly process. This final Design stage lies 
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right at the border with the Build phase and aims at establishing the most economical 
and straightforward DNA fabrication strategy. Therefore, it concerns itself with 
maximizing DNA part reuse as well as “polishing” nucleic acid sequences, so that 
they conform to certain DNA assembly standards and are easy to manufacture (i.e., 
have reasonable GC contents and lack stable secondary structures, as well as repeat 
and homopolymer stretches) (Villalobos et al., 2006; Appleton et al., 2014; Blakes et 
al., 2014; Oberortner et al., 2016). Such multi-objective optimisation is a 
computationally complex task and is difficult to accomplish using manual 
approaches. Various CAD solutions are hence being developed to automatically 
solve user-defined constraints, e.g., the DNALD and Raven DNA fabrication 
planning tools (Appleton et al., 2014; Blakes et al., 2014). Processed DNA 
sequences can be viewed and further edited (if necessary) with different DNA 
sequence editors (e.g., SnapGene, VectorEditor and Benchling), which offer user-
friendly interfaces and an increasing array of DNA view and edit features (e.g., 
visualisation of DNA restriction sites, cloning simulation and DNA editing sites 
design). Their use is therefore becoming increasingly widespread among laboratory 
teams, which commit to one or a number of such tools and use them in general DNA 




Complete DNA designs, with their nucleic acid sequences optimised (to facilitate the 
construction process) and the manufacturing strategies outlined can now be built. 
DNA fabrication is a hierarchical process featuring various chemical and enzymatic 
DNA construction methods, which are each suitable for different DNA fabrication 
scales and strategies (Figure 1.1 A). The process of building nucleic acid sequences 
thus starts with chemically synthesizing short (up to ~200 nucleotides-long) 
oligonucleotides, which are subsequently enzymatically assembled into longer 
(~1,000 nucleotides-long) DNA fragments, during a process termed “gene 
synthesis”. The longer DNA fragments can be next combined using various other in 
vitro and in vivo enzymatic methods, depending on the application, to form even 
longer DNA pieces (up to chromosome sizes) (Ellis, Adie and Baldwin, 2011; L. 




Figure 1.1 DNA Assembly and Editing 
(A) DNA assembly; Different DNA fabrication methods are used to assemble DNA, depending on its 
length. First, multiple short ssDNA oligonucleotides (~60 bp) are annealed and fused to form larger 
dsDNA fragments, up to ~1 kb, in a process referred to as gene synthesis. Larger DNA fragments are 
next combined with sequence homology-based (e.g., Gibson assembly) or restriction-ligation-based 
methods (e.g., Golden Gate DNA assembly). Assembly of DNA pieces > 10 kb is often done in vivo, 
e.g., using the budding yeast homologous recombination machinery. (B) DNA editing; DNA can also 
be edited to obtain the desired nucleic acid sequence. S. pyogenes CRISPR-Cas9 machinery is 
currently one of the most popular DNA editing tools. Cas9 endonuclease forms a ribonucleoprotein 
complex with the single-guide RNA moiety (a crRNA and tracrRNA hybrid), which recognises 20 bp 
protospacer DNA sequences, followed by an NGG protospacer adjacent motif (PAM). Two Cas9 
endonuclease domains, RuvC and HNH, then cleave both strands of the target DNA locus, resulting in 
a blunt-end cut 3 bp upstream of a given PAM sequence. Double-stranded DNA breaks (DSBs) are 
lethal for cells and have to be repaired. Two main mechanisms of DSB repair are used by cells to re-
ligate broken DNA strands, i.e., non-homologous end joining (NHEJ) and homology-directed repair 
(HDR). NHEJ is considered error-prone, as it does not use any reference DNA sequence to repair 
DNA, and thus often leads to insertion-deletion DNA mutations (indels). HDR uses a homologous 
nucleic acid template to guide repair of DSBs. In haploid and polyploid cells, sister chromatids and 
additional chromosomal DNA sets, respectively, are used to precisely (without any errors) repair 
DNA. However, if cells are provided with a sufficient amount of external homologous DNA, custom 




1.2.2.1 Oligonucleotide DNA Synthesis 
 
The first synthetic oligonucleotides were made in the 1950s (Michelson and Todd, 
1955). In 1980s, oligonucleotide synthesis started utilizing solid-phase 
phosphoramidite chemistry methods developed by Martin Caruthers and his 
colleagues and became commercialised (Caruthers et al., 1987). Since then, these 
methods have prevailed as the standard oligonucleotide synthesis methods and have 
become fully automated, with batches of 96 or 384 oligonucleotides being now 
processed simultaneously and synthesis scales of ~10-100 nmol (Kosuri and Church, 
2014). Standard oligonucleotide synthesis proceeds through cycles of: (1) 
deprotection, (2) coupling, (3) capping and (4) oxidation steps, with each cycle 
adding one base to the growing oligonucleotide strand (Fig. 1.2 A). First, a 
protecting dimethoxytrityl (DMT) group is removed from the 5’ end of the last 
nucleoside phosphoramidite, using trichloroacetic acid. Next, another DMT-
protected nucleoside phosphoramidite is added and reacts with the unprotected 5’ 
hydroxide group, through activation with a tetrazole or an imidazole activator. 
Unreacted 5’ ends can be then capped, using an acetate group, and thus excluded 
from the subsequent synthesis cycles to prevent any deletion mutations. The last step 
of the cycle is an iodine oxidatation of phosphite groups, which results in a 
cyanoethyl-protected phosphate backbone. At the last synthesis cycle, this chemical 
reaction is followed by a final deprotection procedure, including deprotection of the 
5’ end and the backbone using e.g., gaseous ammonia. Deprotected oligonucleotides 
are next eluted off the solid support (typically, a controlled pore glass (CPG) 
column) by treating them with a denaturing base (Roy and Caruthers, 2013; Kosuri 





Figure 1.2 Oligonucleotide DNA Synthesis 
(A) Oligonucleotide synthesis using solid-phase phorsphoramidite chemistry: A growing 
oligonucleotide DNA strand is attached to a solid support (typically, a controlled pore glass column). 
DNA synthesis proceeds through cycles of deprotection, base coupling, capping and oxidation. First, a 
dimethoxytrityl (DMT) group is removed from the 5’ end of the last nucleoside phosphoramidite, 
using an acid-catalysed reaction. A second DMT-protected nucleoside phosphoramidite is then 
coupled with the deprotected phosphoramidite moiety, using, e.g., a tetrazole activator. Some 5’ OH 
groups are left unreacted and have to be capped in order to prevent deletion mutations. The hydroxyl 
groups are thus capped with an acetate group. The backbone phosphite groups are next oxidised 
through iodine oxidation and resulting a cyanoethyl-protected phosphate nucleic acid backbone. Once 
the desired DNA sequence is synthesised, via multiple such synthesis cycles, all chemical protection 
groups are removed using, e.g., gaseous ammonia and the oligonucleotide DNA is eluted off the solid 
support. (B) Arrayed oligonucleotide synthesis with photolithography: Photolithography is one of the 
on-chip oligonucleotide synthesis methodologies, using light and photomasking for selective 




Depending on the target oligonucleotide length, an appropriate number of synthesis 
cycles is necessary. However, this number is limited, with DNA syntheses reaching 
oligonucleotide lengths of up to ~200 bases (Clore, 2018). There are a couple of 
reasons behind this limit. First, the correct sequence yield has to be high at each 
synthesis cycle. Yet a seemingly high 99% yield only leads to a final yield of 55% 
for a 60 nucleotides-long oligo and decreases exponentially with every base added. 
Second, depurination can occur during the acid-catalysed deprotection step and pose 
problems for longer oligonucleotides, which tend to break at the resulting abasic sites 
during the final deprotection procedure (Kosuri and Church, 2014). Novel 
chemistries as well as enzymatic DNA synthesis technologies (e.g., the commercial 
DNA Script technology) are therefore emerging to address these issues (Palluk et al., 
2018; Veneziano et al., 2018). 
Solid-phase phosphoramidite chemistry does not solely suffer from its chemical 
limitations. Its other drawback is high running costs (Eroshenko et al., 2012). To 
address this issue, alternative technologies have been therefore arising, allowing 
parallel synthesis of thousands to millions of oligonucleotides on a single DNA chip, 
and contributed to at least a two order of magnitude drop in the synthesis costs 
(Eroshenko et al., 2012). Affymetrix was the first company to develop an on-chip 
synthesis method, in 1990s, and used a light-activated chemistry to selectively 
deprotect photolabile nucleoside phosphoramidites (Fig. 1.2 B) (Fodor et al., 1993; 
Pease et al., 1994). Today, a number of other commercial on-chip synthesis methods 
exist (Eroshenko et al., 2012). For example, Agilent developed an ink jet DNA chip 
printing technology, while CustomArray (recently acquired by GenScript) developed 
a semiconductor-based electrochemical method to selectively produce acid and thus 
selectively deprotect nucleoside phosphoramidites (Eric LeProust et al., 2000; Gao et 
al., 2001; Cleary et al., 2004; Egeland and Southern, 2005). Nonetheless, these more 
economical DNA synthesis approaches did not readily reduce costs and increased 
lengths of the downstream oligonucleotide assemblies (Eroshenko et al., 2012). 
There are a number of technological limitations which hinder further progress. First, 
the substantial throughput of on-chip synthesis can be problematic. Namely, it makes 
it difficult to select and co-localise oligonucleotides which will be further assembled 
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into larger DNA constructs. Second, typically, on-chip-synthesised oligonucleotides 
exhibit higher error rates as compared to the tradition column-based methods. 
Finally, lower oligonucleotide yields are achieved using the on-chip synthesis and 
fall below the nmol range (Eroshenko et al., 2012). Several solutions to these issues 
have nevertheless been demonstrated. For instance, in 2010 Kosuri et al. designed 
primer-binding site barcodes, uniquely identifying sets of oligonucleotides needed 
for a single assembly reaction, and used PCR amplification to enrich for a specific 
oligonucleotide set. Barcode sequences were subsequently enzymatically cleaved off 
and the oligonucleotide DNA was assembled into larger DNA fragments (Kosuri et 
al., 2010). Quan et al., on the other hand, developed a technology to synthesise such 
oligonucleotide sets in physically separated micro-wells and thus perform one 
assembly reaction per such micro-compartment (Quan et al., 2011). This technology 
later paved the way for, e.g., such commercial DNA products as the ones offered by 
Gen9 (part of Gingko Bioworks) (Goldberg, 2013). This year, Plesa et al. reported 
yet another method, DropSynth, to concentrate oligonucleotide assembly sets. 
DropSynth uses barcoded beads, which harvest oligonucleotide assembly sets. 
Oligonucleotide DNA is later processed and assembled in picolitre emulsion droplets 
(Plesa et al., 2018). Lastly, methods to alleviate oligonucleotide error rates were also 
reported and mostly relied on proteins capable of detecting DNA mis-hybridisations 
upon DNA strands denaturation and re-annealing. For example, MutS binds to DNA 
error-containing heteroduplexes, which can be later detected and filtered out by an 
electrophoretic mobility shift assay (EMSA) or a MutS-binding column, while other 
proteins can additionally cleave these off (e.g., the T7 endonuclease I) and so they 
can also be used to repair DNA errors (Carr et al., 2004; Matzas et al., 2010; 
Sequeira et al., 2016). 
1.2.2.2 Oligonucleotide DNA Assembly 
DNA oligonucleotides exhibiting a sufficient DNA sequence quality can be 
assembled into larger nucleic acid fragments using one of the two available 
enzymatic methods – a DNA ligation-based method (LCA – ligase cycling assembly) 
or a PCR-based method (PCA – polymerase cycling assembly). The DNA ligation 
method requires overlapping oligonucleotides, which fully cover both strands of the 
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target DNA sequence, and utilises a thermostable DNA ligase enzyme to ligate the 
oligonucleotide ends (Chandran, 2017). PCA, on the other hand, does not require full 
coverage of the target DNA sequence since gaps between the overlapping 
oligonucleotides are filled by a high-fidelity DNA polymerase (TerMaat et al., 
2009). Both LCA and PCA involve analogous thermal cycling protocols of: DNA 
denaturation, annealing and ligation (LCA)/extension (PCA), to progressively enrich 
for full-length DNA fragments, and a final DNA amplification step using a standard 
PCR reaction. Despite the protocol similarities, both methods however have their 
inherent limitations. For instance, LCA requires an extra 5’ end oligonucleotide 
phosphorylation reaction prior to the thermal cycling protocol, which increases 
overall assembly costs. Moreover, its full oligonucleotide coverage requirement 
further increases the expenses, as compared to the PCA method which requires less 
oligonucleotide DNA. Nonetheless, PCA is more prone to nucleic acid mis-
hybridisation due to its shorter DNA strand overlap regions, and therefore it might 
not be suitable for some DNA sequences, e.g., those with repeats. 
1.2.2.3 Higher Level DNA Assemblies 
Typical gene synthesis reaches DNA lengths of up to 1 kb and suitable enzymatic 
methods are used to assemble larger DNA pieces. Notably, these methods do not 
require PCR amplification of the full-length DNA constructs, which is increasingly 
prone to errors as the DNA constructs grow larger, and do not directly rely on the 
generally error-prone oligonucleotides. Following gene synthesis, or any other DNA 
assembly stage, DNA products are typically further examined using restriction 
digestion, colony PCR and Sanger sequencing to assess correctness of their DNA 
sequences. Once a given DNA fragment passes such a quality control check, it can 
be then used as a substrate in another DNA assembly round. Sequence-verified gene 
synthesis products can be therefore joined to obtain larger DNA pieces. A variety of 
enzymatic methods exist to perform these higher-level DNA assemblies and these 
can be generally split into two major classes – the DNA overlap-directed class and 




Figure 1.3 Sequence Homology- and Restriction-Digestion-based Assembly 
(A) Gibson assemblies are a type of DNA homology-based assemblies, which use a combined action 
of three enzymes to join DNA fragments sharing terminal DNA sequence homologies (~40 bp). First, 
the T5 exonuclease 5’ end resection exposes homologous nucleic acid strands. Complementary DNA 
strands then anneal (thanks to a favorable 50°C reaction temperature). A DNA polymerase re-
synthesises DNA degraded by the T5 exonuclease in a 3’ to 5’ direction. DNA ligase is next used to 
ligate the nicked dsDNA. (B) The BioBrick method is based on DNA restriction digestion and ligation 
mechanism and allows assembling two DNA parts at the time. The DNA parts feature standard prefix 
and suffix sequences, which encode EcoRI and XbaI, and SpeI and PstI restriction sites, respectively. 
Through appropriate restriction digestion of the two DNA fragments (one with the EcoRI and SpeI 
pair of endonucleases and the other one with the EcoRI and XbaI restriction enzyme combination), 
SpeI and XbaI sticky ends anneal, are ligated by a DNA ligase and form a 6 bp scar sequence, which 
cannot be re-cut. (C) The Golden Gate method is based on the restriction-ligation mechanism as well. 
However, it utilises a distinct class of Type IIS restriction enzymes, which cleave DNA outside of 
their recognition sites. BsaI is an example Type IIS endonuclease, which recognition and restriction 
sites are illustrated by the figure. BsaI digestion leads to formation of staggered DNA ends, which 
sequences can be defined by the researcher. Design of uniquely compatible DNA overhangs allows 
multi-part DNA assembly.  
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The first class relies on ~40 bp, or longer, overlaps between the DNA fragments, 
which become exposed upon a 5 to 3’ nucleic acid resection and undergo thermal 
annealing to yield larger DNA products. Such overlaps are typically already encoded 
by design by the DNA fragments to be assembled. However, if they are not, they can 
also be easily added by PCR amplification with DNA primers encoding these. 
Methods belonging to the DNA overlap-directed class can be further split into in 
vitro and in vivo methods. In vitro methods rely on isothermal (e.g., Gibson 
Assembly, SLIC – sequence- and ligase-independent cloning and SLiCE – seamless 
ligation cloning extract) or thermal cycling protocols (e.g., CPEC – circular 
polymerase extension cloning) to carry out the necessary enzymatic reactions. Here, 
the enzymatic DNA fabrication can involve a single enzyme – commonly, a DNA 
polymerase (e.g., the CPEC and SLIC DNA assemblies); a mixture of enzymes, e.g., 
Gibson assembly, which utilises T5 DNA exonuclease, Phusion DNA polymerase 
and Taq DNA ligase (Fig. 1.3 A); or a crude cellular enzymatic extract, which 
circumvents the need of purchasing various (at times, costly) enzymatic components 
(e.g., the SLiCE method) (Gibson et al., 2009; Quan and Tian, 2009; Li and Elledge, 
2012; Zhang, Werling and Edelmann, 2014). In vivo methods, on the other hand, rely 
on DNA transfection protocols, which deliver the DNA assembly fragments inside a 
eukaryotic cell (Fig. 1.1 A). These methods assemble DNA in vivo, harnessing the 
host DNA homologous recombination machinery, and typically use budding yeast or 
bacterial, Bacillus subtilis, cells thanks to their proficiency in DNA recombination as 
well as abilities to handle DNA assemblies of large DNA pieces (e.g., the TAR, 
transformation-associated recombination, and “domino” methods) (Itaya et al., 2008; 
Kouprina and Larionov, 2016). 
Restriction digestion-based methods constitute the second major DNA assembly 
class. These methods rely on DNA restriction enzymes, which generate standard 
sticky end DNA sequences allowing compatible DNA parts to be ligated with each 
other. Such standardised DNA assembly approaches are therefore suitable for 
establishing modular and hierarchical DNA assembly systems, which are particularly 
useful in building combinatorial DNA libraries (Wong, Choi and Lu, 2016). For 
instance, a scientist could be interested in swapping and analysing the function of 
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various components of a biochemical pathway (level 2 and 3 assemblies), which 
consists of several transcription units (level 1 assembly), which in turn consist of, 
e.g., DNA promoter, open reading frame (ORF) and terminator parts (level 0 
assembly). The first restriction digestion-based DNA assembly method to be 
established was the BioBrick DNA assembly method, utilizing 4 restriction enzymes 
(i.e., EcoRI, XbaI, SpeI and PstI) which have their restriction sites encoded in 
standardised “prefix” and “suffix” sequences, flanking the DNA assembly parts (i.e., 
“BioBricks”). Two BioBricks can be combined through digestion with two separate 
sets of enzymes (I – EcoRI and SpeI, II – XbaI and PstI) and a subsequent DNA 
ligation. The resulting DNA assembly product is a new larger BioBrick. This product 
however contains a “scar”, which can prove problematic at some DNA part 
junctions. Another limitation of this method is its throughput. Namely, a labour-
intensive sequential ligation of DNA parts (two DNA parts per one DNA assembly) 
is required (Fig. 1.3 B) (Knight, 2003; Shetty, Endy and Knight, 2008; Shetty et al., 
2011). More recent restriction digestion-based methods address these issues by 
utilizing Type IIS DNA restriction enzymes (e.g., BsaI, BsmBI, BbsI, AarI or SapI), 
which make staggered DNA cuts outside of their recognition sites, therefore allowing 
customizing sticky end sequences, which can be designed to minimise or completely 
eliminate DNA scars (e.g., a DNA scar can encode a stop codon). User-defined DNA 
overhang sequences also open the possibility of assembling all DNA parts in a 
single, “one-pot”, reaction, since they allow the user to set the order of the DNA 
fragments. To date, the most popular Type IIS method is the Golden Gate method, 
which has been harnessed by various DNA fabrication frameworks (e.g., the MoClo 
and Golden Braid systems) featuring their unique overhang sequences, DNA part 
slots as well as hierarchical DNA construction techniques (e.g., utilizing different 
Type IIS DNA endonucleases at different levels of DNA assembly) (Fig. 1.3 C and 
Table 1.1) (Engler, Kandzia and Marillonnet, 2008). Nevertheless, despite the 
increasing adoption of the Golden Gate method, this approach still does not address 
one remaining issue, namely the occasional presence of a relevant Type IIS site 
inside a DNA part, which can lead to decreased efficiencies of DNA assemblies or 
spurious assembly products. Parts to be assembled with the Golden Gate method thus 
similarly to BioBricks require domestication, i.e., removal of the forbidden 
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restriction sites. More recent frameworks (e.g., Mobious Assembly) attempt to 
overcome this issue by using rare Type IIS cutters such as the AarI DNA 
endonuclease (Andreou and Nakayama, 2018).
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1.2.2.4 DNA Editing 
Some synthetic biology projects additionally require various DNA alterations in a 
given host genome, introduction of which can be challenging, depending on the host 
organism (Gaj et al., 2016). Only a handful of characterised living organisms are 
capable of efficiently recombining homologous DNA strands (e.g., Saccharomyces 
cerevisiae or Bacillus subtilis) (Juhas and Ajioka, 2016). Therefore, DNA cassettes 
bearing the desired DNA alterations have to be often flanked by lengthy DNA 
homology regions in order to succeed at altering a given genomic locus. Moreover, 
such DNA cassettes need to include DNA markers as well, to select for the 
successfully modified clones, which means that even more extra DNA is required 
and a suitable DNA screening protocol has to be implemented. Furthermore, one 
might even run at risk of interfering with organism’s phenotype in an unwanted 
manner (Sauer, 1994; Jessop-Fabre et al., 2016; Leng and Song, 2016). 
DNA editing methods try to address these issues by harnessing organisms’ native 
DNA break repair pathways, with the two major DNA break repair routes being the 
NHEJ (non-homologous end joining) and HDR (homology-directed repair) pathways 
(Ceccaldi, Rondinelli and D’Andrea, 2016). Unrepaired double-strand DNA breaks 
(DSBs) are lethal to any living cell and therefore cells are under strong selective 
pressure to repair them. These are repaired either by polishing and ligating the 
exposed ends (NHEJ), which can lead to indel mutations, or by finding a 
homologous piece of DNA (e.g., coming from a sister chromatid). Therefore, 
intentional triggering of DSBs offers an opportunity to randomly mutagenise the 
corresponding DNA loci or to rationally modify them by providing appropriate DNA 
homology cassettes, without the need of using any selective DNA markers. 
Currently, there are three major DNA editing technologies which allow targeted 
introduction of DSBs. The first one established uses custom proteins, called Zinc 
Finger Nucleases (ZFNs). ZFNs are transcription factors in which two “fingers” 
recognise ~3 to 6 DNA nucleotide triplets each. Therefore, appropriate mixing and 
matching of the finger modules allows recognition of almost any DNA sequence. 
ZFNs use the FokI endonuclease domain to cleave a given DNA locus. This domain 
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is active only as a dimer and therefore a good DNA targeting accuracy is typically 
achieved, since two DNA-binding events are required (Urnov et al., 2010). 
Transcription activator-like effector nucleases (TALENs) are another editing 
technology which similarly relies on dimeric transcription factor nucleases. TALEN 
DNA-binding domains however each recognise a single nucleotide. Moreover, 
TALENs’ DNA-protein interactions are less complex, as compared to ZFNs, and 
hence TALENs are generally more straightforward to design, and so are currently 
more frequently used (Joung and Sander, 2012). 
One common limitation of ZFNs and TALENs however is that a custom protein has 
to be designed and manufactured every time a researcher wants to introduce a new 
DSB. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) DNA 
editing technology circumvents this issue by utilizing a single type of DNA 
endonuclease (a Cas protein), which is guided to the target locus by a short crRNA 
sequence. CRISPR loci are naturally present in bacteria and archaea and were first 
characterised by Francisco Mojica. In 2005, further work led this researcher to an 
observation that these repeat DNA sequences include fragments of bacteriophage 
genomes, which in turn led to a (now confirmed) hypothesis that CRISPR loci play a 
role in adaptive immunity (Mojica, Juez and Rodríguez-Valera, 1993; Mojica et al., 
2005). 
Upon viral infection of a prokaryotic cell, Cas proteins cleave foreign DNA into 
small DNA pieces (~20 bp) and incorporate them into the CRISPR locus, in-between 
the DNA repeat sequences (these DNA fragments are referred to as “protospacer” 
sequences). This DNA information is later used to combat any other analogous viral 
infection. Here, a separate set of Cas proteins expresses the CRISPR locus and 
processes the resulting pre-crRNA molecules into mature crRNAs. An additional 
RNA species is however usually necessary (in Type II systems) to process pre-
crRNAs and trigger formation of the targeting Cas ribonucleoprotein complex – a 
trans-activating crRNA (tracrRNA). TracrRNA binds to pre-crRNA, through its 
homology to the DNA repeat sequences, forming an RNA duplex which triggers 
recruitment of an RNase III and an RNA-guided Cas endonuclease, which then work 
together to form separate defensive crRNA:tracrRNA:Cas ribonucleoprotein 
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complexes. To date, many distinct CRISPR/Cas systems have been identified and 
classified into different classes, yet the one derived from Streptococcus pyogenes 
(belonging to the Type II class) is by far the most popular. The system utilises an 
RNA-guided Cas9 protein, which requires an NGG protospacer-adjacent motif 
(PAM) downstream of the targeting sequence. Once bound to the target DNA, Cas9 
uses its two endonuclease domains (RuvC and HNH) to cleave both DNA strands, 3 
nucleotides upstream of the PAM sequence (Figure 1.1 B) (Haurwitz et al., 2010). 
Thanks to their straightforward RNA-guided mechanism, CRISPR/Cas systems have 
quickly become popular DNA editing tools, with one of their biggest advantages 
being the ease of design and construction of genome-wide DNA editing libraries, 
which are powerful phenotypic screening tools (Smith et al., 2016; Kurata et al., 
2017; Metzakopian et al., 2017; Bao et al., 2018; Guo et al., 2018; Roy et al., 2018; 
T. Wang et al., 2018). Moreover, Cas proteins have not only been exploited as DNA 
endonucleases, but also as proteins capable of silencing or activating selected DNA 
loci – applications, which however first require mutagenizing the Cas DNA cleavage 
domains and re-engineering the resulting “dead” Cas, dCas, proteins to bear suitable 
silencing/activating modules (e.g., the Krüppel-associated box, KRAB, domain is 
frequently used to repress transcription of a target gene) (Qi et al., 2013; La Russa 
and Qi, 2015; Zheng et al., 2018). Nonetheless, CRISPR/Cas systems also have their 
limitations. Notably, they have been reported to exhibit off-target DNA-binding 
activities (Pattanayak et al., 2013; Zhang et al., 2015). Various scoring metrics have 
therefore been developed to estimate performance of individual crRNAs as well as 
partially dead “nickase” Cas protein variants, which similarly to ZFNs and TALENs 
have to dimerise on the target DNA to catalyse DSBs (Ran et al., 2013; Doench et 
al., 2014; Haeussler et al., 2016; Abadi et al., 2017). More recently, chemical 
modifications of single-guide RNAs have also been shown to increase CRISPR 






Once the products of DNA fabrication are ready, they have to be screened and tested 
for the desired function. Typically, this is accomplished using a range of standard 
and well-established laboratory methods, e.g., spectrometry, chromatography, 
cytometry or microscopy (Petzold et al., 2015). However considering our growing 
ability to rapidly build DNA and generate large combinatorial nucleic acid variant 
libraries, the commonly used screening and testing approaches are increasingly 
incapable of rapidly evaluating numerous DNA designs and therefore are often 
becoming synthetic biology’s cycle bottleneck (Rogers, Taylor and Church, 2016). 
 
For instance, metabolic engineers are currently applying synthetic biology 
methodologies to rapidly construct numerous biosynthetic pathway variants, which 
require further screening and testing to identify the most efficient biomolecule 
producers. Therefore, scientific progress of the metabolic engineering field is largely 
dependent on surpassing the DNA construct evaluation bottleneck (Rogers, Taylor 
and Church, 2016). Liquid chromatography and mass spectrometry are gold standard 
methods of metabolite measurement. Nevertheless, they are commonly limited to 
approximately a thousand measurements per instrument daily (Rogers, Taylor and 
Church, 2016). Recent high-throughput screening methods are trying to address these 
technological limitations, including mass spectrometry techniques directly analyzing 
microbial colonies or harnessing acoustic dispensing methods (Fang and Dorrestein, 
2014; Sinclair et al., 2016). Nonetheless, rational synthetic biology approaches are 
still desirable to efficiently and more economically navigate through combinatorial 
spaces. At present, biosensor-based methods are one of the main synthetic biology 
solutions to the metabolic pathway evaluation issue. Namely, genetic biosensor 
modules can be engineered in production hosts, chassis, to sense the biomolecules 
being synthesised and report on their yields. Different biosensor outputs can be used 
to support either screening or selection efforts. For example, fluorescent protein 
signal strength can indicate production levels and flow cytometry methods can be 
later used to screen and sort cells according to their metabolite yields. Alternatively, 
expression of an antibiotic resistance marker can be linked a with metabolite’s 
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biosynthesis, so that only top producers will be able to withstand a certain level of 
selection pressure (Rogers, Taylor and Church, 2016). To date, several studies have 
reported successful application of such biosensor devices, including published work 
on 1-butanol, mevalonate and vanillin biosensors (Pfleger et al., 2007; de los Santos 
et al., 2016; Shi et al., 2017). Some of the more recent examples feature much more 
extended functionalities, e.g., can alter mutagenesis rates, proportionally to a 
biomolecule’s yield; and monitor biosynthesis in real-time (Chou and Keasling, 




In an attempt to build DNA constructs and organisms capable of performing certain 
functions, one iteration of the synthetic biology cycle might not be enough to meet a 
previously specified objective. Despite the best efforts of synthetic biologists to 
forward and rationally engineer biology, researchers continue to stumble across 
various unexpected obstacles, due to our still limited knowledge of how biological 
systems function (Kwok, 2010). Such discrepancies between expectations and 
observations provide an opportunity to learn new biology revise our prior beliefs and 
update any established molecular interaction models. Furthermore, the increasing 
amounts of manufacturing and biological data we are currently generating provide 
yet another occasion to discover any previously unknown patterns and dependencies 
through data mining (McCulloch, 2013). Therefore, the field of synthetic biology is 
now also intersecting with such research fields as the systems biology and machine 
learning fields (Nesbeth et al., 2016). 
 
Systems biology is a research discipline which concerns itself with computational 
and mathematical modelling of complicated biological systems to better understand 
their function. Machine learning, on the other hand, is a computer science research 
field which uses statistical methods to allow computer systems to learn patterns and 
dependencies in data without being thoroughly programmed to do so. Thus, systems 





During the Test stage, different kinds of experimental data can be collected and their 
subsequent analysis reveals whether performance of a rationally designed biological 
system is consistent with the specifications stated beforehand. If not, revision and 
updating of various model parameters and assumptions is required. Here, a synthetic 
biologist could, e.g., go back to one of the CAD modelling frameworks used and 
adjust the relevant model parameters. Otherwise, different modelling languages 
could provide more flexible means of studying the unexpected results. For instance, 
rule-based modelling languages, such as the Kappa modelling language, allow the 
user to indirectly construct a mathematical model by specifying a set of rules. These 
modelling frameworks are therefore straightforward to use and were, e.g., applied by 
undergraduate students participating in the iGEM competition, to model a complex 
mechanism of light-based communication in Escherichia coli (Stewart and Wilson-
Kanamori, 2011; Wilson-Kanamori et al., 2015). 
 
Modelling analyzes might however be insufficient to account for the observed 
experimental results. Information needed to elucidate a certain biological 
phenomenon might be often inaccessible to scientists, which impedes efficient model 
updating and refining. Therefore, machine learning methods can be used to mine data 
in search of its hidden characteristics. Thus far, machine learning approaches have 
helped in gaining of several new insights into different biological systems. For 
example, data mining studies allowed mapping of the relationship between promoter 
sequence and promoter strength, which led to a further development of custom 
synthetic promoters (Meng et al., 2013). Work exploring messenger RNA (mRNA) 
secondary structure, on the other hand, made it possible to develop a prediction tool 
capable of predicting translation rate given an mRNA sequence; while analysis of the 
CRISPR system target nucleic acid sequences and the corresponding Cas9 cutting 
efficiencies allowed construction of a machine learning model predicting the 
cleavage performance (Huang et al., 2011; Abadi et al., 2017). More widespread 
application of the machine learning algorithms however requires a continuing effort 
to make these methods more accessible to researchers who do not have the relevant 
background knowledge. This is now achieved by developing more high-level 
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machine learning software and computer programming libraries (e.g., the e1071 and 
scikit-learn R and Python programming language packages, respectively) (Piccinini 
et al., 2017). 
 
1.3 High-throughput Technologies Help Accelerating the DBTL Cycle 
 
Increasingly widespread application of the synthetic biology approaches coincides 
with the growing implementation of high-throughput technologies in the field of life 
sciences and creates an even bigger demand for high-throughput laboratory methods 
(Chao et al., 2017). This trend reflects synthetic biology’s main goal of making 
forward engineering of living organisms easier.  
 
1.3.1 A Brief History of Laboratory Automation 
 
In the past few decades, laboratory automation has been focusing on reduction of 
protocol durations (e.g., through simultaneous processing of large sample batches) 
and progressive elimination of the error-prone human labour. One of the first reports 
of an automated laboratory device was in 1875 and described an automated filtration 
device (Stevens, 1875). In 1894, Greiner published his work on developing an 
automated pipette, which was designed to help scientists determining milk fat 
content using the Babcock test (Greiner, 1894). At the beginning of the new century, 
electrical equipment for conductivity measurements facilitated development of the 
first commercially-available automated gas detection devices for both laboratory and 
field use (Taylor and Hugh, 1922). In the 1950s, laboratory automation was 
becoming even more mainstream. For instance, for the first time a high-throughput 
device was connected with a digital computer, namely the Atlantic Refining 
Company released a mass spectrometer capable of performing a biochemical analysis 
of a complex organic mixture in about 10 minutes and automatically typing out its 
results (Olsen, 2012). Moreover, microplates were starting to become a popular 
laboratory consumable (their design specifications became later standardised by the 
American National Standards Institute (ANSI)) (Olsen, 2012; Astle, 2016b, 2016a). 
Three decades later, in 1984, the first computer-controlled and programmable robotic 
arm was developed and was able to pick up and transfer labware (Olsen, 2012). This 
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achievement paved the way for integrating multiple laboratory automation devices to 
conduct larger scale processes. 
 
1.3.2 Modern Lab Automation for Synthetic Biology 
 
1.3.2.1 Accelerating DNA Fabrication 
 
Today, a life sciences laboratory has a variety of commercial automated laboratory 
devices to choose from and synthetic biology workflows can benefit from this choice 
(Chao et al., 2017). A typical synthetic biology DNA construction workflow 
involves: (1) preparation of DNA assembly mixes; (2) incubation or thermal cycling 
of the DNA assembly reactions; (3) a heat shock E. coli bacterial transformation of 
the assembly products; (4) bacterial colony picking, to identify clones propagating 
the right DNA assembly construct; (5) DNA extraction from the candidate clones; 
and (6) DNA restriction digestion and/or sequencing verification of the purified 
DNA samples. The verified DNA constructs can be subsequently characterised in a 
chosen host organism by, e.g., analyzing its growth and responses to various 
environmental cues. Currently, all these steps can be facilitated by dedicated 
automation systems (Fig. 1.4).
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Figure 1.4 Integrated Automation of DNA 
Fabrication 
At present, most of the DNA fabrication 
operations can be automated. Example DNA 
manufacturing steps and the corresponding 
robotic devices are indicated. Integrated 
automation of different DNA manufacturing 
processes requires use of articulated robot 
arms, which transport microplates (bearing 
biological samples) between different pieces of 
automation equipment, as well as specialised 
software, to enable communication between 
robots. Robotic setup outline - courtesy of the 




First, several liquid handling technologies exist, e.g., using tips, pins, valves or sound 
waves, to transfer liquids, which can be used to automatically prepare the DNA 
assembly mixes (Kong et al., 2012). Liquid handling devices can prove especially 
useful when dealing with large 96, 384 or 1,536 sample batches, which are tedious to 
handle and prone to human error. Moreover, they can also accurately transfer even 
nanolitre liquid amounts, which is something that cannot be done by hand using a 
standard single-channel pipette. Liquid handling devices have now also become 
larger workstations (e.g., the Tecan, Hamilton Robotics and Beckman Coulter 
workstations) performing various additional tasks, e.g., purifying nucleic acid 
samples or shaking and incubating microplates. Therefore, they can be used to run 
isothermal or thermal cycling DNA assembly protocols, set up DNA transformations 
or extract DNA from microbial cultures. Pin tools are yet another type of high-
throughput laboratory device, able to pick and re-array microbial colonies as well as 
plate various microorganisms onto solid media in a sterile manner (Cleveland and 
Koutz, 2005; Kong et al., 2012). Microbial clones can be picked, based on their 
colony size or colour, which facilitates the downstream verification efforts. DNA 
restriction digestion is one of the typical primary DNA verification methods and 
involves digestion of a DNA assembly product with a suitable restriction 
endonuclease (or a mixture of these),to yield a specific pattern of DNA fragments, 
which is used by researchers to validate DNA assembly. The fragments first have to 
be separated and visualised by gel electrophoresis before they can be analysed. At 
present, a number of high-throughput solutions exist to automate gel electrophoresis 
protocols. For instance, liquid handling workstations can prepare and incubate 
digestion reactions and load their DNA products into wells of suitable pre-cast gels 
(e.g., the E-Gel agarose gels, from Thermo Fisher Scientific) (Wu et al., 2016). 
Furthermore, high-throughput capillary gel electrophoresis instruments can perform 
electrophoretic separations with greater sensitivity, if necessary; are able to quantify 
DNA more accurately, as compared with regular agarose gels and gel imaging 
systems; and can perform automated gel image analyses, outputs of which are 
computer-readable (Li et al., 2018). PCR is yet another primary DNA verification 
method, which uses DNA primers designed to differentiate between the right and 
wrong DNA assembly products. Similarly to the DNA restriction digestion methods, 
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PCR reactions, including their downstream electrophoretic analyses, can be run by 
suitable liquid handling workstations (i.e., including an on-deck thermal cycler and a 
gel electrophoresis unit) (Chao et al., 2017). High-throughput quantitative PCR 
(qPCR) methods can also be used, as alternatives to the traditional end-point PCR 
approaches. These methods do not require any downstream gel electrophoresis 
analyses and, furthermore, provide digital PCR reaction results right at the end of a 
thermal cycling run. A recent publication by Mitchell et al. reports such a method, 
developed to genotype an entire synthetic yeast chromosome in a single qPCR run, 
which involved 1,536 reaction wells (Mitchell et al., 2015).  
 
1.3.2.2 NGS for High-throughput DNA Sequence Analysis 
 
Besides DNA restriction digestion and PCR methods, more stringent approaches are 
commonly required to confirm correctness of the DNA assembly products (notably, 
when PCR-based DNA assembly protocols are used). DNA sequencing can detect 
small nucleic acid sequence polymorphisms, which might be overlooked by the 
methods mentioned above. Here, Sanger sequencing methods are a common choice. 
However, their limited throughput is currently encouraging scientists to harness 
some of the next-generation sequencing (NGS) technologies instead (Green, Rubin 
and Olson, 2017; Shendure et al., 2017). In contrast to the Sanger sequencing 
methods, NGS allows sequencing of heterogenous DNA samples and combining tens 
of such samples in a single sequencing run. A single NGS run generates millions of 
sequencing reads (as compared to a single Sanger sequencing read). Therefore, 
bioinformatics analyses are carried out to map these against the reference nucleic 
acid regions. Each of these regions is usually covered by multiple read sequences, 
which allows an accurate insight into unknown DNA variations (Magi et al., 2010). 
To date, NGS technologies have made it possible to, e.g., completely sequence 4,000 
plasmid DNA assemblies, in a single NGS run, with a coverage of 15 reads per 
plasmid region and a cost of less than $3 per plasmid, which led to an overall 20-fold 
cost reduction as compared to the Sanger sequencing process (Shapland et al., 2015). 
Moreover, NGS workflows were also used to screen sequence errors in chip-
synthesised oligonucleotides and track off-target CRISPR genome editing events 
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(e.g., the GUIDE-Seq method) (Matzas et al., 2010; Tsai et al., 2014). Lastly, NGS 
is increasingly used in large-scale phenotypic screening projects, as it allows 
researchers to analyze multiple screening experiments in parallel (i.e., with the so-
called “Bar-Seq” methods). Here, short, pre-designed barcode sequences are used to 
measure growth of individual cells in complex pools by quantifying their read 
depths. Enrichment, depletion or dropout of clones can be thus studied under certain 
environmental conditions (Robinson et al., 2014). Clones of interest can be later 
further analysed, if necessary. For instance, high-throughput platforms such as 
microplate readers or micro-bioreactors can more accurately monitor cellular growth 
as well as dynamically control some of the culture parameters (e.g., the dissolved 
oxygen concentrations and pH) (Mühlmann et al., 2017; Paytubi et al., 2017). 
 
1.3.3 Integrated Platforms for DNA Manufacturing 
 
1.3.3.1 DNA Foundries 
 
While high-throughput devices are already assisting synthetic biologists in many 
tedious tasks, the ultimate goal of automation technologies is to completely free 
scientists from manual sample handling. This can be achieved by connecting the 
necessary high-throughput platforms with each other, so that they can work together 
to accomplish an entire process (e.g., to build, verify and test an entire library of 
standard promoter DNA parts). Currently, integration of robotic equipment is not 
only limited to the life sciences industry, but is also becoming increasing employed 
by academic facilities. For instance, so-called “DNA foundries” are emerging 
academic DNA manufacturing facilities, which feature semi- or fully-integrated 
laboratory automation systems using robotic arms to shuttle biological samples 
between various high-throughput devices. These facilities serve various academic 
customers and help them advance their scientific projects faster by providing various 
high-throughput DNA construction and cellular screening services (Chao et al., 
2017). For example, some of the work presented in this thesis benefited from access 
to the Edinburgh Genome Foundry (United Kingdom). To date, a number of 
publications have reported successful applications of the DNA foundry high-
throughput platforms. For example, Liang et al. demonstrated a high-throughput 
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process capable of assembling hundreds of DNA constructs encoding transcription 
activator-like effector (TALE) proteins within one day and with a cost of $5 per 
TALE (Liang et al., 2013). Si et al., on the other hand, reported a high-throughput 
process capable of generating and screening complex genome-wide S. cerevisiae 
overexpression and knockdown libraries and using these to optimise various 
phenotypes, e.g., isobutanol production or acetic acid tolerance (Si et al., 2017). 
These positive case studies can be encouraging for many academic organisations and 
laboratories to build their own integrated laboratory automation platforms. This task 
is now becoming easier as various companies offer custom construction of such 
systems and assistance in setting up various automated workflows (e.g., HighRes 
Biosolutions or Thermo Fisher Scientific); thereby minimizing the amount of expert 
electrical and mechanical engineering knowledge as well as hardware programming 
skills required. 
 
Nevertheless, efficient operation of such systems requires a suitable software 
infrastructure. For instance, laboratory information management systems (LIMS) are 
typically needed to, e.g., track information on numerous biological samples (DNA 
parts, plasmids, primers, microbial strains etc.) or manage inventories (e.g., of lab 
consumables and reagents). Manufacturing execution systems (MES), on the other 
hand, track high-throughput workflows, i.e., transformation of raw biological 
materials into finished DNA assembly (or, e.g., microbial strain) products (Chao et 
al., 2017; Craig et al., 2017). Therefore, synthetic biology labs and facilities have to 
develop their own software suites, or “stacks”, to plan, schedule, execute, manage, 
track, control and analyze high-throughput workflows. A growing number of 
computer applications supporting automated synthetic biology protocols is now 
conveniently emerging. These are often open-source and web-based, and so readily 
available to the synthetic biology community, which can benefit from these without 
the need for individual research teams to develop their own software (Appleton et 
al., 2017). For instance, the CIDAR (Cross-disciplinary Integration of Design 
Automation Research) Lab, based at Boston University, offers versatile software 
automation tools, which include both CAD and CAM (computer-aided 
manufacturing) tools (Xia et al., 2011; Appleton et al., 2014; Nielsen et al., 2016). 
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Puppeteer is one of these, and combines utilities of LIMS and MES systems. 
Puppeteer allows users to define laboratory protocols, which are later interpreted and 
transformed into a set of robot- and human-readable manufacturing instructions, as 
well as assists in tracking and controlling laboratory tasks, reagents and equipment 
(Vasilev et al., 2011). PaR-PaR, on the other hand, is a robot programming language 
developed by JBEI (Joint BioEnergy Insitute). This robot communication tool 
features a biologist-friendly syntax and is designed to simplify the task of writing 
complex biological protocols for robotic platforms (Linshiz et al., 2013). In the 
future, widespread adoption of a single robot programming standard could facilitate 
sharing of high-throughput protocols between different labs worldwide. 
 
1.3.3.2 Cloud Labs 
 
Despite the increasing engineering and software support, costs of setting up and 
operating high-throughput systems are however still considerably high (i.e., 
oscillating around millions of British pounds) (Chambers, Kitney and Freemont, 
2016). Therefore, since not every academic organisation can afford such an expense, 
and consequently not every laboratory can have access to a DNA foundry, other 
high-throughput services are emerging. For instance, “cloud labs” such as the 
Emerald and Transcriptic Cloud Laboratories, offer remote laboratory automation 
services, which involve customers specifying their high-throughput experiments and 
shipping the starting biological materials. Results data can be then accessed and 
downloaded online (Check Hayden, 2014). The straightforwardness with which 
high-throughput data can be obtained through such remote services encourages 
reflection on the future of high-throughput synthetic biology. Outsourcing high-
throughput experiments might at some point become a routine practice and perhaps 
results data will be commonly used to automatically trigger other experiments 
necessary to reach a pre-specified objective. Recent work on “robot scientists” able 
to autonomously formulate and test biological hypotheses suggests that such 




1.4 Remaining Challenges Facing Synthetic Biology 
 
Despite recent advances in the field of synthetic biology, including the increasing 
application of high-throughput methodologies, new technological challenges are 
nevertheless arising. Therefore, this thesis will focus on three particular challenges: 
(1) further boosting throughput of nucleic acid manufacturing to meet the growing 
demand for synthetic DNA, which requires more cost-effective DNA fabrication 
methods; (2) development of more efficient genome-scale DNA engineering 
methodologies, to facilitate mapping of complex genotype-phenotype relationships; 
and, (3) finally, harnessing the growing amounts of data generated by high-
throughput nucleic acid manufacturing pipelines to allow more efficient predictive 
analytics and therefore more robust DNA manufacturing process optimisation 
(McCulloch, 2013; Esvelt and Wang, 2014; Katz et al., 2018). 
 
1.4.1 1st Challenge: Lowering DNA Assembly Costs 
 
DNA assembly is one of the main enabling technologies for synthetic biologists and 
as synthetic biology workflows are becoming increasingly high-throughput there is a 
growing need for making it cheaper (Katz et al., 2018). Miniaturisation of DNA 
assembly reactions is one of the possible approaches towards achieving a more cost-
efficient DNA fabrication. 
 
Traditional, tip-based high-throughput liquid handling technologies are usually 
incapable of accurately transferring liquids below the microlitre threshold (Ellson et 
al., 2016). Nevertheless, a couple of alternative methodologies now exist, which are 
adept at moving sub-microlitre volumes. For instance, pin tools are able to transfer 
liquid amounts as low as ~2 nL, and have proven useful for, e.g., high-throughput 
screening of compound libraries, usually dissolved in dimethyl sulfoxide (DMSO) 
(Fig. 1.5 A) (Cleveland and Koutz, 2005; Kong et al., 2012). High concentrations of 
DMSO in the screening assay reactions are undesirable due to toxicity of this solvent 
and therefore minimal compound library transfers are desirable, to e.g., avoid any 
intermediate dilution steps. Furthermore, other common applications of this 




In order to ensure accurate liquid transfer, pin tools however require control of 
various factors. For example, pin diameter, surface tension of the liquid material 
being transferred, pin retraction speed and immersion depth (both in the source and 
destination liquid), pin dwell period in an empty destination well and volume of the 
pin slot/groove are some of the key factors controlling the amount of fluid material 
being moved. Moreover, every pin tool liquid transfer requires a thorough wash 
cycle to avoid contamination issues. Different concerted approaches, combining use 
of chemical solutions (e.g., bleach), sonication, UV light sterilisation and mechanical 
cleaning methods (e.g., using brushes) as well as lint-free blotting strategies, are 
therefore applied. Additional pin coatings are also exploited, to prevent non-specific 
binding of proteins and lipids onto the pin surface as well as liquid dislocation 
throughout the transfer process. Lastly, pin tools are rather inflexible when it comes 
to moving different liquid volumes in a single liquid handling workflow and can 
necessitate mounting of several suitable pin arrays to complete a given liquid transfer 
operation (Cleveland and Koutz, 2005). 
 
Other liquid transfer technologies are now emerging to address these limitations, 
which originate from the contact-based approach. For example, acoustic dispensing 
technologies are based on a contactless acoustic droplet ejection (ADE) phenomenon 
and allow flexible transfer of variable liquid amounts through ejection of nanolitre 
droplets from specialised source plates into various destination microplates, using 
appropriate sound wave parameters (Fig. 1.5 B). The physical ADE phenomenon 
was first described in 1920s and since then it has been applied in, e.g., ink jet 
printing (in the 1970s). In the 2000s, this “drop-on-demand” technology was adopted 
by the field of life sciences and is at present pioneered by such companies as Labcyte 
Inc. and EDC Biosystems (Ellson et al., 2016). 
 
Microfluidic technologies are alternatives to robotic liquid handlers and are 
becoming increasingly accessible to researchers as high-resolution 3D printing 
services and benchtop 3D printers are turning into commodities (Gach et al., 2017). 
To date, microfluidic devices helped downscaling various biological protocols, 
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including DNA fabrication methods such as Gibson and Golden Gate DNA 
assemblies as well as PCR amplification protocols (Patrick et al., 2015; Khilko et al., 
2018). However, successful application of microfluidic technologies to DNA 
fabrication and verification (via PCR) requires relevant expertise and has been also 
shown to necessitate additional supplementation of, e.g., molecular crowding agents 
and surfactants as well as excess amounts of enzyme, to optimise nanoscale reaction 
systems, which might not be desirable and cost-efficient (Khilko et al., 2018). 
 
In the first results chapter, I therefore present published work on further 
miniaturisation of the Gibson and Golden Gate methods, using the acoustic 
dispensing technology, which thus far has not been used to assemble DNA. 
Miniaturisation efforts led to scaling down the reaction sizes by up to two orders of 
magnitude. Nanolitre DNA assemblies did not require supplementation of any 
additional reaction components and led to up to ~200-fold reagent cost reductions. 
Aside from the DNA fabrication methods, end-point PCR reactions, which are often 
used to validate synthetic DNA constructs, were also downscaled and were 





Figure 1.5 Contact and Contactless Liquid Handling Technologies 
(A) Contact liquid transfer, Contact liquid transfer methods mainly use tips (disposable or fixed) and 
pins to transfer different types of liquids. Tip-based methods use air or liquid displacement 
mechanisms to aspirate and dispense liquids. Pin tools, on the other hand, transfer fixed liquid 
amounts, depending on the physical properties of a given pin and the fluid being transferred (e.g., the 
liquid’s surface tension). Grooved pins are one type of pin tool used, which harness properties of 
capillaries to move various liquids. (B) Contactless liquid transfer, Acoustic dispensing is a 
contactless liquid transfer method, which uses sound waves to shoot nanolitre droplets from standard 
source plates to inverted destination plates (empty or pre-filled). Coupling fluid (water) is used to 




1.4.2 2nd Challenge: Building Tools for Mapping Genotype-Phenotype Relationships 
 
By making DNA fabrication more economical and straightforward, synthetic 
biologists hope to better elucidate genotype to phenotype relationships. In eukaryotic 
cells these relationships are primarily governed by complex genetic interaction 
networks, which ensure cellular robustness against various environmental 
perturbations (Sanchez et al., 1999). Baker’s yeast, Saccharomyces cerevisiae, is a 
unicellular eukaryotic organism which for decades has been serving as an accessible 
model biological system to investigate more complicated molecular mechanisms, 
e.g., control of human cell function, and consequently has become one of the key 
eukaryotes to study this intricate cellular wiring (Duina, Miller and Keeney, 2014; 
Costanzo et al., 2016; Kuzmin et al., 2018). S. cerevisiae cells can be easily 
genetically modified (thanks to their short doubling times, efficient transfection 
protocols and robust homologous recombination capabilities), are able to rapidly 
proliferate on relatively inexpensive carbon sources, are resistant to many growth 
inhibitors and feature a metabolism rich in various useful biosynthesis precursors. 
These characteristics have been therefore encouraging application of S. cerevisiae 
strains in both molecular biology and applied research fields (Duina, Miller and 
Keeney, 2014). The genetic “interactome” studies are valuable for both of these 
research domains, by increasing our understanding of compound phenotypes, 
including industrially relevant ones (Si et al., 2015, 2017; Costanzo et al., 2016; 
Kuzmin et al., 2018).  
 
Synthetic genetic array (SGA) technology was the first high-throughput approach for 
studying S. cerevisiae genetic interactions genome-wide (Fig. 1.6) (Kuzmin et al., 
2016). SGA harnesses standard yeast deletion collections, which comprise S288c 
genetic background strains individually harbouring complete single open reading 
frame (ORF) deletions. The ORF deletion mutations target all ~6,000 S. cerevisiae 
genes, which are replaced by a KanMX4 antibiotic resistance selectable marker and 
uniquely tagged with short nucleic acid sequences. Automated pin tool devices are 
later used to mate a given query gene knockout strain with every member of an 
appropriate deletion library, i.e., of an opposite mating type; and distinct 
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auxotrophies and antibiotic resistances are used to select for the resulting digenic 
knockout strains (Giaever and Nislow, 2014). Double gene mutants can feature 
unexpected phenotypes, considering the underlying single gene deletion effects, 
which indicate a genetic interaction. Such a genetic interaction can be either positive 
or negative. Double mutants which exhibit higher than expected viabilities indicate 
positive gene-gene interactions, while those which become unexpectedly sick or die 
(i.e., exhibit “synthetic sickness” or “synthetic lethality”, respectively) imply 
negative ones (Kuzmin et al., 2016). To date, more than 23 million digenic 
knockouts have been investigated in S. cerevisiae yeast using the SGA method and 
revealed ~550,000 negative and ~350,000 positive gene-gene interactions. Statistical 
correlation analysis of these allowed computation of interaction strengths, which 
were later used to construct a genetic interaction network diagram. This visual 
representation of the cellular wiring led to a number of observations. For instance, 
negative gene-gene interactions tend to connect functionally related genes, whereas 
positive relationships tend to indicate regulatory connections (Costanzo et al., 2016). 
More recently, the first attempts at mapping trigenic interactions (~200,000) in S. 
cerevisiae using SGA were also reported. Kuzmin et al., revealed that these link 
more distantly functionally-related bioprocesses, as compared with the digenic 





Figure 1.6 SGA Genetic Interaction Studies 
(A) Synthetic genetic arrays, A query strain harbouring a gene deletion of interest is mated with the 
Yeast Knockout Collection. Dense mating arrays are generated by high-throughput pin replicators. 
Diploid yeast strains are selected using a double antibiotic selection, corresponding to different 
antibiotic resistance cassettes integrated into the query and library strains (kanMX4 and natMX6). 
Replication of diploids onto a growth medium with limiting carbon source and nitrogen amounts leads 
to sporulation. Double haploid mutants are selected using a combined antibiotic (G418 and ClonNat), 
auxotrophic (histidine) and chemical (canavanine and thialysine) selection. Reduced growth or lack of 
growth on the resulting double mutant array indicates synthetic sick and lethal genetic interactions, 
respectively. Image taken by Young and Loewen (Young and Loewen, 2013) (B) Building a genetic 
interaction network, Deviation from the expected double mutant phenotype (A x B) indicates either a 
positive (yeast cells are less sick than expected) or a negative genetic interaction (more sick than 
expected). Positive genetic interactions indicate genetic suppression, while negative genetic 
interactions indicate genes which impinge on the same biological process. Pearson correlation 
coefficient (PCC) is used to measure strength of genetic interactions and interactions with PCC > 0.2 
are used in construction of an interaction map. Statistical measures of interaction strengths provide 





Nevertheless, despite these valuable insights, throughput of classical SGA methods 
has its physical scalability limits. Namely, classical SGA methods rely on yeast 
colony size measurements of densely populated colony arrays as proxies for strain 
fitness and so the number of double mutants that can be investigated, e.g., per day, 
depends on the number of colonies which can be fitted onto a single growth medium 
plate (e.g., too densely populated arrays could cause cross-contamination issues and 
complicate image analyses) (Kuzmin et al., 2016). Therefore, alternative approaches 
have been emerging to address this bottleneck. These, e.g., study digenic interactions 
in heterogenous double mutant pools proliferating in liquid growth media, using the 
unique yeast deletion collection “barcode” sequences in microarray hybridisation 
(e.g., the dSLAM method) or NGS studies (e.g., the Bar-Seq experiments). Intensity 
of each of the resulting barcode readouts is later used to infer individual strain fitness 
and is a readily quantitative measure, as compared with the image analysis 
approaches (Pan et al., 2007; Robinson et al., 2014). Moreover, modern NGS 
analyses are capable of analyzing tens of such genetic interaction screens in parallel, 
while ensuring statistically significant read depths. Other methods concerned 
themselves with eliminating SGA’s strain S288c genetic background, auxotrophy 
and selectable drug resistance marker requirements, which can be impractical for 
some applications. For instance, studies of industrially-relevant phenotypes are often 
performed in more suitable laboratory strains (e.g., the CEN.PK strains with an 
enriched set of maltose metabolism genes), rather than the S288c derivatives. 
Moreover, such studies often aim not only at dissecting the genotypic basis of a 
given phenotype, but also at evolving an optimal one, which is frequently 
accomplished by investigating effects of genomic knockouts (or, alternatively, 
knockdowns, overexpression, or a combination of those) in the presence of, e.g., a 
certain synthetic metabolic pathway or chemical stress associated with the industrial 
bioprocess of interest (e.g., elevated concentrations of vanillin or acetic acid, which 
can lead to a growth defect, during lignocellulosic biofuel production) (Si et al., 
2015, 2017). Hence, genome editing protocols which heavily dependent on 
auxotrophic and drug resistance selection are not favored by such applications, as 
they are limited by the number of available selectable markers as well as being often 
constrained by sub-optimal and costly growth media formulations, which are 
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required to maintain a suitable selective amino acid and/or antibiotic 
supplementation (Sauer, 1994; Leng and Song, 2016).  
 
Novel marker-free genome editing approaches can tackle these drawbacks. For 
example, CRISPR genome editing approaches take advantage of lethal double-strand 
DNA breaks as a means of selecting correctly edited cells and are readily accessible 
in various S. cerevisiae strains, given an appropriate short crRNA sequence design. 
Consequently, a growing number of different CRISPR engineering methods for this 
budding yeast is being developed. These methods rely on S. cerevisiae’s preferred 
homology-directed repair (HDR) DSB repair pathway, and include DNA editing 
approaches which are suitable for constructing genome-wide CRISPR libraries for 
this model eukaryote, as well as allowing introduction of multiple, “multiplex”, 
genome edits in a single cell (e.g., the HI-CRISPR method or approaches targeting 
repetitive retrotransposon delta sequences) (Stovicek, Holkenbrink and Borodina, 
2017). HDR CRISPR methods have already proved effective in genome-wide 
targeting of bacterial loci (i.e., the CREATE method) and are now being exploited in 
S. cerevisiae yeast (Garst et al., 2016). Recently, three such methods have been 
reported for this eukaryotic organism (Bao et al., 2018; Guo et al., 2018; Roy et al., 
2018).  
 
In the second results chapter, I therefore present an approach to S. cerevisiae DNA 
engineering on a genomic scale using an HDR CRISPR mechanism. This approach 
harnesses the HDR DSB repair pathway to insert unique DNA barcode cassettes at 
Cas9 cleavage sites, which were designed to knock out every gene in the S. 
cerevisiae genome via generation of pre-mature stop codons. Barcode cassettes 
allowed tracking individual single-gene mutants in heterogenous populations of S. 
cerevisiae yeast using next-generation sequencing and served as direct (one-to-one) 
proxies for mutant abundance tracking. Moreover, the constructed library is 
compatible with the synthetic yeast chromosomes designed by the Sc2.0 consortium 
(i.e., it complies with all of their design features, e.g., the relocation of tRNA genes 
and presence of the synthetic DNA watermark sequences). This genetic tool is 
therefore meant to ultimately facilitate the process of mapping novel genetic 
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interactions in the Sc2.0 project strains as well as “debugging” their synthetic 
genomes. 
 
1.4.3 3rd Challenge: Using Manufacturing Data to Optimise DNA Fabrication 
 
As automation solutions for synthetic biology emerge, DNA fabrication workflows 
are increasingly resembling industrial production lines. Therefore, there is a growing 
need for statistical tools for rational setup and examination of DNA manufacturing 
processes (Chao et al., 2017). At present, researchers still tend to make ad hoc 
decisions and draw intuitive conclusions regarding high-throughput bioprocesses, 
while these should be supported by logical statistical studies (Jahangirian et al., 
2010; Cameron, Bashor and Collins, 2014; Mourtzis, Doukas and Bernidaki, 2014). 
Therefore, quantitative answers are required to questions such as: How beneficial is 
it to run a given DNA fabrication step overnight? How significant is a particular 
process parameter, e.g., PCR mean duration or failure rate? How do technician 
working hours impact total duration of a DNA manufacturing process?  
 
Analysis of DNA manufacturing processes has one more caveat, i.e., every DNA 
sequence has its unique degree of “manufacturability”. Too high or too low GC 
content, nucleic acid secondary structure, DNA repeats and homopolymers are some 
of the most problematic DNA features which synthetic biologists have to cope with 
when synthesizing, assembling and validating different DNA species. Hence, 
sometimes two distinct DNA constructs, although originating from the same 
production workflow, can have a distinct impact on the manufacturing costs and 
turnaround times (TATs) (Oberortner et al., 2016). DNA sequence features should 
therefore ideally also be considered when examining high-throughput DNA 
fabrication workflows. Such DNA sequence-specific studies could lead to better 
predictions of the expected process costs and TATs, which could in turn help 
companies and other DNA manufacturing services (e.g., DNA foundries) to provide 
better order turnaround time estimates to their customers or to better constrain 




Since the number of high-throughput DNA manufacturing processes is growing, both 
in industry and in academia, there is an increasing amount of data available 
concerning durations and failure rates of individual process steps as well as nucleic 
acid sequence-specific failures (Chao et al., 2017). This data is often stored in 
computer databases supporting function of lab automation processes and can be 
readily used to develop predictive tools which could predict expected manufacturing 
costs and TATs, given an input nucleic acid sequence (Craig et al., 2017). Such tools 
require two components. First, means of predicting the probability of failure of a 
given DNA sequence in a given process step is needed, to incorporate DNA-
sequence specific information into the analysis pipeline. This could be accomplished 
with a statistical classification model, which could be trained using a machine 
learning algorithm and the DNA construct failure data to infer failure probabilities of 
other nucleic acid sequences, e.g., based on their chosen features (i.e., supervised 
learning). Such model could be continuously updated, using the new incoming DNA 
data, so that its predictive capabilities could increase over time. Second, means of 
analysing the underlying experimental workflows is needed, given their unique 
experimental step progressions, step failure “rescue” paths etc. Since these can be 
complex, and therefore hard to analyze using analytical methods, Monte Carlo (MC) 
methods can be used instead. MC simulations are computer experiments sampling 
random numbers from probability distributions pre-defined by a modeler and best 
describing a given process random variable (e.g., a PCR reaction duration) (Kroese 
et al., 2014).  
 
In the third results chapter, I therefore propose a simple MC simulation framework, 
usable by non-specialists, which allows the user to define a manufacturing process 
model (including its experimental steps, their order, failure rates, rescue paths, step 
duration probability distributions, as well as the work schedules of the employees 
involved), using a simple Microsoft Excel spreadsheet, and to simulate it. Apart from 
the turnaround time estimations, this simulation framework is also able to identify 
manufacturing steps which have the most significant impact on the production 
turnaround times, using a one-factor-at-a-time sensitivity analysis, and therefore to 
guide the user towards the most promising optimisation targets. If desired, DNA 
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sequence-specific failure estimates can be incorporated into MC simulation studies, 
thanks to a statistical model which was constructed using industrial DNA 







Chapter 2  







2.1 General Materials and Methods 
 
2.1.1 Microbial Strains, Media and Chemicals 
 
2.1.1.1 Microbial Strains 
 
One Shot TOP10 (F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara- leu)7697 galU galK rpsL (StrR) endA1 nupG) and MAX Efficiency 
DH5α Competent Cells (F- Φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 (rk-, mk+) phoA supE44 λ-thi-1 gyrA96 relA1) from 
Thermo Fisher Scientific were used to perform chemical transformations of E. coli 
cells. SURE Electroporation-Competent Cells ('14)(McrA)) Δ(mcrCB-hsdSMR-
mrr)171 endA1 gyrA96 thi-1 supE44 relA1 lac recB recJ sbcC umuC::Tn5 (Kan1) 
uvrC [F ́ proAB 23456ZΔM15 Tn10 (Tet1)]) from Agilent Technologies were used 
to electroporate DNA into E. coli. All experimental budding yeast work used an 





Chemicals from Sigma-Aldrich and Formedium were used to prepare microbial 
growth media. Chemicals used to make various buffer solutions were purchased from 
Sigma-Aldrich only, unless otherwise stated. 
 
2.1.1.3 Bacterial Media 
 
LB (Lysogeny Broth) and SOC (Super Optimal Catabolite repression) media were 
used in bacterial cell experiments. The LB medium contained 1% w/v tryptone and 
NaCl, and 0.5% w/v yeast extract. Its pH was adjusted to 7.0 and the resulting liquid 
medium was then sterilised. LB plates were made by combining 2-times 
concentrated liquid LB medium with sterile 4% w/v agar. LB media harbouring 
antibiotic selection were used in this thesis project. Therefore, depending on the 
plasmid antibiotic resistance marker, sterile carbenicillin and kanamycin at final 
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concentrations of 50 μg/mL were added. The SOC medium was used to recover cells 
after transformation. The medium was sterilised and contained 0.5% w/v yeast 
extract, 2% w/v tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4 
and 20 mM dextrose. 
 
2.1.1.4 Yeast Media 
 
All yeast growth media were first prepared as 2-times concentrated (2X) solutions 
and filter-sterilised. Depending on whether a liquid or a solid medium was needed, 
these were 2-times diluted with sterile ddH2O or sterile 4% w/v agar. The rich YPD 
(Yeast extract Peptone Dextrose) medium contained 1% w/v yeast extract, 2% w/v 
peptone and 2% w/v dextrose. The minimal SC (Synthetic Complete) medium 
contained 6.9 g/L of yeast nitrogen base (Formedium) without amino acids and with 
ammonium sulfate, 2% w/v dextrose carbon source and an appropriate amount of the 
Kaiser drop-out mixture (as indicated by Formedium). For the purpose of URA3 
marker plasmid counter-selection experiments, SC media (containing all amino acid 
supplements) were in addition supplemented with 5-fluoroorotic acid (5-FOA), at a 
final concentration of 1 g/L. Ingredients of all media formulations were always 
combined in their powder forms and dissolved in sterile ddH2O, with a sterile 
magnetic stirrer and a heat block (set at ~50°C) with a stirring option. 
 
2.1.2 Molecular Cloning 
 
2.1.2.1 Commercial DNA Purchasing 
 
Primer DNA (DNA Oligonucleotides and Ultramer DNA Oligonucleotides) and 
larger DNA constructs (gBlocks Gene Fragments) were purchased from Integrated 
DNA Technologies. The oligonucleotide pool used in experiments presented in 




2.1.2.2 DNA Assembly 
 
Gibson and Golden Gate DNA assembly was performed in this thesis project. 15 µL 
Gibson assembly master mixes were used to assemble DNA pieces with terminal ~40 
bp homologies. Each master mix contained 4 µL of a 5-times concentrated ISO 
buffer, 0.16 µL of T5 Exonuclease (cat. no: T5E4111K; from Epicentre), 0.25 µL of 
Phusion High-Fidelity DNA Polymerase (cat. no: F-530L; from NEB), 2 µL of Taq 
DNA Ligase (cat. no: M0208L; from NEB) and 8.59 µL of distilled water. The ISO 
buffer consisted of 0.5 M Tris-HCl pH 7.5, 50 mM MgCl2, 1 mM dATP, 1 mM 
dTTP, 1 mM dCTP, 1 mM dGTP (dNTPs from NEB; cat. no: N0446S), 50 mM 
DTT, 25% w/v PEG 8000 and 5 mM NAD+. Gibson assembly was performed by 
combining 15 µL of the master mix with 5 µL of an equimolar DNA fragment 
mixture (~0.02 – 0.5 pmoles of DNA fragments) and incubating the resulting 
reaction mix at 50°C for 1 hour. Golden Gate DNA assembly was used to assemble 
DNA fragments with compatible 4 nt ssDNA overhangs generated by cleaving 
flanking BsaI restriction sites. A 7.5 µL Golden Gate reaction mix contained 0.7 µL 
of concentrated T4 DNA Ligase (2,000 units/µL; from NEB), 0.7 µL of BsaI-HF 
restriction endonuclease (NEB), 1 µL of T4 DNA Ligase Reaction Buffer (NEB), 0.5 
µL of bovine serum albumin (cat. no: B9000S; NEB) and 4.6 µL of an equimolar 
DNA fragment mixture. Once prepared, the mix was subjected to a thermal cycling 
protocol of 15 cycles of 5 min at 37°C and 10 min at 16°C, 5 min at 50°C, 10 min at 
80°C and final storage at 4°C. 
 
2.1.2.3 Bacterial DNA Transformation 
 
E. coli cells were transformed with plasmid DNA using either a chemical heat shock 
method or electroporation. The chemical protocol started with a brief thawing of 
chemically-competent bacterial cells on ice. Plasmid DNA was added and mixed 
with the cells, with the DNA volume always constituting less than 10% of the 
competent cell volume. The DNA-cell mixture was next incubated on ice for 20 min, 
heat shocked at 42°C for 45 sec and, again, incubated on ice for 5 min. 950 μL of 
pre-warmed (to 37°C) SOC medium was then pipetted into the mixture and the 
 
 58 
transformant cells were allowed to recover at 37°C for 1 hour, with 200 rpm shaking. 
Following this step, bacterial cells were concentrated by brief centrifugation at 
17,000 x g and/or diluted, and plated onto solid LB medium plates harbouring a 
relevant antibiotic for plasmid selection. The plates were incubated overnight at 
37°C. A MicroPulser Electroporator (Bio-Rad) was used to conduct DNA 
electroporation, and protocols of the electroporation device and the competent cells 
manufacturers were followed when electroporating E. coli cells. 
 
2.1.2.3 Yeast DNA Transformation 
 
Mid-logarithmic growth phase cells were used as competent cells in the yeast 
transformation procedures. Yeast competent cells were always prepared fresh, prior 
to the transformation protocol. A 10 mL single-colony culture was first prepared by 
overnight incubation at 30°C in YPD medium with 200 rpm shaking. The next day, a 
pre-warmed (30°C) 2X YPD medium was inoculated to a starting concentration of 
0.5 ODU/mL using the overnight culture. Pre-warmed (30°C) flasks were always 
used and were filled with the inoculated medium up to a 20% of their total volume to 
ensure sufficient culture aeration. The cells were then allowed to divide twice and 
reach a concentration of 2.0 ODU/mL. This growth takes about 4 hours. Each 
transformation reaction typically requires 10 ODU. Therefore, in order to carry out, 
e.g., 10 of them, a 50 mL mid-logarithmic phase culture is needed. Once the mid-
logarithmic phase was reached, the cells were collected by centrifugation at 3,000 x 
g for 10 min. Two wash cycles with 25 mL of sterile ddH2O were next conducted, 
using the same centrifugation settings. The washed cell pellets were then transferred, 
using the remaining liquid, to 1.5 mL polypropylene (PP) tubes (100 ODU per tube). 
Again, the yeast cells were spun down by centrifugation (17,000 x g for 30 sec) and 
were next re-suspended, with sterile ddH2O to a volume of 1 mL. 100 μL portions of 
cells (10 ODU) were distributed across all transformation reaction 1.5 mL PP tubes. 
Cells were pelleted by 30 seconds centrifugation with the same speed settings. A 
transformation reaction mix was next transferred to each of the tubes and mixed with 
the cells. Each transformation reaction consisted of 273 μL of 44% w/v PEG 4000, 
36 μL of 1 M LiOAc, 20 μL of 10 mg/mL herring sperm DNA (pre-boiled at 100°C 
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for 10 min and briefly cooled on ice; Promega), up to 5 μg of plasmid DNA and 
sterile ddH2O up to a volume of 360 μL. The transformation mixtures were incubated 
at 30°C for 30 min and were next subjected to heat shock at 42°C for 15 min. 
Following this step, the transformant cells were collected by a brief 30 sec 
centrifugation at 17,000 x g and re-suspended in sterile ddH2O (typically > 400 μL). 
The cells were next plated onto pre-warmed (30°C) solid SC medium plates with 
suitable auxotrophic plasmid selection and incubated for 4 to 7 days at 30°C. 200 and 
400 μL liquid volumes were typically plated onto 90 and 150 mm diameter media 
plates, respectively. Appropriate dilutions were prepared and plated, if necessary. 
This transformation protocol yielded a CFU range of ~105 – 106 CFU/μg of plasmid 
DNA, using the BY4741 yeast strain. 
 
2.1.2.4 Bacterial DNA Extraction 
 
When working with E. coli cells, plasmid DNA extraction was performed using a 
commercial kit from Qiagen (QIAprep Spin Miniprep Kit), unless stated otherwise. 
The extracted DNA was quantified with a NanoDrop spectrophotometer (Thermo 
Fisher Scientific), unless a more accurate method was required, e.g., fluorometry.  
 
2.1.2.5 Yeast DNA Extraction 
 
Total DNA was extracted from yeast cells using a phenol-chloroform method. A 50 
ODU yeast cell pellet was first re-suspended in 400 μL of lysis buffer (10 mM Tris-
HCl pH 8.0, 0.1 M NaCl and 1% w/v Triton X-100). A ~200 μL volume of acid-
washed glass beads (Sigma-Aldrich; cat. no: G8772) was combined with the cell 
suspension. 400 μL of a 25:24:1 v/v phenol:chloroform:isoamyl alcohol mixture (pH 
8.0) was then added. The resulting mixture was vigorously vortexed for 10 min and 
then centrifuged at 17,000 x g. All experimental work involving phenol and 
chloroform was performed in a suitable fume hood. About 300 μL of the upper 
aqueous phase was collected and transferred to a clean 1.5 mL PP tube. The DNA 
was then precipitated with absolute isopropanol (1:1 sample to alcohol volume ratio), 
by addition of the alcohol followed by 30 min incubation on ice. The precipitated 
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DNA was collected by centrifugation at 17,000 x g for 10 min and washed once with 
80% v/v ethanol. The washed nucleic acid pellet was then briefly dried in a 
Vacufuge Concentrator (Eppendorf) for 5 min and gently re-suspended in 100 μL of 
elution buffer (10 mM Tris-Cl pH 8.5). 1 μL of 10 mg/mL RNase A (Thermo Fisher 
Scientific; cat. no: EN0531) was added and the solution was incubated at 37°C for 30 
min to degrade residual RNA. 200 μL of TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM 
EDTA, pH 8.0) was next added, followed by 300 μL of 24:1 v/v chloroform:isoamyl 
alcohol mixture. The resulting solution was vigorously vortexed for 5 min and 
centrifuged at 17,000 x g for 10 min. The upper aqueous phase (about 200 μL) was 
collected and transferred to a clean 1.5 mL PP tube. DNA was then precipitated 
using absolute isopropanol, dried with the Vacufuge Concentrator and the resulting 
DNA pellet was gently re-suspended in 35 μL of nuclease-free water. DNA 
concentration was quantified with both spectrometry (i.e., with the NanoDrop 
instrument) and fluorometry (with a Qubit fluorometer and the dsDNA HS Assay Kit 
from Thermo Fisher Scientific), to account for the presence of any impurities and 
accurately quantify dsDNA, respectively. 
 
2.1.2.6 DNA Precipitation 
 
Purified plasmid and genomic DNA were precipitated either with absolute ethanol 
(1:2.5 sample to alcohol volume ratio) or with absolute isopropanol (1:1 sample to 
alcohol volume ratio). Both alcohol precipitations followed the same experimental 
procedure. First, 0.1 volume 3 M sodium acetate was added to a given DNA sample. 
Visibility of precipitated DNA was increased by subsequent addition of GlycoBlue 
Coprecipitant (Thermo Fisher Scientific) at a final concentration of 50-150 μg/mL. 
Ice-cold ethanol or room temperature isopropanol was next combined with the 
resulting DNA mixture. Following this step, ethanol precipitations were incubated at 
-80°C for ~2 hours or overnight, while isopropanol precipitations were kept on ice 
for 30 min. The precipitated nucleic acid material was collected by centrifugation at 
17,000 x g for 10 min, washed once with 80% v/v ethanol and dried for 5 min, using 




2.1.2.7 Plasmid DNA Restriction Digestion 
 
Restriction endonucleases from New England Biolabs (NEB) were used to cleave 
plasmid DNA to assess its correctness or to obtain particular plasmid DNA 
fragments. The manufacturer’s instructions were followed when setting up the 
digestion reactions. 
 
2.1.2.8 Thermal Cycling Equipment 
 
ProFlex PCR System thermal cycling instruments (Thermo Fisher Scientific) were 
used to conduct endpoint PCR thermal cycling protocols, DNA assemblies and 
scaled-down bacterial DNA transformations. The LightCycler 96 System (Roche 
Life Science) was used to perform quantitative PCR experiments. 
 
2.1.2.9 Gel Electrophoresis Assay 
 
Gel electrophoresis was used to separate digested DNA fragments and to judge 
appropriate restriction digestion DNA products, purity of DNA and its quantity. 1% 
w/v agarose gels, pre-stained with SYBR Safe intercalating dye (Thermo Fisher 
Scientific), were used, unless otherwise stated. TAE buffer (40 mM Tris-acetate and 
1 mM EDTA; at a pH of ~8.3) was used to prepare agarose gels and run 
electrophoresis. Bio-Rad equipment was used to run gel electrophoreses at ~100 V 
for ~40 min as well as image the resulting nucleic acid gels with the Gel Doc XR+ 
Gel Documentation System. NEB gel loading dyes and DNA ladders were used to 
track DNA migration through the agarose gel matrix and judge size of the separated 
DNA, respectively. 
 
2.1.2.10 DNA Extraction from Agarose Gels 
 
MiniElute Gel Extraction Kits (Qiagen) were used to extract DNA from agarose gels 
and ensured high concentration of the final eluted DNA solutions. The 
manufacturer’s instructions were followed. The Bio-Rad gel imaging system was 




2.1.2.11 Sanger DNA Sequencing 
 
Plasmid and PCR amplicon DNA was sequenced at the University of Edinburgh 
DNA sequencing facility (Edinburgh Genomics). Prior to DNA sample submission, 
chain terminating PCR reactions were performed, using the BigDye Terminator v3.1 
Cycle Sequencing Kit (Thermo Fisher Scientific). Edinburgh Genomics PCR 
protocol specifications were followed (URL: 
http://genomics.ed.ac.uk/services/sanger-sequencing).  
 
2.1.3 Computational Work 
 
Programming scripts were used to plot graphs illustrating experimental data, analyze 
output of next-generation sequencing experiments, mine DNA sequence data, run 
machine learning algorithms and develop computational tools for probabilistic 
simulation studies. Python programming language (version 3.6.5) was used to write 
programming scripts. Atom source code editor and Jupyter Notebook were used to 
document, edit and store computer code. Several Python programming language 
libraries were used to accomplish different computational tasks. Pandas, NumPy and 
SciPy libraries were used to conduct general statistical data analyses. Matplotlib and 
Seaborn libraries were used for data visualisation. Nucleotide sequence alignment 
analyses were performed with the blastn tool from the NCBI BLAST+ software suite 
(via Biopython programming tools). 
 
2.2 Chapter 3 Materials and Methods 
 
2.2.1 Acoustic Dispensing Equipment and Consumables 
 
The Echo 550 acoustic dispenser (Labcyte Inc.) was used to set up nanolitre reaction 
systems. Echo Plate Reformat software was used to define and run liquid handling 
protocols. Echo Qualified Source Plates were used to store and transfer individual 
reaction components into inverted destination microplates. In particular, 384-Well 
LDV COC Source Plates were used to store DNA, while 384-Well Polypropylene 
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Source Plates were used to store nuclease-free water and reaction master mixes. 
MicroAmp Endura Optical 96-Well Reaction Plates (Thermo Fisher Scientific) were 
used as the destination plates. 
 
2.2.2 Nanolitre DNA Assembly 
 
2.2.2.1 Gibson Assembly 
 
Two ~3 kb DNA fragments were amplified from the pPC025 plasmid vector using 
Phusion High-Fidelity DNA Polymerase (NEB) and following the manufacturer’s 
guidelines. Two pairs of primers were used to amplify the fragments (YCp2391-
YCp2392 and YCp2393-YCp2394; all primer DNA sequences are listed in the 
Supplementary Table 1.1.1 in Appendix 1.1). The two resulting DNA amplicons 
harboured terminal 40 bp homologies and spanned the complete pPC025 sequence. 
DNA assembly junctions were located within an ampicillin resistance gene (bla) and 
a red fluorescent protein reading frame, therefore providing means for antibiotic 
selection and colorimetric confirmation of successful DNA assemblies. Successful 
PCR amplification was confirmed by gel electrophoresis and the PCR products were 
extracted from the agarose gel and purified. Triplicate 50 nL, 250 nL, 500 nL, 1 μL 
and 20 μL (positive control) Gibson assembly reactions were set up with the Echo 
acoustic dispenser in a pre-chilled destination microplate (except for the positive 
control experiment, which was set up manually) and incubated at 50°C for 1 hour. As 
the Echo 550 dispenser transfers liquids with 2.5 nL droplets, accurate setup of the 
smallest reaction systems was challenging (a 50 nL volume constitutes of only 20 
droplets). Therefore, volumes of some reaction components had to be rounded up or 
down to obtain liquid amounts corresponding to multiples of 2.5 nL (Supp. Table 
1.1.2 in Appendix 1.1) 
 
2.2.2.2 Golden Gate Assembly 
 
Golden Gate DNA assembly experiments aimed at cloning a 500 bp yeast promoter 
(pMBP1) into a ~3 kb plasmid acceptor vector (HcKan_P). The acceptor plasmid 
encoded a red fluorescent protein ORF flanked by outward facing BsaI endonuclease 
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recognition sites. The pMBP1 fragment was amplified from purified BY4741 yeast 
genomic DNA with primers YCp2395 and YCp2396, using a similar PCR protocol 
to the nanolitre Gibson assembly experiments. DNA amplification flanked the 
promoter part with inward facing BsaI endonuclease recognition sites. Subsequent 
restriction digestion of the plasmid vector and amplicon DNA with BsaI led to 
generation of compatible 4 nt ssDNA overhang sequences allowing assembly of the 
promoter part into HcKan_P and replacing the red fluorescent protein reading frame. 
The amplified promoter DNA was purified using the PureLink PCR Purification Kit 
(Thermo Fisher Scientific) and used to set up the nanolitre DNA assemblies. 
Triplicate 50 nL, 250 nL, 500 nL, 1 μL and 7.5 μL (positive control) Golden Gate 
assemblies were set up similarly, using the acoustic dispenser, and subjected to the 
assembly thermal cycling protocol (Supp. Table 1.1.3 in Appendix 1.1). 
 
2.2.2.3 Bacterial Transformation of the Assembled DNA 
 
Assembled DNA was next transformed into MAX Efficiency DH5α Competent 
Cells using the chemical DNA transformation method. However, there were several 
differences in the transformation protocol. Specifically, 20 μL of thawed competent 
cells were added to microplate wells containing the nanolitre reactions, as it was not 
feasible to pipette these out of the microplate. Following the heat shock procedure, 
conducted in a thermal cycling machine, 200 μL of SOC medium were added to each 
DNA transformation well. Microplates were then incubated at 37°C for 1 hour with 
200 rpm shaking. 100 μL of the recovered bacterial cells were plated onto selective 
LB media (Gibson assembly – w/ carbenicillin, Golden Gate DNA assembly – w/ 
kanamycin). The resulting inoculated solid media were incubated at 37°C overnight. 
Only red colonies were expected to grow following the Gibson assembly 
experiments, and indicated correct DNA assemblies. Both red and white colonies 
were anticipated from the Golden Gate assemblies where white colonies indicated 
successful assembly.  
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2.2.2.4 Validation of the Assembled DNA 
 
1-2 bacterial clones (red – Gibson method, white - Golden Gate method) were 
verified for each successful miniaturised assembly. Assembled plasmid DNA was 
extracted from these and purified. The purified plasmids had both of their assembly 
junctions sequenced by Sanger sequencing to validate successful and correct 
(without mutations) DNA assembly. 
 
2.2.3 Nanolitre PCR Reactions 
 
The HcKan_P vector (120 ng/µL) was used as a template in the nanolitre PCR 
experiments, and a pair of primers (YCp2214 and YCp2215) was designed to 
amplify its red fluorescent protein reading frame region (1,378 bp). GoTaq Green 
Master Mix (Promega) was used to amplify the target nucleic acid fragment. 50 nL, 
250 nL, 500 nL, 750 nL, 1 µL and 10 µL (positive control) PCR reactions were set 
up in quadruplicate, using the Echo acoustic dispenser and a pre-chilled destination 
microplate (details of the reaction setups are in the Supp. Table 1.1.4 in Appendix 
1.1). The reactions were loaded into a pre-heated thermal cycler and the following 
thermal cycling protocol was run: 2 min at 95°C, 32 cycles of 10 sec at 95 °C, 30 sec 
at 50°C and 2 min at 72°C, 7 min at 72°C, and final storage at 4°C. Once finished, 5 
µL of nuclease-free water was added to each reaction to facilitate their recovery from 
the microplate. The resulting ~5-6 µL solutions, together with the positive control, 
were analysed by agarose gel electrophoresis. 
 
2.3 Chapter 4 Materials and Methods 
 
2.3.1 Single-Gene CRISPR Knockout Experiments 
 
2.3.1.1 CRISPR Plasmid Construction 
 
The ADE2, CAN1 and SEN34 gene knockout cassettes were ordered as Ultramer 
DNA oligonucleotides (details of the corresponding crRNA sequences are in the 
Supp. Table 3.1.1 in Appendix 3.1). For the HDR and NHEJ tests, ssDNA gene 
knockout cassettes were amplified and flanked with 50 bp CRISPR library vector 
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homologies via PCR. PKp001 and PKp002 primers and Phusion High-Fidelity DNA 
Polymerase (NEB) were used. The manufacturer’s protocol was followed. 
Amplification products were run on a 2% w/v agarose gel. DNA from correct size 
bands was extracted and purified. The resulting cassettes were next cloned into SapI 
restriction enzyme-linearised pGZ110 (with LEU2 marker) CRISPR system plasmid 
using the Gibson method. The assembly products were transformed into chemically-
competent One Shot TOP10 E. coli. Transformant cells were plated onto LB w/ 
carbenicillin plates and incubated overnight at 37°C. Several clones were later picked 
per construct and their plasmid DNA was subjected to Sanger sequencing 
verification of the insert region. Correct plasmid isolates were used in the subsequent 
yeast knockout experiments. For the HDR positive control experiments, double-
stranded donor DNA was prepared by annealing equimolar amounts of forward and 
reverse Ultramer DNA strands in a thermal cycler (program used: 95°C for 5 min, 
cool down at a ramp rate of 0.1°C/sec to 25°C and hold at 25°C for 5 min). 
 
2.3.1.2 Yeast Transformation with CRISPR Plasmids 
 
BY4741 yeast strain was transformed with the constructed DNA. Each 
transformation was set up in duplicate and contained 200 ng of plasmid DNA and, if 
applicable, 2 µg of the 90 bp double-stranded oligo DNA donor. Dilution series of 
transformant cells were plated onto SC-Leu medium plates. 
 
2.3.1.3 CRISPR Knockout Efficiency Assessment 
 
All SC-Leu plates were incubated for 3 days at 30°C. Following this incubation 
period, the total number of colonies recovered after each transformation was 
recorded for all CRISPR deletion tests as well as the negative control (empty 
pGZ110 plasmid). For the ADE2 knockout tests, the plates were in addition 
refrigerated at 4°C for up to a day to facilitate red pigment development and the ratio 
of red (mutant) to white clones (a knockout efficiency measure) was quantified. For 
the the CAN1 knockout tests the plates were replica plated onto SC-Arg-Leu plates 
with canavanine (final conc. = 50 mg/L) and the resulting replica plates were further 
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incubated at 30°C for 2 days. Ratio of colony counts on plates with and without 
canavanine was computed as the knockout efficiency measure. 
 
2.3.1.4 Further DNA Sequencing Validation of the Gene Mutants 
 
The ADE2 gene mutant colonies (plasmid HDR donor and barcoded plasmid HDR 
donor tests) were subsequently subjected to an extra DSB locus Sanger sequencing 
validation step to confirm 8 bp deletions and barcode insertions, respectively. In 
order to investigate the corresponding genomic DNA regions using the Sanger 
sequencing method they had to be first amplified. Mutant yeast colonies were used as 
colony PCR templates. Each colony was suspended in 50 μL of 20 mM NaOH and 
incubated at 95°C for 5 min. 10 μL of the resulting lysate was next used in a 50 μL 
PCR reaction following the GoTaq Green Master Mix (Promega) protocol with an 
extended 1.5 min annealing step and using primers PKp003 and PKp004. Correct 
amplification was assessed by gel electrophoresis. The remaining amplicon DNA 
was purified using the PureLink PCR Purification Kit (Thermo Fisher Scientific) and 
used as a template in the Sanger sequencing verification. 
 
2.3.2 Genome-wide CRISPR Knockout Experiments 
 
2.3.2.1 CRISPR Deletion Library Cloning 
 
2.3.2.1.1 Oligonucleotide Pool Amplification and Purification 
 
A lyophilised DNA library was re-suspended in ddH2O to a final concentration of 50 
nM as storage stock. A 5 nM working stock was prepared through a 10-fold dilution 
of the storage stock. The library DNA was amplified and flanked with 50 bp cloning 
vector (pGZ110 with URA3 marker) homologies via PCR, using 20 μL of 5X 
Herculase II Reaction Buffer (Agilent Technologies), 4 μL of the working stock 
(0.02 pmol), 1 μL of dNTP mix (final conc. of 0.25 mM/dNTP; NEB), 2.5 μL of 10 
μM forward (PKp001) and reverse (PKp002) primers, 1 μL of Herculase II Fusion 
DNA Polymerase (Agilent Technologies) and 63 μL of nuclease-free ddH2O for a 
total reaction volume of 100 μL. A 15 cycle thermal cycling protocol was followed: 
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3 cycles of 95°C for 20 sec, 50°C for 20 sec and 72°C for 30 sec, 12 cycles of 95°C 
for 20 sec, 56°C for 20 sec and 72°C for 30 sec, followed by a final storage at 4°C to 
avoid entering the PCR saturation phase and therefore prevent DNA amplification 
bias (Aird et al., 2011). Amplicon DNA was run on a high-resolution 2% w/v 
MetaPhor agarose gel (Lonza) to confirm successful PCR amplification. A correctly 
sized DNA band was extracted from the gel and purified. 
 
2.3.2.1.2 Cloning of the Amplified Pool and Purification of the Plasmid Library 
 
The amplified library cassettes were cloned into SapI-linearised pGZ110 CRISPR 
vector, using the Gibson method. A 3:1 molar ratio of insert to vector DNA was 
followed. The assembled DNA was electroporated into SURE Electroporation-
Competent E. coli Cells. The number of electroporations performed was based on 
efficiency of the test DNA assemblies and aimed at sufficient library representation 
(~20-fold). The transformed cells were pooled in a pre-chilled tube (kept on ice) and 
vortexed briefly. 400 μL aliquots of the resulting cell suspension were each plated 
onto a single 150 x 15 mm LB w/ carbenicillin medium plate. Plates were incubated 
at 37°C for 18 hours. The colonies were well-separated, to avoid excessive 
competition for growth resources and therefore growth bias. The colonies were 
scraped off the agar plates with 2 x 5 mL of cold LB medium and the resulting cell 
suspensions were transferred to a common pre-chilled bottle and kept on ice. The cell 
pool was mixed by swirling. Aliquots were made and E. coli cells were pelleted by 
centrifugation. The pellets were stored at -20°C until plasmid DNA extraction. 300 
mg wet cell weight pellet portions (approx. 3 ×	1011 cells) were used per single 
plasmid DNA extraction. Qiagen Plasmid Maxi Kit was used to purify the plasmid 
library. DNA yield and quality were assessed by the NanoDrop spectrophotometer 
(Thermo Fisher Scientific) and gel electrophoresis. 
 
2.3.2.2 CRISPR Library Yeast Transformation 
 
BY4741 was transformed with the purified plasmid pool, so that ~50-100 colonies 
were obtained per plasmid. The yeast transformation protocol was appropriately 
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scaled up to accomplish this coverage, and 5 μg of plasmid DNA were transformed 
per each ten ODUs used in the transformation procedure. Transformant cells were 
plated onto the large SC-Ura media plates and the plates were incubated at 30°C for 
4 days. A small portion of cells was also plated onto two small SC-Ura media plates 
to assess coverage of the CRISPR library. 
 
2.3.2.3 First CRISPR Library Screen in Yeast 
 
Following the plate outgrowth period, yeast cells were harvested from the large Petri 
dishes by scraping them with 2 ×	5 mL of sterile cold 15% w/v glycerol solution 
using sterile L-shaped spreaders. The scraped cells were stored in a sterile bottle and 
kept on ice until all plates were processed. The resulting cell mixture was mixed by 
swirling and aliquoted into cryovials, which were later flash-frozen on dry ice and 
stored at -80°C as glycerol stocks. Serial dilutions of a small sample were also 
performed to assess cell concentration with spectrometry. One glycerol stock was 
later thawed and re-suspended in pre-warmed YPD medium and the re-suspended 
cells were transferred to a pre-warmed 1 L flask, containing 200 mL of the rich YPD 
medium (pre-warmed glassware was always used, filled up to 20% of its volume, to 
ensure good aeration). Cell concentration of this starting culture was measured with a 
spectrophotometer and did not exceed a 1 ODU/mL concentration (2 × 10= library 
coverage). Further sub-culturing steps aimed at a starting cell concentration of 0.1 
ODUs/mL. The YPD culture was incubated at 30°C with 200 rpm shaking until mid-
logarithmic cell growth was observed. A portion of cells was washed with sterile 
water and sub-cultured into 200 mL of pre-warmed plasmid counter-selection 
medium (SC complete medium w/ 5-Fluoroorotic acid). A portion of yeast cells (50 
ODUs) was also washed with nuclease-free water, pelleted by centrifugation and 
stored at -20°C until DNA extraction. Again, cells were allowed to grow in the 
minimal counter-selection medium until mid-logarithmic phase and were sub-
cultured into the same medium until the counter-selection period reached 24 hours. 
Once the plasmid counter-selection was completed, again a 50 ODUs portion of cells 
was washed, pelleted and stored at -20°C. Three more portions were washed with 
sterile water. One of them was sub-cultured into pre-warmed YPD medium (200 mL) 
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and serial dilutions of two others were plated onto both SC complete and SC-Ura 
plates to confirm successful plasmid loss. Plates were incubated at 30°C for 3 days, 
while the liquid yeast culture was similarly grown until mid-logarithmic phase. 
Following the rich medium outgrowth, once again, 50 ODU of cells were collected, 
washed and stored at -20°C. Once the three days plate outgrowth was completed, on 
the other hand, growth on both auxotrophic and non-auxotrophic minimal media was 
assessed and the ratio between the SC-Ura and the SC complete media yeast colony 
counts was computed to assess the magnitude of the CRISPR plasmid loss. Once 
confirmed, total DNA was extracted from all of the frozen 50 ODU cell pellets using 
the phenol-chloroform extraction method. 
 
2.3.2.4 Yeast Library Screens with an Additional Plasmid-selective Outgrowth 
 
To assess whether more time was needed for the plasmid-encoded CRISPR system to 
introduce the designed gene knockouts, a second library glycerol stock was 
recovered (as described above). The same sub-culturing and sample collection 
procedure was followed, however this time the library was grown in plasmid-
selective SC-Ura liquid medium. Cell samples were collected at two timepoints, at 
48 and 96 hours. Total DNA (including plasmid and genomic DNA) was extracted 
using the phenol-chloroform method. 
 
2.3.2.5 NGS Sequencing Library Preparation, Purification and Quantification 
 
2.3.2.5.1 Illumina Sequencing Library Preparation 
 
Illumina next-generation sequencing libraries were constructed by initial 
amplification of the barcode sequences from the plasmid or yeast (total or genomic) 
DNA. PAGE-purified forward P5 and reverse P7 w/ BC1-10 primers were used to 
amplify barcode DNA, and encoded read 1 or read 2 Illumina sequences as well as 
the P5 and P7 flow cell adapters. Reverse primers harboured additional 6 bp Illumina 
index sequences. Different index sequences were used in amplification of samples 
coming from different growth condition tests. Amplified samples could therefore be 
mixed and sequenced together in a single NGS run. Q5 High-Fidelity DNA 
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Polymerase (NEB) was used to perform PCR amplification according to the 
manufacturer’s instructions. For the plasmid DNA templates, a 22-cycle thermal 
protocol was used. For the yeast DNA samples, the number of cycles was increased 
to 28. Efforts were made to minimize the number of DNA amplification cycles to 
avoid reaching the PCR plateau phase, which can lead to barcode abundance bias 
(Aird et al., 2011). Decreasing the number of PCR cycles can however be impeded 
by, e.g., poor DNA template purity, in which case the cycle number might have to be 
increased to achieve a high enough yield for the downstream protocol steps. 
Increasing DNA template concentrations, reaction volumes or setting up replicate 
PCR reactions can also help remedying any yield issues. 
 
2.3.2.5.2 Illumina Sequencing Library Purification 
 
A small portion of each PCR reaction sample was next run on a high-resolution 2% 
w/v MetaPhor agarose gel (Lonza) to confirm efficient amplification of 266-271 bp 
NGS library cassettes. The remainder PCR reaction volumes were purified using 
AMPure XP magnetic beads (Beckman Coulter). A 1:1.3 DNA sample to beads ratio 
was followed and the protocol was carried out using the DynaMag-2 Magnet 
(Thermo Fisher Scientific), according to the manufacturer’s instructions. 
 
2.3.2.5.3 Illumina Sequencing Library Quantification 
 
The eluted amplicon DNA was next quantified with the Qubit fluorometer (Thermo 
Fisher Scientific), using the double-stranded DNA HS Assay Kit (Thermo Fisher 
Scientific). An additional qPCR DNA quantification was performed as well, using an 
Illumina-compatible qPCR master mix kit, from Kapa Biosystems (cat. no: 
KK4854). The manufacturer’s protocol was followed. This extra measurement step 
allowed assessment and quantification of specific DNA amplification, as opposed to 
the previous total dsDNA assessment. Results of both quantification protocols should 
however be consistent, as any DNA misquantification errors can lead to over- or 




2.3.2.6 NGS Runs and Raw Sequencing Data Processing 
 
2.3.2.6.1 Illumina DNA Sequencing 
 
The Illumina MiniSeq sequencer was used to perform paired-end sequencing of the 
CRISPR barcode cassettes. Illumina MiniSeq High Output Reagent Kits (75 cycles) 
were used. These kits achieve a maximum output of 25 million reads per run. 
Therefore, to achieve an approximate 100X read depth per barcode sequence, up to 
10 DNA samples were typically processed by a single NGS procedure. Prior to NGS, 
the barcode amplicon samples, tagged with the different 6 bp indices, were mixed to 
yield an equimolar 10 nM sequencing library. This library was later further diluted, 
denatured, neutralised and combined with Hybridization Buffer, according to the 
Illumina Denature and Dilute Libraries Guide (URL: 
https://support.illumina.com/content/dam/illumina-
support/documents/documentation/system_documentation/miniseq/miniseq-
denature-dilute-libraries-guide-1000000002697-00.pdf). The prepared mixed 
sequencing library was loaded into a previously thawed and mixed Illumina 
cartridge, which was then inserted together with a clean flow cell into a primed 
sequencing machine. Optionally, the NGS sample can also be supplemented with a 
suitable amount of a PhiX control from Illumina (cat. no: FC-110-3001), as per the 
above guide instructions. Such a DNA “spike-in” can be harnessed as an NGS 
clustering reaction or a sequencing error control. Alternatively, it can also introduce 
sequence diversity to DNA samples lacking it. 
 
2.3.2.6.2 Raw Sequencing Data Processing and Mining 
 
Raw FASTQ format sequencing files were analysed and used to align read 1 and 
read 2 sequences to the reference 27,000 oligo pool list. A Python script was written 
to convert this list to a FASTA file. Bowtie 2 software was then used to create a 
reference alignment library, which was later used to perform a paired-end read 
alignment of the FASTQ read files. SAM format alignment files were obtained and 
analysed using a Python script, to compute number of sequencing reads per barcode 
in the CRISPR library. Barcode read depths were next used as proxies for 
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investigating individual gene deletion mutant viability in different environmental 
conditions. Python scripts were used to further analyse the barcode read count 
datasets. 
 
2.3.3 Development of a Novel NGS Library Preparation Procedure 
 
2.3.3.1 Construction of a Yeast Strain Encoding the New Barcode System 
 
In order to construct a yeast strain carrying the proof-of-concept barcode cassette, a 
CRISPR homology-based DNA insertion method was used. A previously constructed 
plasmid, targeting the ADE2 reading frame, was used to introduce a double-strand 
break in the yeast genome, which was later repaired with a double-stranded 
oligonucleotide donor harbouring the new barcode cassette. Donor DNA (139 bp) 
was purchased as a gBlock. 200 ng of plasmid DNA was co-transformed with 2 μg 
of the donor fragment into the BY4741 strain. A sample of red (putative) mutant 
colonies was collected and, as previously, subjected to colony PCR amplification of 
the ADE2 gene locus region, followed by gel electrophoresis verification, amplicon 
PCR purification and Sanger sequencing of the amplicon fragment. A single yeast 
clone containing a correct barcode insertion was used in the downstream new 
protocol testing experiments. 
 
2.3.3.2 Purification and Quantification of Test DNA Templates 
 
Genomic DNA was extracted from the positive barcode-containing yeast strain using 
the phenol-chloroform method and served as one of the two DNA templates in the 
new protocol tests. The second template was obtained by amplification of a 775 bp 
genomic DNA region, centrally-encoding the barcode cassette. Q5 High-Fidelity 
DNA Polymerase (NEB) and primers PKp005 and PKp006 were used to amplify the 
target genomic DNA fragment. The manufacturer’s instructions were followed. 
Correct amplicon size was confirmed by running a small portion of the finished PCR 
reaction on an agarose gel. Once confirmed, the remaining DNA was purified using 
the QIAquick PCR Purification Kit (Qiagen). Large quantities of both template 
samples were used in the downstream tests (1 μg of each per test) and therefore 
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replicate extraction and amplification reactions were set up. Purified DNA was then 
accurately quantified using the Qubit fluorometer and the dsDNA HS Assay Kit 
(Thermo Fisher Scientific). 
 
2.3.3.3 Streptavidin Magnetic Beads-bound Reactions 
 
2.3.3.3.1 Pre-protocol Preparation 
 
Streptavidin Magnetic Beads (NEB) and the DynaMag-2 Magnet (Thermo Fisher 
Scientific) were used to perform bead-bound enzymatic reactions. Prior to starting 
the protocol, magnetic beads were brought to room temperature and the required 
buffers were prepared (Wash/Bind, Low Salt and Elution Buffers) according to the 
manufacturer’s instructions. The Low Salt and Elution Buffers were later pre-chilled 
and pre-warmed (to 70°C), respectively. 
 
2.3.3.3.2 Biotinylated ssDNA Elongation 
 
The initial biotinylated ssDNA elongation step was performed using Q5 High-
Fidelity DNA Polymerase (NEB) and a biotinylated primer (PKp007). A 50 μL 
reaction was set up and included 10 μL of 5X Q5 Reaction Buffer (NEB), 2.5 μL of 
10 μM biotinylated primer DNA, 1 μg of either of the DNA templates (genomic or 
amplicon DNA), 1 μL of a 10 mM dNTP mix (NEB), 0.5 μL of Q5 High-Fidelity 
DNA Polymerase, and nuclease-free water up to a 50 μL volume. The elongation 
reaction was performed in the ProFlex PCR System thermal cycler and consisted of a 
single thermal cycle: 3 min denaturation at 98°C, rapid cool down to 72°C (6°C/s), 
slow cool down to 50°C (0.1°C/s) and a 30 sec hold at 50°C (DNA annealing step), 
rapid ramp to 72°C (6°C/s), with a 15 min incubation (a prolonged extension step), 
and a rapid ramp (6°C/s) to 98°C, followed by a final 3 min 98°C denaturation step. 
Once the program was completed, PCR tubes were immediately put on ice to keep 
the DNA strands denatured.  
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2.3.3.3.3 Setup of the Bead-bound Reaction System 
 
Bead-containing 1.5 mL PP reaction tubes were next prepared. 50 μL of mixed 
streptavidin magnetic beads were aliquoted into two tubes. The magnet was then 
applied to the side of each tube for approx. 30 sec and the bead storage buffer was 
removed. A bead wash cycle was next performed. 100 μL of Wash/Binding Buffer 
were added to each tube, the tubes were vortexed to suspend the beads, the magnet 
was applied for approx. 30 sec and the supernatant was discarded. The elongation 
DNA products were transferred into their respective tubes and the resulting DNA-
bead mixtures were vortexed briefly and incubated at room temperature for 5 min, 
with occasional agitation by hand. Following the incubation step, the magnet was 
applied to the side of each tube and the supernatants were carefully removed. Two 
wash cycles (as above) were performed. 
 
2.3.3.3.4 ssDNA 5’ End Phosphorylation 
 
The first bead-bound reaction was the 5’ end phosphorylation. A single 
phosphorylation reaction mix included 5 μL of 10X T4 PNK Reaction Buffer (NEB), 
5 μL of 10 mM ATP (Illumina), 1 μL of T4 Polynucleotide Kinase (NEB) and 39 μL 
of  nuclease-free water (up to a total volume of 50 μL). Once prepared, this was 
added to each tube and the resulting reaction mixtures were mixed by vortexing. The 
tubes were then incubated at 37°C for 30 min, with occasional agitation by hand. 
Once the phosphorylation reactions were completed, the magnet was applied and the 
supernatants were discarded. Two wash cycles (as above) were performed. 
 
2.3.3.3.5 ssDNA Circularisation 
 
Single-stranded DNA circularisation was the next enzymatic step. Two 
circularisation reaction mixes were set up, containing: 5 μL of 10X CircLigase II 
Reaction Buffer (Illumina), 2.5 μL of 50 mM MnCl2, 2.5 μL of CircLigase II ssDNA 
Ligase (Illumina) and 40 μL of nuclease-free water (a 50 μL reaction). Once 
prepared, they were added to the bead-containing tubes. The resulting reaction mixes 
were vortexed briefly and incubated at 60°C for 1 hour, with occasional agitation by 
 
 76 
hand. Following this incubation period, the magnet was applied, the supernatants 
discarded and, again, two wash cycles were performed. 
 
2.3.3.3.6 DNA Linearisation 
 
A single-stranded oligonucleotide (PKp008) was subsequently annealed to the 
circularisation DNA products at a pre-designed BamHI restriction site, to allow DNA 
linearisation. Each 49 μL annealing mix contained 5 μL of 10X NEB 3.1 Buffer 
(NEB), 1.5 μL of 10 μM oligonucleotide DNA and 42.5 μL of nuclease-free water. 
The mixes were dispensed into the PP tubes, and their contents were mixed and 
incubated at 95°C for 5 min in a heat block. Once the incubations were completed, 
the heat block was switched off and allowed to passively cool down to room 
temperature. This process took up to 1 hour and the tubes were thus, during this time, 
agitated by hand several times. 1 μL of BamHI restriction endonuclease was next 
added to each tube. The tubes were vortexed briefly and incubated at 37°C for 30 
min, with occasional mixing. Following the linearisation reaction, the magnet was 
applied and the supernatants were discarded. Two wash cycles were performed. 
 
2.3.3.3.7 DNA Elution and Precipitation 
 
The linearised DNA products were eluted off the magnetic beads. First, a DNA wash 
with cold Low Salt Buffer was performed. 25 μL of pre-warmed (70°C) Elution 
Buffer were next dispensed into each tube. The tubes were quickly vortexed and 
incubated at room temperature for 2 min. The magnet was applied to the side of each 
tube and the supernatants were carefully collected to clean PP tubes. This elution 
procedure was then repeated one more time. The resulting 50 μL eluents were later 
precipitated, using the ethanol precipitation method, and re-suspended in 10 μL of 
nuclease-free water.  
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2.3.3.4 Test Sequencing Library Amplification, Purification and Validation 
 
2.3.3.4.1 PCR Amplification 
 
The Q5 High-Fidelity DNA 2X Master Mix (NEB) was used to amplify the 
linearised DNA. PCR reactions contained 10 μL of nuclease-free water, 2.5 μL of 
each of the standard Illumina read 1 and read 2 primers, containing their respective 
P5 and P7 flow cell adapters (P5 and P7 w/ BC1), 10 μL of either of the DNA 
samples and 25 μL of the Q5 High-Fidelity DNA 2X Master Mix (final reaction 
volume of 50 μL). A 30-cycle PCR program was used :98°C for 30 sec; 30 cycles of 
98°C for 10 sec, 68°C for 20 sec and 72°C for 15 min; 72°C for 2 min and a final 
4°C incubation. 
 
2.3.3.4.2 Gel Electrophoresis and Nucleic Acid Extraction 
 
PCR products were run on a 3% w/v agarose gel of 100 V for 40 min. Entire reaction 
volumes were loaded into the gel wells. Following the electrophoretic separation, the 
resulting DNA smears were extracted from the gel matrix. Caution was taken to omit 
gel areas below 200 bp as indicated by the 50 bp DNA ladder, as these were likely to 
contain primer dimer DNA (Illumina read primers share a 13 bp 3’ end homology). 
 
2.3.3.4.3 Blunt-end Ligation and Sanger Sequencing of the PCR Products 
 
4 μL of each of the two purified DNA smears (40% of the total amplicon library) 
were ligated to a plasmid vector using the Zero Blunt TOPO PCR Cloning Kit 
(Thermo Fisher Scientific). Total 6 μL reaction mixture volumes were next 
transformed into 100 μL of the commercial One Shot TOP10 E. coli cells. The 
resulting transformant cells were then plated onto LB media plates with 50 μg/mL 
kanamycin and incubated at 37°C overnight. 12 colonies were next picked per DNA 
template test (24 colonies in total) and plasmid DNA was extracted. The DNA inserts 
were then sequenced using the Sanger sequencing method and a standard M13 




2.4 Chapter 5 Materials and Methods 
 
2.4.1 Development of the Monte Carlo Simulation Software 
 
Pandas Python library was used to parse and analyze Microsoft Excel spreadsheets. 
The SciPy library (scipy.stats.truncnorm.rvs function) was used to sample random 
manufacturing step durations from the truncated normal distributions. The NumPy 
library was used to perform other general statistical analyses, e.g., percentile 
calculations. Datetime Python module was needed to conduct calendar date-aware 
simulation studies. Matplotlib and Seaborn libraries were later used for plotting 
simulation results data.  
 
2.4.2 DNA Sequence Data Mining and Classification 
 
Primer3 and ViennaRNA Python programming packages were used to analyze 
nucleic acid thermodynamics, i.e., calculate primer hairpin and PCR amplicon free 
energies, respectively. The nearest-neighbour method was used to calculate primer 3’ 
end - PCR template duplex free energies (Watkins et al., 2005). Scikit-learn Python 
package was used to conduct machine learning studies. Prior to application of the 
machine learning algorithm, GC content and DNA sequence length data was 
standardised by dividing nucleic acid features by arithmetic means of the 
corresponding datasets. Sklearn.svm.SVC class was used to perform support vector 
classification, with kernel, C (regularisation parameter) and gamma (kernel 
coefficient) parameters chosen by the sklearn.grid_search.GridSearchCV, a 
hyperparameter assessment method which used a default three-fold cross-validation. 
To make it possible to estimate probabilities of belonging to a given data class (i.e., 
failed gene synthesis or successful gene synthesis), SVC classification object’s 
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3.1 Work Contributions 
 
Work presented in this chapter was published in the Journal of Laboratory 
Automation (Appendix 2.4) (Kanigowska et al., 2016). 
 
Together with Yue Shen, I performed the nanolitre DNA fabrication and endpoint 
PCR experiments, analysed data and wrote the published manuscript. Besides the 
DNA assembly reagent cost calculations, described in the manuscript, I also 
performed additional expected reagent cost calculations, taking into account failure 
rates of the nanolitre DNA assemblies tested. Yijing Zhang helped in setting up the 
acoustic dispensing instrument. Prof. Yizhi Cai wrote the published manuscript and 









High-throughput DNA manufacturing requires more economical approaches to liquid 
handling. To date, DNA has been assembled mainly in microlitre-scale reactions 
(Kong et al., 2012). However, there is an interest in scaling their volumes down to a 
nanolitre range, as such miniaturisation would reduce the use of expensive enzymatic 
components and valuable DNA parts and therefore lead to cost savings, as well as 
establishment of more scalable DNA fabrication methodologies (Ellson et al., 2016; 
Gach et al., 2017). 
 
Today, tip-based methods are a dominant approach towards liquid handling, but are 
unable to accurately transfer sub-microlitre volumes. Moreover, due to their strong 
dependence on disposable tips, they are expensive and unsustainable, i.e., generating 
large amounts of plastic waste (Kong et al., 2012; Ellson et al., 2016). Fixed tips 
eliminate the costs associated with disposable tips, however as they still require 
physical contact to transfer liquids their usage necessitates thorough wash cycles to 
prevent any contamination issues (Fregeau et al., 2007). Pin tools are liquid handling 
instruments which similarly require contact with biological samples and the reagents 
used and thus also involve precise cleaning procedures. However, they are able to 
accurately transfer nanolitre amounts of liquid. Nevertheless, various physical factors 
have to be appropriately adjusted and controlled to ensure accurate transfer of 
volumes as small as ~2 nL. For instance, pin diameter, size of the pin slots/grooves 
(if applicable) which take up liquid material through capillary action, pin dwell time 
in an empty destination well, retraction speed and immersion depth (both in the 
source and destination liquids) are some of the parameters which have to be 
considered. Furthermore, pin tool instruments are not practical when several different 
liquid volumes have to transferred in a single liquid handling workflow, since this 
would require exchanging pin arrays (Cleveland and Koutz, 2005). Microfluidic 
chips are an alternative to large liquid handling workstations and have been used to 
downscale DNA assembly (Patrick et al., 2015; Gach et al., 2017; Khilko et al., 
2018). For instance, Khilko et al. demonstrated a sub-microlitre (600 nL) protocol 
consisting of a 12 DNA parts Gibson Assembly, PCR and enzymatic error correction 
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of a human influenza virus hemagglutinin gene (339 bp-long), using a commercial 
digital microfluidics device, while Patrick et al. demonstrated a 2 DNA parts 
nanolitre (490 nL) Golden Gate assembly of a plasmid, using a cheaper 3D printed 
microfluidics chip (Patrick et al., 2015, Khilko et al., 2018). Synthetic DNA has also 
been recently assembled in picolitre volumes. Plesa et al. has demonstrated assembly 
of more than 7,000 genes, using barcoded beads co-localizing individual DNA 
assembly array-synthesised oligonucleotides in picolitre droplets (Plesa et al., 2018). 
Such microfluidic and water-in-oil emulsion methodologies however require 
significant expertise and therefore are not yet readily accessible to researchers. 
 
Contactless acoustic liquid handling methodologies are also able to handle nanolitre 
volumes with high accuracy (Ellson et al., 2016). These methods are easy to use and 
are based on the acoustic droplet ejection phenomenon (ADE), which involves sound 
waves causing ejection of discrete liquid droplets. ADE phenomenon has been, e.g., 
exploited by the inkjet printing industry and since the early 2000s has been 
progressively employed by life sciences, mainly by compound library screening 
procedures (Dawes et al., 2016). 
 
This project therefore applied acoustic liquid transfer technologies to miniaturise 
DNA assembly. Using an acoustic liquid transfer instrument, dispensing 2.5 nL 
droplets with high frequency, two popular DNA fabrication methods, the Gibson and 
the Golden Gate methods, as well as a common DNA validation method, endpoint 
PCR, were miniaturised down to 250, 50 and 250 nL, respectively. Reaction 
miniaturisation efforts led to up to a ~200-fold reduction of reagent costs and thus 
paved the way towards more cost-efficient high-throughput DNA construction. This 
chapter further discusses how this ultimate goal can be achieved, taking into account 







To test reaction miniaturisation limits of the Gibson and Golden Gate DNA assembly 
reactions their volumes were downscaled to 50 nL, 250 nL, 500 nL and 1,000 nL, 
using the Echo 550 acoustic dispenser. This corresponded to 20-400- and 7.5-150-
fold miniaturisation of the Gibson and Golden Gate methods, respectively, as 
compared with the reaction volumes of the positive control nucleic acid assemblies 
(Fig. 3.2 and 3.4).  
 
3.3.1 DNA Assembly Methodology 
 
As miniaturisation of DNA assembly reactions had not been previously demonstrated 
using the acoustic droplet ejection methodology, a minimal number of the DNA 
assembly fragments (2 fragments) was first tested. However, the DNA fragment 
design differed for the Gibson and Golden Gate DNA assemblies. For the Gibson 
assembly experiments, the two fragment junctions were placed inside a red 
fluorescent protein (RFP) reading frame and a beta-lactamase open reading frame 
(bla), conferring resistance to ampicillin (Fig. 3.1). Upon bacterial transformation, 
correct DNA assemblies therefore resulted in red E. coli colonies, capable of growth 
on a solid medium which contained ampicillin. Cells propagating incorrect DNA 
assembly products were prevented from producing red pigmentation and surviving in 
the presence of ampicillin. The Golden Gate experiments, on the other hand, aimed 
at cloning a DNA insert encoding a budding yeast promoter into a plasmid vector, 
likewise encoding a red fluorescent protein. To do that, the promoter and RFP DNA 
sequences were flanked by inward and outward facing Type IIS BsaI endonuclease 
recognition sites, respectively, generating compatible sticky ends (Fig. 3.3). Correct 
assemblies hence led to white colonies and incorrect ones to red colonies. 
 
Two types of metrics were computed to evaluate success of the miniaturisation 
experiments. For the Gibson assembly, the total number of (red) colony forming 
units (CFUs) was counted. Golden Gate DNA assemblies, in contrast with the 
Gibson experiments, yielded correct (white) and incorrect (red) colony forming units. 
The percentage of correct clones was termed assembly efficiency. Low efficiencies 
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mean that more colonies have to be tested to find correct DNA constructs, in 
scenarios without an appropriate, e.g., colorimetric, marker. To stay consistent with 





Figure 3.1 Gibson Assembly 
Methodology 
DNA assembly junctions were 
located inside the RFP and bla 
marker reading frames to facilitate 
identification of bacteria propagating 





Figure 3.2 Golden Gate Assembly Methodology 
The Golden Gate experiments aimed at cloning a budding yeast promoter into a plasmid DNA vector. 
The vector DNA harboured a DNA assembly slot, which encoded an RFP reading frame flanked by 
outward facing BsaI recognition sites and standardised DNA sticky ends. Upon successful DNA 
assembly, the RFP marker is replaced by the promoter DNA, which, likewise, was flanked by the 
restriction digestion sequences. These sequences were added through PCR and were compatible with 




3.3.2 Results of the Nanolitre DNA Assembly 
 
Using the proposed miniaturisation approach, correct DNA assemblies were 
observed at volumes as low as 50 and 250 nL, which led to proportional 150- and 80-
fold reagent cost reductions (Supp. Tables 2.1.1-3 in Appendix 2.1) for the Golden 
Gate and Gibson methods, respectively (Fig. 3.2 and 3.4). These results were 
confirmed by sequencing of the assembly junctions (Supp. Fig. 2.2.1 in Appendix 
2.2). The number of correct CFUs and the percentage efficiencies (for the Golden 
Gate miniaturisation experiments) however both decreased as the reactions were 
becoming smaller (2-fold dilutions of transformation mixes were plated). Moreover, 
the reliability of DNA assembly has also decreased and was particularly low for the 
smallest DNA assembly reactions, as indicated by considerably low mean CFU 
counts and large standard errors (exceeding the means), demonstrating that 50 nL 
Golden Gate and 250 nL Gibson DNA assemblies are not readily feasible (Fig. 3.2 
and 3.4). In order to better estimate the success rate of the smallest DNA assembly 
reactions, and thus better dissect their feasibility, more biological replicate 
experiments should be set up in the future. Results presented in this manuscript 
represent data derived from three biological replicates. 
 
The Gibson method uses a DNA polymerase which fills DNA gaps at the junction 
regions. Therefore, this DNA fabrication method can result in mutations. The 
proposed Golden Gate assembly methodology, on the other hand, posed a risk of 
obtaining false positive (white) colonies due to an illegitimate intracellular ligation 
of linear DNA under strong selective pressure (Shimizu et al., 1997). However, 
nucleic acid mutations and spurious DNA constructs were not observed in the 
plasmid DNA samples tested (1-2 colonies tested per successful DNA assembly 
experiment). More colonies however should have been tested to be able to conclude 





Figure 3.3 Results of Nanolitre Gibson Assemblies 
(A) DNA assembly is feasible in volumes as low as 250 nL. The number of colony forming units 
propagating correct plasmid DNA decreases in proportion to the decreasing reaction volumes. Three 
biological replicates were set up in each nanolitre reaction experiment and the presented error bars 
represent standard error of the mean. The corresponding reagent costs per single reaction are 
provided. (B) Correct DNA assemblies led to reconstitution of the RFP reading frame and thus red 






Figure 3.4 Results of Nanolitre Golden Gate Assemblies 
(A) DNA assembly is feasible in volumes as low as 50 nL. Two measures of DNA assembly success 
are provided, i.e., number of colony forming units (CFUs) bearing correct DNA constructs and 
percentage of white (correct) CFUs in the colony population. Both are generally decreasing in 
proportion to the decreasing reaction volumes. Three biological replicates were set up in each 
nanolitre DNA assembly experiment and the presented error bars represent standard error of the mean. 
The corresponding reagent cost prices per single reaction are provided. (B) Correct DNA assemblies 
led to replacement of the RFP reading frame and thus gave rise to white colonies. Incorrect DNA 




3.3.3 Nanolitre PCR Reactions 
 
In addition to miniaturising DNA construction, acoustic dispensing was also applied 
to downscale endpoint polymerase chain reactions (PCRs). Endpoint PCRs, along 
with other methods, such as restriction digestion, are typical assays used to test 
correctness of the DNA fabrication products, and are based on amplification of the 
DNA fragment junction regions. Acoustic liquid handling was therefore used to 
miniaturise these reactions down to 50, 250, 500, 750 and 1,000 nL. This work led to 
a successful and reproducible amplification of a ~1.4 kb DNA fragment at volumes 
as low as 250 nL (Fig. 3.5). All four biological replicates exhibited amplicons of the 
correct size. For all PCR experiments, including the positive control, the amount of 
amplicon DNA also decreased in proportion to the dropping reaction sizes (total 





Figure 3.5 Endpoint PCR Miniaturisation Experiments 
(A) Plasmid DNA PCR template and the amplicon DNA; (B) Results of the PCR miniaturisation 
experiments: DNA amplification was successful and reproducible at volumes as low as 250 nL. The 






In conclusion, the first successful application of the acoustic dispensing technology 
to downscale DNA fabrication beyond the microlitre threshold was demonstrated. 
The presented data shows that DNA assemblies can be successful in reaction 
volumes as low as 50 nL and can be as cheap as 1 British pence. 
 
Despite the low reagent costs per single DNA assembly the overall reagent expenses 
can however turn higher as the DNA construction failure rate at the lowest reaction 
scales is significant (i.e., one successful DNA construction experiment out of three 
biological replicates). As the number of experiment repetitions upon a DNA 
fabrication failure is a geometric random variable, the expected overall DNA 
fabrication costs can be computed by multiplying the expected number of repetitions 
(i.e., 1 ÷ likelihood of success) and the reagent costs per single DNA assembly. 
Therefore, for a 50 nL Golden Gate DNA assembly reaction the expected reagent 
costs are 3 × 1 p, while for a 250 nL Gibson assembly they equal to 3 × 2 p (Supp. 
Calculation in Appendix 2.3). It is however important to emphasise that the 
expected total costs of DNA fabrication depend not only on the costs of reagents, but 
also on the costs of labware used as well as on the costs of personnel involved in 
setting up the corresponding automation procedures. 
 
Volumes of 50 and 250 nL were the smallest functional Golden Gate and Gibson 
DNA construction scales. These reaction size boundaries could reflect a decreasing 
resolution of transferable liquid volumes. As the reaction components were 
dispensed in volumes which constituted multiples of 2.5 nL droplets, setting up 
equimolar mixtures of the DNA assembly fragments for the lowest reaction sizes 
tested was problematic. For instance, a 50 nL Golden Gate reaction was set up with 
20 2.5 nL droplets. The volumes required to achieve equimolar amounts of insert and 
plasmid DNA were 30 and 3 nL, respectively. However, since 3 nL is not a multiple 
of 2.5 nL, the plasmid DNA volume had to be round down to 2.5 nL (1 droplet), 




Golden Gate reaction miniaturisation experiments relied on screening bacterial 
colonies using a colorimetric marker (RFP), which allowed to estimate DNA 
assembly efficiency. However, future applications of the presented nanolitre DNA 
fabrication methodology could use a ccdB gene instead. Failure to replace this gene 
by the insert DNA, through successful DNA restriction digestion and ligation, would 
lead to expression of a toxic CcdB protein and death of cells propagating an 
undigested vector (Wang et al., 2014).  
 
As pointed out earlier, E. coli transfection with linear plasmid DNA can lead to 
growth of false positive bacterial colonies (Golden Gate experiments) (Shimizu et 
al., 1997). In the future, this issue could be mitigated by an additional treatment of 
the finished DNA assembly reactions with an exonuclease, which would digest the 
unligated plasmid (e.g., Plasmid-Safe ATP-dependent DNase from Epicentre). Such 
an enzymatic treatment would yet require an additional incubation period of the 
nanolitre reactions, which could lead to increased evaporation. Therefore, optimising 
duration of the Golden Gate thermal cycling protocol might be needed to 
accommodate this extra DNA digestion step. 
 
PCR reaction miniaturisation work has also led to downscaling endpoint PCR 
reactions, down to 250 nL. It is however uncertain whether DNA amplification has 
failed below 250 nL (at a 50 nL reaction volume) or the detection method used failed 
to detect it. According to the manufacturer, the fluorescent DNA-intercalating dye 
used (SYBR Safe DNA Gel Stain from Thermo Fisher Scientific) has a detection 
limit of 500 pg per band for DNA fragments larger than 200 bp (when viewed on a 
300 nm transilluminator), which corresponds to 336,161,661 molecules of 1,378 bp 








 is an average ?@ of 1 base pair; 500 pg thus corresponds to 0.558 fmol of 
amplicon DNA or 0.558	 ×	10)#=	XY2	 × 	6.022 × 10Z[ 	BGD\F]D\^
BGD
= 336,161,661 
molecules of amplicon DNA). The mass of template DNA used in the 50 nL reaction 
was 0.6 ng, which corresponds to 193,550,460 molecules of 2,872 bp template DNA 
(the number of template DNA molecules calculated as above). The ratio of the 
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detection threshold DNA amplicon molecule count to the starting amount of the 
template molecules used is thus 1.74. Such amplicon molecule count can be obtained 
in a single 86.8% efficient PCR cycle (the amount of DNA doubles at a 100% PCR 
efficiency, and therefore _`ab2'	cde	df42'	ghh`4`'a4f = #ii%	×	#.kl
Z
= 86.8%). It 
is therefore unlikely that the lack of the amplification signal (visible DNA gel band) 
was caused by an insensitive detection method, given 32 PCR cycles performed in 
this study. In the future, a 500 pg amplicon DNA control could be run on the agarose 






Chapter 4  
CRISPR Deletion 









4.1 Work Contributions 
 
Work presented in this chapter was a result of collaboration between the Cai Lab 
(The University of Manchester, UK), Tyers Lab (The University of Montreal, 
Canada) and the Tollervey Lab (The University of Edinburgh, UK). 
 
Under supervision of Prof. Patrick Yizhi Cai and Prof. Michael Tyers, I outlined 
design of the deletion library, performed proof-of-concept experiments, cloned the 
library, conducted genome-scale screens in budding yeast, prepared NGS sequencing 
libraries, ran NGS experiments and analysed their results computationally. Dr. 
Jasmin Coulombe-Huntington (Tyers Lab) designed nucleic acid sequences of the 
genome editing constructs and performed additional computational analyses (not 
presented in this thesis). Dr. Ghada Ghazal (Tyers Lab) helped in establishing yeast 
screen protocols and performed additional genome-scale yeast experiments (not 
presented in this thesis). Dr. Tomasz Turowski (Tollervey Lab) filtered long non-
coding RNA data, proposed the alternative NGS sequencing library preparation 
protocol and supervised setup of the NGS experiments. Dr. Thierry Bertomeu (Tyers 








Saccharomyces cerevisiae is one of the main eukaryotic organisms used by synthetic 
biologists, with applications ranging from industrial biotechnology to synthetic 
genomics (Runguphan and Keasling, 2014; L. Wang et al., 2018). To date, yeast 
metabolism has been harnessed to cost-effectively produce an antimalarial drug 
precursor, artemisinic acid, and opioid compounds, while its model eukaryote status 
as well as its ability to efficiently recombine homologous DNA strands have 
encouraged its application as a platform to build the first “designer” set of eukaryotic 
chromosomes (i.e., the Sc2.0 Project) (Ro et al., 2006; Richardson et al., 2017). 
Therefore, efficient genome engineering tools continue to be required to facilitate 
understanding, debugging and evolution of custom phenotypes (Stovicek, 
Holkenbrink and Borodina, 2017).  
 
Eukaryotic organisms, including S. cerevisiae, feature intricate genetic interaction 
networks which govern their phenotypic plasticity (Kuzmin et al., 2016). For years, 
genetic underpinnings of various phenotypes have been investigated through gene 
deletion experiments. Synthetic Genetic Array (SGA) methodology is one of the 
most established methodologies for conducting such studies genome-wide. SGA 
experiments however suffer from an extensive usage of auxotrophic and drug-
resistance markers, which are known to lead to unintentional phenotypic 
perturbations and are limited to particular S. cerevisiae strain genetic backgrounds 
(S288C) (Kuzmin et al., 2016; Leng and Song, 2016). 
 
This chapter describes development of a gene deletion library addressing these 
limitations. The library is suitable for genome editing of a broad range of wild-type 
S. cerevisiae strains as well as the Sc2.0 project strains and harnesses a novel 
genome editing approach – CRISPR. CRISPR leverages activity of an RNA-guided 
endonuclease, which introduces programmable double-stranded DNA breaks 
(DSBs). Unrepaired DSBs are lethal and necessitate repair by generally either of the 
two major DSB repair pathways – NHEJ (non-homologous end joining) or HDR 
(homology-directed repair). As opposed to NHEJ, which re-ligates broken DNA ends 
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without a reference DNA template (often leading to small indel mutations at the DSB 
sites), HDR uses a homologous DNA template (“donor DNA”) to repair DSBs and 
thus allows introduction of custom changes at the DSB loci (e.g., premature 
termination codons) without the need for genetic marker selection (i.e., unrepaired 
DSBs lead to cell death). Moreover, HDR is a preferred S. cerevisiae DSB repair 
mechanism (Jasin and Rothstein, 2013). The described gene deletion library 
approach therefore leveraged mutagenic HDR donors to knockout S. cerevisiae 
genes genome-wide. The approach was first tested via deletion of example essential 
and non-essential genes, then assessed for correct identification of characterised S. 
cerevisiae essential genes genome-wide. 
 
The library comprises 27,000 HDR donor – crRNA gene deletion DNA cassettes, 
constructed by a commercial array oligonucleotide synthesis. The HDR donor – 
crRNA pairs target every gene in the ~6,000 genes 12 Mb S. cerevisiae genome 
approximately 4-times (to maximise chances of successful gene knockout), including 
a set of appropriate positive and negative controls, as well as various characterised 
and uncharacterised RNA transcription units (TUs), e.g., the small nucleolar RNA 
(snoRNA), transfer RNA (tRNA) and long non-coding RNA (lncRNA) TUs, which 
are known to have significant impact on cellular phenotypes via guiding chemical 
modification of other RNAs, actively participate in the process of translation and 
regulate expression of other genes, respectively (Watkins and Bohnsack, 2012; Raina 
and Ibba, 2014; Wu, Yang and Chen, 2017). The target Cas protein cleavage sites 
were biased towards close proximity to transcription start sites (TSSs) by design to 
ensure efficient gene knockouts and prevent production of truncated proteins, which 
premature termination codon-bearing mRNAs escaped nonsense-mediated mRNA 
decay pathway surveillance, and designed to preserve the Sc2.0 genome synthetic 
DNA “watermark” sequences (PCRTags) as well as take into account its reduced 
stop codon set (Dymond et al., 2011). 
 
Construction of a genome-wide gene deletion library necessitated a physical link 
between the HDR donor and the crRNA sequences, so that corresponding HDR 
donors and crRNAs could co-localise in a single cell. This was done by encoding 
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both on a single plasmid (within a “gene deletion cassette”) and therefore using 
plasmid DNA as the HDR donor. While donor DNA does not require genetic 
expression to serve its function, it had to be included inside cRNA’s RNA 
polymerase III transcription unit (in contrast with the analogous prokaryotic 
CREATE system). Eukaryotic promoters are longer than their prokaryotic 
counterparts and therefore their inclusion within the synthetic oligonucleotide gene 
deletion cassette constructs was not feasible (it would lead to exceeding the 
commercial synthesis length limit) (Kristiansson et al., 2009; Garst et al., 2016; 
Clore, 2018). Feasibility of this approach was supported by previous publications, 
which demonstrated that various nucleic acid sequences, including HDR donors and 
ribozymes, can be placed upstream of crRNAs, within their TUs, without interfering 
with their post-transcriptional function - and with some likely serving protective 
purposes, due to formation of secondary structures protecting crRNAs from nuclear 
5’ RNA exonucleases (e.g., Rat1) (Houseley and Tollervey, 2009; Ryan et al., 2014). 
Furthermore, previous work showed that plasmid-encoded HDR donors can be used 
to efficiently repair double-stranded DNA breaks (DSBs), provided that there are 
sufficient intracellular plasmid copies (Bao et al., 2015). However, prior to the 
library construction effort described by this manuscript, none of the previous studies 
have tested these findings on a genome-wide scale. 
 
To efficiently delete genes and monitor behavior of the resulting knockout strains, 
HDR donors harboured internal “barcode” cassettes, integration of which at the Cas9 
cleavage sites was designed to elicit formation of premature stop codons, as well as 
partial protospacer and complete protospacer-adjacent motif deletions, to prohibit the 
Cas9 enzyme from further endonucleolytic cleavages which tend to compromise 
strain fitness and are particularly problematic during non-mutagenic HDR and NHEJ 
(Cagney et al., 2006). Genomic barcodes allowed tracking, using NGS, abundance of 
individual single-gene mutants in several heterogenous yeast mutant pools in parallel 
as well as ensuring a one-to-one correspondence of the genomic barcode and the 
underlying mutant copy number (which cannot be guaranteed with, e.g., plasmid-
encoded barcode sequences). Moreover, a second alternative method of sequencing 
barcode DNA was proposed and tested, relying on single-stranded DNA 
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circularisation, and aimed at facilitating unambiguous confirmation of successful 
CRISPR editing events. It has been shown that CRISPR can result in off-target 
genome editing (Tsai et al., 2014). Therefore, an ideal deletion library sequencing 
methodology should be able to capture DNA sequences neighbouring barcode DNA, 
in order to confirm its correct insertion. Inability to differentiate between off-target 
and correct insertions can lead to experiment noise. The alternative barcode DNA 




4.3.1 Deletion Library Design 
 
27,000 deletion cassettes were encoded on separate plasmids, which harboured all 
components of the CRISPR machinery, i.e., the homology donor – crRNA 
transcription unit and the Cas9 endonuclease expression module. The plasmids also 
encoded a two micron origin of replication, to ensure their high-copy propagation 
and thus sufficient expression of the CRISPR system and abundance of the donor 
DNA (Fig. 4.1). Human codon-optimised Streptococcus pyogenes Cas9 
endonuclease was used under control of a strong constitutive TEF1 promoter. The 
homology donor - crRNA module was put under control of the RNA polymerase III 
transcriptional machinery, employing the often used SNR52 promoter and SUP4 
terminator (Stovicek, Holkenbrink and Borodina, 2017). Polymerase III expression, 
as opposed to polymerase II, does not incorporate any undesirable RNA 
modifications, e.g., 3’ polyadenylation, which can interfere with the guide RNA - 
Cas9 ribonucleoprotein complex formation (Bentley, 2014; Turowski and Tollervey, 
2016). Polymerase III transcription can however be terminated by the presence of 
poly(T) stretches (Nielsen, Yuzenkova and Zenkin, 2013). The design parameters 
thus avoided more than 4 consecutive thymine residues in the genome targeting 
cassettes.  
 
The HDR donor portions of the gene deletion cassettes comprised two flanking 45 bp 
homologous recombination arms, corresponding to the downstream crRNA 
sequence. The arms harboured an 8 bp deletion, deleting the last 3 bp of the 
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protospacer (tampering with the last 12 bp of the protospacer sequence negatively 
impacts the RNA-guided recognition (DiCarlo et al., 2013; Jiang et al., 2013)) and 
the protospacer adjacent motif (PAM) to, as mentioned earlier, lead to efficient 
knockout of a given gene and prevent further Cas9 recognition and the burden of 
resulting DNA cleavage.  
 
The barcoding module was placed in between the 5’ and 3’ HDR donor sequences. It 
included a 16-21 base-pair barcode, identifying the target genomic locus, and two 
flanking Illumina NGS sequencing-compatible primer binding sites. Insertion of this 
module at a given cut site should mark the editing event and allow accurate tracking 
of the abundance of individual deletion mutants in complex mutant pools. As pointed 
out previously, the barcode sequences were also designed to trigger premature RNA 
translation termination by introduction of premature stop codons. Moreover, their 
varying 16-21 bp size was intentional and was designed to facilitate optical readout 
of the Illumina sequencing machine used by avoiding regions in which all 







Figure 4.1 Design of the Plasmid Library and its Mechanism of Function 
CRISPR library plasmids harboured all components of the CRISPR machinery as well as an 
homology-directed repair (HDR) donor sequence under control of the sgRNA (guide – tracrRNA) 
expression unit. The homology arm, barcode and guide DNA sequences constitute a gene deletion 
cassette targeting a given gene of interest. Every gene deletion cassette harbours two types of primer-
binding sites, (1) plasmid-homologous primer-binding sites, allowing cassette amplification and 
subsequent cloning into the CRISPR library plasmid, and (2) NGS primer-binding sites, allowing 
amplification and sequencing of the plasmid-encoded and genome-integrated barcode sequences. 
Upon transformation of a given S. cerevisiae strain of interest, a single plasmid DNA molecule is 
introduced inside a cell and multiplies inside of it to a high-copy number. The Cas9 protein is 
expressed and the HDR donor - sgRNA sequence is transcribed by RNA polymerase III (Pol III). A 
Cas9::sgRNA ribonucleoprotein complex is formed and the redundant part of the RNA transcript 
(encoding the HDR donor sequence) is possibly degraded by host nucleases. The complex localises to 
the genomic site of interest via complementarity between the guide RNA sequence and the 
corresponding genomic DNA protospacer sequence, located downstream the PAM (protospacer-
adjacent motif) sequence required for the complex recognition. Cas9 endonuclease introduces a DSB 
3 bp downstream the PAM sequence. Plasmid DNA is used to repair the break. HDR repair leads to a 
partial deletion of the protospacer sequence and a complete deletion of the PAM sequence (both 
preventing further complex recognition and cleavage), as well as insertion of the barcode sequence at 
the site of the DSB, which leads to a nonsense mutation (premature stop codon generation) in the gene 
of interest. Location of the nonsense mutation is biased towards the TSS of the gene of interest to 
avoid production of aberrant truncated protein species due to the escape of the corresponding 
truncated mRNA species from the nonsense mediated mRNA decay pathway surveillance.  
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4.3.2 Deletion Library Composition 
 
The plasmid pool included 24,854 DNA cassettes targeting 6,499 protein-coding 
genes. Each of the protein-coding genes was therefore targeted with ~4 different 
homology HDR donor - crRNA cassettes, maximizing the chance of obtaining at 
least one successful deletion mutant. The choice of cleavage loci was based on high 
on-target crRNA scores as well as their proximity to the start codon (median distance 
of 100 bp) (Bertomeu et al., 2018). The latter prerequisite was imposed to ensure fast 
knockouts and avoid possible aggregation of truncated and misfolded peptides 
(negatively impacting cell viability), in case premature stop codons were missed by 
the nonsense-mediated decay mRNA surveillance machinery (Decourty et al., 2014). 
Location of the cleavage loci was not biased towards sequences encoding 
characterised protein functional domains, which posed a danger of introducing 
measurement noise in the NGS assessment of yeast viability, caused by the NHEJ 
DSB repair pathway. NHEJ is a competing and less efficient DSB repair pathway in 
the budding S. cerevisiae yeast, which tends to introduce small DNA mutations at the 
DSB sites (Bétermier, Bertrand and Lopez, 2014). Thus, NHEJ-mediated mutations 
distal from DNA sequence regions encoding functional protein domains and, 
additionally, not disrupting the corresponding open reading frames are unlikely to 
cause gene knockouts. While this scenario does not interfere with NGS experiments 
based on amplification and sequencing of genomic DNA only, i.e., the barcoding 
cassette cannot be genome-integrated once the unwanted mutagenic NHEJ-mediated 
edit is made, it could prove problematic if a mixture of plasmid and genomic DNA, 
both bearing barcoding cassettes, was to be used as an NGS template (or if unwanted 
traces of plasmid DNA were present during the barcode amplification reaction), 
leading to possible false conclusions regarding yeast viability post-gene knockout. 
Bias of the cleavage sites towards functional S. cerevisiae protein domains can 
however be a complex task and does not guarantee efficient knockouts either, i.e., 
not all of the domains are fully characterised and some of their DNA sequence 
regions are additionally located far away from the TSSs, posing the aforementioned 
truncated protein production issue (Decourty et al., 2014). Therefore, it was decided 
that targeting of the functional domain-encoding DNA sequences will not be pursued 
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and that the NGS data analysis should be cautious of the possible measurement noise 
instead. 
 
As pointed out earlier, the library targeted non-protein-coding genes as well. Long 
non-coding RNA (lncRNA), small nucleolar RNA (snoRNA) and transfer RNA 
(tRNA) genes were targeted. It was hypothesised that a larger (as compared with the 
protein-coding gene deletion cassettes) deletion of 50 bp anywhere in these genes 
would be sufficient to introduce a null mutation, in particular in the case of snoRNAs 
and tRNAs in which secondary structure is highly conserved (Watkins and 
Bohnsack, 2012; Raina and Ibba, 2014). To validate this strategy, a set of 100 
essential gene 50 bp deletion control cassettes was included. However, it was 
anticipated that successful knockouts of lncRNAs might still be challenging. 
LncRNAs are ubiquitous cellular moieties, yet their function and modes of action are 
still largely unknown (Wu, Yang and Chen, 2017). Moreover, they exhibit lower 
sequence conservation, which makes it difficult to map nucleic acid regions 
susceptible to mutagenesis (Rivas, Clements and Eddy, 2017). To maximise chances 
of obtaining lncRNA null mutants, a list of putative lncRNAs was filtered in search 
for the most highly expressed RNAs which do not coincide with the neighbouring 
protein-coding reading frames (to circumvent any knockout effect misinterpretations) 
and resulted in a set of 200 gene targets. As with the protein-coding deletion 
cassettes, these, together with the snoRNA and tRNA sets, were each targeted by ~4 
crRNAs. 
 
The remaining portion of the pool was populated with different types of control 
constructs. Cassettes were designed with non-targeting random homology arms 
and/or crRNAs, which served as negative CRISPR and homologous recombination 
controls to investigate Cas9 cleavage in the absence of a repair template and 
homologous recombination in the absence of a dsDNA cut, respectively. Aside from 
these, 684 DNA cassettes targeted non-conserved non-coding genomic loci (negative 
DNA function knockout controls) and 182 cassettes were targeted at uncharacterised 
and conserved non-coding loci, which were considered promising novel function 




4.3.3 Proof-of-concept Single-gene Deletion Experiments 
 
Prior to conducting the genome-wide deletion experiments, the design was validated 
using example single-gene knockout experiments. In these proof-of-concept studies, 
deletions of two non-essential budding yeast genes (ADE2 and CAN1) and one 
essential gene (SEN34) were investigated. ADE2 is a protein-coding gene encoding a 
phosphoribosylaminoimidazole carboxylase, an enzyme catalysing a step in the de 
novo purine nucleotide biosynthesis pathway. Knockout of this gene leads to 
intracellular accumulation of a red pigment when insufficient amounts of adenine are 
present in the growth medium (Fig. 4.2 B). Therefore, successful deletion of the 
ADE2 gene can be easily identified by looking at the yeast colony colour (Gedvilaite 
and Sasnauskas, 1994). Successful CAN1 gene knockouts are also straightforward to 
identify. The CAN1 gene encodes an arginine permease, involved in transmembrane 
transport of basic amino acids, and its knockout confers resistance to canavanine, a 
non-proteinogenic amino acid, which is a toxic analogue of arginine. CAN1 mutants 
can thus be easily detected as they are able to grow in the presence of canavanine 
(Ahmad and Bussey, 1986). To test the capability of the CRISPR system to knock 
out essential genes, an HDR donor – crRNA cassette was constructed, which targeted 
the SEN34 gene. The SEN34 gene is an essential gene, which encodes a subunit of a 
tRNA splicing endonuclease (i.e., the SEN complex). However, its function has also 
been associated with, e.g., ribosomal RNA processing (Dhungel and Hopper, 2012). 
 
At first, single-gene deletion cassettes did not harbour the barcoding sequences. 
These were incorporated in subsequent experiments, once efficient knockouts using 
the initial design were achieved (Fig. 4.4 A). 81 and 82% knockout efficiencies were 
achieved in the ADE2 and CAN1, respectively, and were comparable to the positive 
control results (with a double-stranded oligo HDR donor), i.e., 82 and 91%, 
respectively (Fig. 4.4 B and C). As anticipated, control experiments, which did not 
harbour an HDR donor but crRNA and tracrRNA only (i.e., the single guide RNA), 
resulted in either no yeast colonies (the CAN1 knockout experiments) or scarce 
colonies (2 and 3) and much lower gene deletion efficiencies  - 3% (the ADE2 
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knockout experiments). In the absence of a mutagenic HDR donor, haploid yeast 
cells can take advantage of their duplicated genetic material (S and G2 cell cycle 
phases) and use it as an alternative HDR donor (Jasin and Rothstein, 2013). 
However, usage of endogenous chromosomal DNA leads to error-free DNA repair 
and thus recurring Cas9 cleavage events, which reduce cell viability (Cagney et al., 
2006). Double-stranded DNA breaks can also be repaired in G0 and G1 phases of the 
cell cycle, without the need for a homologous DNA donor. In these phases, the non-
homologous end joining (NHEJ) pathway constitutes the predominant mode of the 
DNA break repair (Jasin and Rothstein, 2013). The NHEJ pathway has long been 
considered as error-prone. However, more recent data indicates that it is also capable 
of accurate DNA lesion repair, which leads to the aforementioned burdening 
cleavage cycles (Bétermier, Bertrand and Lopez, 2014). Therefore, the error-free 
repair mechanisms explain the observed low recovery of yeast cells and inefficient 
gene knockouts following transfection of control gene deletion constructs (Fig. 4.3A 
and 4.4 C). 
 
Having demonstrated efficient non-essential gene knockouts using non-barcoded 
gene deletion constructs, the effect of the barcode sequence incorporation was 
investigated. An ADE2 gene deletion cassette was constructed, which harboured a 56 
bp sequence, including the unique barcode identifier and two flanking next-
generation sequencing primer binding sites (Fig. 4.4 A). Transformation of the 
construct, cloned into the CRISPR plasmid vector, did not lead to a significant drop 
in the knockout efficiency (Fig. 4.4 C), as confirmed by an unpaired two-sample t-
test (t-statistic = -0.054, p-value = 0.962). To further prove correct and efficient 
function of non-barcoded and barcoded CRISPR vectors, Sanger sequencing was 
used to sequence the corresponding genomic DNA loci. More than 15 samples were 
sequenced per plasmid vector design. The results validated the observed gene 
deletion phenotypes and confirmed insertion of the barcode cassettes (Supp. Fig. 
3.2.1 in Appendix 3.2). 
 
The gene deletion design was tested using an essential gene example. A ~3-4 orders 
of magnitude drop in the recovered yeast colonies, following transfection of the 
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CRISPR system, was observed, as compared to one of the non-essential gene 
examples (Fig. 4.4 D). This decrease implied successful knockout of the essential 
SEN34 gene. Both the non-essential and essential gene examples exhibited lower 
CFU counts as compared to the negative control (missing the gene deletion cassette), 
although, as opposed to the essential gene example, the number of recovered CFUs 
for the non-essential gene knockout experiments, was much less different from the 
result obtained in the negative control experiment (Fig. 4.4 D). A small decrease in 
the number of recovered yeast colonies was expected in the non-essential gene 
knockout experiments. The recovered CFU count in a non-essential gene experiment 
depends on the speed of mutagenesis (also deleting the Cas9 recognition sequences), 
as Cas9 cleavages have a negative impact on the cell viability (Cagney et al., 2006). 
Three yeast colonies were recovered, following transfection of the essential gene 
deletion construct. To investigate the reason behind their survival, their genomic 
DNA was extracted and the Cas9 cleavage locus sequenced. The results revealed that 
two yeast colonies did not have their genomic DNA mutagenised (due to the error-
free DNA repair), while the third colony harboured a 3 bp insertion which did not 
disrupt the SEN34 reading frame and either of the underlying protein active sites, 
leading to the observed cell survival (Trotta et al., 1997). This DNA insertion could 
have been a product of the NHEJ repair pathway, exemplifying the aforementioned 
danger of measurement noise due to the competing NHEJ DSB repair pathway. Such 
measurement noise could be minimised by biasing the CRISPR targeting sites 
towards protein functional domain sites. Some functional domain sites are however 
distal from transcription start sites and their targeting was therefore compromising 
the other aforementioned design objective, i.e., minimizing the probability of long 
pre-maturely terminated transcripts escaping surveillance of the nonsense mediated 
decay machinery. It was therefore decided that this issue will not be addressed 
through biased CRISPR target site design. Instead, sequencing exclusively genome-
inserted DNA barcodes aimed at avoiding the following experimental noise, which 
absence was vital for the success of the genome-wide proof of concept experiments 




Sequencing exclusively genomic DNA material can be achieved through counter-
selection of the plasmid DNA (encoding the barcode sequences as well). The library 
plasmids were shuttle vectors, which encoded an auxotrophic URA3 gene marker 
(Fig. 4.1). It was thus possible to counter-select plasmid DNA by adding 5-
fluoroorotic acid (5-FOA) to the yeast growth medium. The URA3 gene encodes 
orotidylate decarboxylase, which catalyses 5-FOA decarboxylation to 5-fluorouracil, 
a toxic metabolite which causes death of URA3 gene-expressing cells (Boeke, La 
Croute and Fink, 1984) (Fig. 4.2). 
 
 
Figure 4.2 Plasmid DNA Counterselection Strategy 
CRISPR library plasmids encoded a URA3 auxotrophic marker, allowing their selection in ura3 
mutant cells and counterselection of plasmid DNA in the presence of 5-Fluoroorotic acid (5-FOA). 
Yeast cells harbouring a URA3 gene express an orotidine 5’-phosphate decarboxylase, which 
decarboxylates 5-FOA (supplemented in the growth medium) giving rise to a toxic product – 5-
Fluorouracil. Yeast cells which continue to propagate URA3-encoding plasmid DNA should therefore 
die and dropout from the cellular pool. Successful plasmid counterselection can be confirmed through 





Figure 4.3 Library Design and Proof-of-concept Experiments Rationale 
(A) Rationale for an HDR-based CRISPR deletion library; Upon a CRISPR-induced double-stranded 
DNA break (DSB), the cell has to repair the broken chromosomal DNA, otherwise it will die. There 
are two main DSB repair pathways in S. cerevisiae, the non-homologous end joining pathway (NHEJ) 
and the homology-director repair pathway (HDR). NHEJ can lead to erroneous repair (introduce indel 
mutations at the site of the break), but can also repair DNA without errors. HDR does not introduce 
errors, as it is guided by a homologous template (coming from newly replicated DNA or a second 
chromosome set). HDR (in bold) is a preferred DSB repair pathway in yeast (Jasin and Rothstein, 
2013). Therefore, in the absence of a mutagenic homologous template CRISPR systems typically 
continue introducing DSBs for an extended amount of time, severely impacting cell viability and even 
leading to cell death (if NHEJ-induced indels are not introduced fast enough - mutating the Cas9 
recognition sites). (B) Rationale for plasmid DNA-encoded HDR donors; Mutagenic HDR donors are 
typically introduced inside the cell through co-transformation with the CRISPR system plasmid DNA. 
This strategy however does not work on a library scale, as HDR cassettes have to be physically 
connected with the rest of the CRISPR system to appropriately co-localise with the corresponding 
sgRNAs inside single yeast cells. Proof-of-concept single-gene deletion experiments were performed 




Figure 4.4 Proof-of-concept Single-gene Deletion Experiments 
(A) CRISPR plasmid inserts tested: Function of several gene deletion constructs was assessed in 
proof-of-concept experiments to test whether plasmid-encoded HDR donors can repair DSBs as 
efficiently as co-transformed HDR donor DNA (Fig 4.3B). NHEJ repair (plasmid sgRNA 
transcription unit) and HDR positive controls (plasmid sgRNA transcription unit with the ds oligo 
HDR donor co-transformed) were included. Two versions of test constructs were tested, i.e., with and 
without the barcoding cassette (B) Example plate results of the ADE2 gene knockout experiments: 
ADE2 gene knockouts result in yeast cells exhibiting red pigmentation (C) Results of the single-gene 
knockout experiments: ~80% knockout efficiencies were observed in the ADE2 and CAN1 non-
essential gene knockout experiments. Three biological replicates were tested per each experiment and 
error bars indicate standard error of the mean. (D) Results of the single-gene knockout experiments 2: 
Low recovery of cells was observed in the essential gene deletion experiments, implying successful 
gene knockout. Three biological replicates were tested per each experiment and error bars indicate 













4.3.4 Cloning of the Deletion Library 
 
Having validated the design, the next step was cloning and testing the entire genome-
wide gene deletion library en masse. The deletion cassettes were cloned into the 
plasmid backbone using Gibson assembly (Fig. 4.5). To ensure presence of each of 
the deletion cassettes in the resulting plasmid DNA pool 4 DNA assemblies and 34 
E. coli plasmid DNA electroporations were performed, which led to 20X CFU 
coverage of the library.  
 
To investigate correctness of the obtained bacterial clones, 20 E. coli colonies were 
picked and their plasmid insert regions sequenced. 15 out of 20 colonies (75%) 
harboured correct full-length HDR donor – crRNA cassettes. 3 colonies propagated 
truncated DNA cassettes, while the remaining 2 sequences did not align against the 
reference deletion library (Supp. Table 3.1.2 in Appendix 3.1). Agilent quotes that 
1 sequence error is to be expected per 300 nt of synthetic oligonucleotide DNA. This 
means that the likelihood of synthesis success at each nucleotide sequence position is 
0.997 ((300 − 1) 300⁄ ) and therefore at least one sequence error was expected in 
50.2% of the ~209 nt oligonucleotide constructs (1 − 0.997Ziq). Thus, results of the 
initial Sanger sequencing assessment indicated a more moderate error rate. 
 
Following the initial Sanger sequencing assessment, the entire plasmid pool was 
sequenced to investigate coverage of the genome-wide deletion cassettes. Next-
generation Illumina sequencing was used to sequence the DNA barcode regions, so 
that the sequencing reads allowed to assess the abundance of individual deletion 
cassettes. Results indicated that a vast majority (~98%) of deletion cassettes was 




Figure 4.5 Cloning of the Genome-wide Plasmid Pool – Experimental Procedure 
A commercial ssDNA oligonucleotide pool, harbouring 27,000 gene deletion cassettes, was amplified to yield double-stranded oligonucleotides with terminal plasmid homologies. 
These oligonucleotide fragments were later assembled into the library vector using Gibson Assembly. DNA assembly products were electroporated into E. coli. Multiple DNA 





Figure 4.6 Cloning of the Genome-wide Plasmid Pool - Results  
Distribution of the plasmid barcode cassettes’ NGS paired-end read coverage. NGS verification of the 




4.3.5 Genome-wide Gene Deletion Experiments 
 
Having confirmed completeness of the plasmid library, it was decided to first test its 
function in a standard S288C-derivative laboratory yeast strain. This should result in 
strong depletion of the essential gene barcodes as compared to the non-essential 
ones, which would indicate correct genome-wide function of the CRISPR system. 
However, this was not seen in the first genome-wide experiments (Fig. 4.7, 4.8, 4.9 
and 4.10). In these experiments, the plasmid deletion pool was first transformed into 
the wild-type strain, obtaining a ~50X CFU coverage of the library (each 
transformation procedure contained a set of appropriate controls, (1) a positive 
control: transformation of plasmid DNA without the CRISPR system, to monitor 
plasmid DNA transformation efficiency; and (2) a negative control: transformation 
of a blank water sample, to confirm no yeast growth on auxotrophic media in the 
absence of plasmid DNA). Following a plate outgrowth period, the yeast clones were 
harvested, pooled and stored in glycerol stocks, which were used in the subsequent 
experiments. One of the glycerol stocks was used to inoculated a rich liquid medium 
and sub-cultured into a plasmid counter-selection minimal medium (with 5-FOA) to 
compare barcode read depths for the plasmid-containing and plasmid-deficient yeast 
populations (to confirm successful genomic editing). Following the counter-
selection, the mutant pool was further transferred into the rich non-selective medium 
and grown until mid-exponential phase (Fig. 4.7). While there was a significant 
difference between the essential and non-essential gene barcode read count 
distributions (as judged by a two-sample Kolmogorov-Smirnov test), no strong 
depletion of the essential gene barcodes was observed in either of the harvested solid 
and liquid media populations (Fig. 4.9 and 4.10). Both essential and non-essential 
gene read count distributions exhibited large standard deviations (sample 1 – 
236/432, sample 2 – 690/1,612, sample 3 – 445/945 and sample 4 – 93/219 
essential/non-essential gene reads) and comparable means (sample 1 – 173/188, 
sample 2 – 135/184, sample 3 – 118/156 and sample 4 – 40/61 essential/non-
essential gene reads). Moreover, presence of the essential gene read signal in these 
populations indicated failure to knock out essential genes upon the barcoding 




Figure 4.7 Setup of Genome-scale Knockout Experiments 
The CRISPR plasmid pool was transformed into a standard laboratory yeast strain (BY4741). The transformation procedure was scaled up to obtain multiple coverage of the library. 
Yeast clones (grown on CRISPR system-selective media plates for several days) were harvested and stored in glycerol stocks. A single glycerol stock was later recovered in a rich 
non-selective YPDA liquid medium and the recovered cells were subjected to a chemical plasmid counter-selection treatment. Following plasmid counter-selection, plasmid loss was 
confirmed and the mutant population cultured in YPDA medium until exponential phase was reached. 50 ODUs samples were collected, following growth in every condition 




Figure 4.8 First Yeast Genome-wide Screens Workflow 
The CRISPR plasmid library is cloned and library representation of individual barcoded gene deletion 
cassettes is determined by NGS (serving as a baseline time zero reference later on). The library 
harbours deletion cassettes targeting non-essential and essential genes. Upon transformation of an 
Saccharomyces cerevisiae strain of interest with the plasmid pool, significant depletion of strains 
harbouring the essential gene deletion cassettes is expected. In order to test this hypothesis, after a 
period of post-transformation outgrowth a yeast cell pool is harvested by centrifugation and total 
DNA is extracted from the pool. Barcode DNA is later amplified through PCR, quantified and 
subjected to NGS. Read count per individual non-essential and essential gene barcodes is obtained 
and its fold-change between the post-transformation (t1) and pre-transformation steps (t0) is 
computed. Because total read counts vary between sequencing runs, barcode read counts are 
normalised by the total sequencing run read counts before the fold-change computation. Different 
yeast deletion library outgrowth conditions can be tested in one sequencing run, as amplified barcode 





Figure 4.9 First Yeast Genome-wide Screens – Results 
No strong essential gene mutant depletion was observed, as compared to non-essential gene mutants. No depletion was observed for both plasmid-selective (SC-ura media) and 
plasmid non-selective / counterselective growth conditions (YPDA and SC-complete w/ 5-FOA media, respectively). Fold-change data is presented, which describes change in 
barcode read counts relative to the starting plasmid read counts (CRISPR plasmids cloned in E. coli). Plasmid read counts are projected onto a logarithmic scale for better data 




To investigate whether more time is needed to knock out yeast genes, a further 
experiment tested whether an additional plasmid-selective liquid outgrowth (48 and 
96 hours), following growth on the plasmid-selective media plates, would lead to the 
anticipated strong essential gene mutant depletion. However, again, a strong 
reduction in the essential gene read signal was not observed. The read count standard 
deviations were considerable (48 hours: 1,164 and 1,970; 96 hours: 2,971 and 3,195 
essential and non-essential gene reads) and the read count means counts similar (48 
hours: 207 and 253; 96 hours: 271 and 314 essential and non-essential gene reads). 
 
Aside from comparing the essential and non-essential gene read count distributions, 
the same analysis was conducted for the negative control non-targeting experiments, 
which used plasmids with random HDR donor and crRNA sequences. Results 
revealed a significant enrichment of the non-targeting construct barcodes, as 
compared with read counts of the genome-targeting constructs, in all growth 
condition experiments. While such enrichment was expected in the plasmid-selective 
screens, it was not anticipated in growth conditions lacking plasmid selection. In the 
plasmid selective screens, targeting constructs should lead to DSBs and barcode 
sequence insertions, while non-targeting constructs should lead to neither, therefore 
conferring growth advantage. In the non-selective conditions, non-targeting 
constructs should however not be enriched, as they are not designed to be integrated 
into the genome and thus they are only encoded by plasmid DNA, which is not 
selected for. Possible reasons for these results could be an inefficient counter-
selection protocol (although, its correct function was assessed; Fig 4.2 and 4.7) or 






Figure 4.10 Genome-scale Knockout Experiments (including negative control data) 
Significant difference between essential and non-essential gene read count distributions was observed, as judged by the two-sample Kolmogorov-Smirnov test. However, no strong 
depletion of the essential gene barcodes was detected. Significant enrichment of non-targeting construct barcode reads was observed as well in all growth condition experiments, and 




To further investigate the unexpected lack of a strong essential gene read depletion, 
individual barcode reads of three example genes were traced, including two non-
essential genes (YHR101C and YNL036W) and one essential gene (YNL151C). These 
were followed at different experimental stages to look into the consistency of their 
NGS signal. For YHR101C, all 4 constructs exhibited a similar read count trend (with 
a noticeable population bottleneck at the cryopreservation recovery). However, for 
the remaining examples inconsistencies were observed (Fig. 4.11). For instance, 
reads of the fourth essential gene barcode exhibited a general decreasing tendency, to 
then increase ~2-fold at the last experimental stage. Read number of the third 
YNL036W gene barcode, on the other hand, reached 824 reads at the glycerol stock 
recovery, to then drop to 0 reads at the final experimental stage. It was therefore 
presumed that measurement noise was present in the gene deletion screen results, 
which could have obscured the NGS read analyses. Genetic suppression could have 
contributed to the following measurement noise. Namely, some cells could have 
harboured a second mutation, introduced by chance, which could have relieved the 
essential gene knockout phenotype, giving them a growth advantage and leading to 
their enrichment in the gene knockout strain pool. For instance, deletion phenotype 
of the YNL151C (RPC31) gene, encoding an RNase III C13 subunit, can be 
supressed by the SSD1 gene deletion (Uesono, Toh-e and Kikuchi, 1997). 
Eliminating such experimental noise on a library scale is difficult and could have 
only been possible through additional whole genome sequencing of the gene deletion 





Figure 4.11 Barcode Read Count Anomalies 
Some barcodes exhibited abnormal read counts, e.g., essential gene barcode read count increased following a decrease. Three example genes were investigated, including two non-




4.3.6 Establishing a New Method for Evaluating Correct Mutagenesis 
 
The initial approach towards confirming successful genome editing relied on 
quantifying genomic barcode reads in the absence of the barcode-encoding plasmid 
DNA. However, this strategy relied on an indirect method for confirming plasmid 
loss (i.e., testing cell growth on a uracil-deficient minimal medium) and was unable 
to detect barcode mis-integrations. Therefore, given the unexpected results of the 
first genome-wide experiments, a new sequencing method was proposed, which 
would better distinguish true genome insertion events as well as spot mis-integration 
events. 
 
To do that, a different sequencing sample preparation protocol was devised and was 
designed to capture DNA sequences proximal to the barcoding cassettes (Fig. 4.12 
B). The new method relied on a sequence of enzymatic reactions processing 
biotinylated ssDNA bound to streptavidin-coupled magnetic beads. Immobilisation 
of the single-stranded DNA aimed at facilitating progression through consecutive 
enzymatic steps, e.g., by circumventing the need to precipitate and wash low DNA 
amounts to set up subsequent reaction steps. 
 
To test the new strategy, a yeast strain was constructed, harbouring an ADE2 gene 
deletion triggered by a barcoding sequence insertion. In proof-of-concept 
experiments, a different barcoding cassette design was used to make the first future 
NGS tests easier, i.e., without the need to design and use custom sequencing primers 
(Fig. 4.12 A). Two types of starting nucleic acid materials harbouring the barcoding 
cassette were tested - a pre-amplified ~600 bp genomic region and full-length 
genomic DNA. It was hypothesised that using a less complex DNA template (i.e., the 
amplicon DNA) would help prove that this approach is feasible and later optimise 
the new experimental protocol (i.e., the amplicon sequence being used to set up 
positive control experiments). 
 
The barcode-neighbouring DNA sequences were captured through a single round of 
DNA polymerase extension (using a biotinylated primer), past the barcoding cassette 
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sequence and one of the homology arms. The resulting single-stranded DNA was 
next separated from the template through thermal denaturation to be then 
circularised, using a ssDNA ligase catalysing intramolecular ligation. Annealing of a 
single-stranded oligonucleotide complementary to a pre-designed BamHI restriction 
site allowed circular DNA to be linearised between outward facing NGS primer-
binding sites. The resulting varied size population of linearised fragments was eluted 
and used as a heterogenous template in a PCR reaction harbouring NGS primers, 





Figure 4.12 New Next-generation Sequencing Library Preparation Protocol 
(A) Application of the new method to original barcoding cassette design: Application of the new 
method requires using an extension primer with an overhang region encoding outward facing custom 
read primer binding-sites and an internal restriction site (B) New method for generating NGS 
sequencing libraries: The second alternative NGS sequencing method includes a series of enzymatic 
reactions, processing a single-stranded DNA extension product bound to streptavidin magnetic beads, 




Successful generation of NGS sequencing cassettes containing portions of the 
starting nucleic acid templates was tested by cloning them into a commercial plasmid 
vector and sequencing the insert region of the plasmid DNA extracted from 12 E. 
coli clones (Fig. 4.13 A and B). For the amplicon template, 10 correct sequencing 
cassettes were identified (although, successful sequencing cassette generation is 
questionable in case of the 3 1 bp elongation products), with 3 of them capturing the 
complete amplicon nucleic acid sequence (Fig. 4.13 B). However, for the full-length 
genomic DNA template no correct sequencing cassette inserts were observed, with 
some inserts harbouring short sequences of random DNA. Therefore, further efforts 





Figure 4.13 Testing the New NGS Protocol 
(A) Sanger sequencing analysis of putative NGS inserts: Amplified DNA products were analysed by 
agarose gel electrophoresis. DNA fragment smear signal (indicated in green) above a putative NGS 
primer dimer region (indicated in black) indicates successful generation of NGS cassettes. In the 
amplicon template experiment, a distinct ~600 bp DNA band indicates NGS cassettes harbouring 
complete amplicon sequences (indicated in green). DNA was extracted from the smear regions and 
cloned, using a commercial vector system. The resulting plasmid insert regions were later verified by 
Sanger sequencing; (B) Sanger sequencing results: Generation of successful NGS cassettes was 






In conclusion, following successful single-gene deletion experiments using the 
proposed CRISPR system design, correct genome-wide function of the system was 
not demonstrated. There might be several causes of these unexpected results, the 
combined effects of which could have led to the lack of a strong essential gene read 
depletion. 
 
As mentioned before, the oligonucleotide error rate stated by the manufacturer 
indicated that 50.2% of the purchased oligonucleotide constructs were expected to 
contain at least one sequence error. Errors in the single guide RNA could have 
reduced genome editing efficiency, by impeding DNA recognition and cleavage, 
therefore leading to a lack of selective pressure to incorporate the mutagenic barcode 
sequences through the homology-directed DNA repair mechanism. This issue should 
however be identifiable by efficient plasmid counter-selection, resulting in a weak 
non-essential gene read signal. Errors in the donor DNA could have also impeded 
barcode insertion, but also could have resulted in barcode mis-integrations, which 
could have confounded analyses of the essential gene barcodes. Barcode mis-
incorporation at non-essential genomic loci should give rise to viable cells bearing 
essential gene identifiers, therefore leading to spurious results. Such mis-
incorporation events are however unlikely in the absence of double-stranded DNA 
breaks at the corresponding genomic DNA loci (i.e., no selective pressure for DNA 
integration) and given the length of homologous arms used (Hua et al., 1997). 
Synthesis errors could have also been present in the barcode sequences and could 
have had two negative implications. First, they could have led to false clone 
identification. Second, they could have prevented introduction of premature stop 
codons. Here, even a small indel mutation could have led to undesired frameshifts or 
conversion of a programmed termination triplet into an amino acid-coding codon. 
 
A recent publication by Roy et al., describing the MAGESTIC system, presented 
solutions to the synthesis error-related issues (Roy et al., 2018). The published 
genome-wide editing system tagged the already synthesised oligonucleotides with 
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unique 31 bp barcode sequences, which reduced the danger of using erroneous 
barcodes (through a more error-prone synthesis of longer oligonucleotides). 
Moreover, post-synthesis assignment of these resulted in identical editing cassettes 
bearing different barcode identifiers, which served as internal replicates. As opposed 
to the CRISPR system developed in this project, the MAGESTIC system barcoded 
the underlying gene mutants by integrating the entire barcoded HDR donor – crRNA 
construct, flanked by NGS-compatible primer-binding sites, at a separate (from the 
corresponding gene locus) engineered landing pad bearing a counter-selectable gene 
marker. Longer read next-generation sequencing of this insert therefore allowed 
identification of mutants propagating erroneous editing constructs. Separate genomic 
location of the barcoded sequence, unlinked to the target gene locus, is however not 
ideal, since the landing pad insertion does not provide direct proof of a successful 
gene editing event. Moreover, this methodology requires prior engineering of a 
landing pad for the barcoded editing cassette in every yeast strain of interest, leading 
to a perturbation of the original genetic background, which might be undesirable (see 
Table 4.1 for detailed methodology comparison). 
 
Genomic insertion of the barcoded gene editing cassette in the MAGESTIC editing 
pipeline was accomplished through a homology-directed CRISPR-Cas9 mechanism, 
yet using a different single-guide RNA sequence from the gene targeting sgRNA. 
This RNA sequence was encoded by the plasmid vector used to deliver the gene 
editing cassettes and targeted two genomic sites flanking the landing pad construct, 
as well as one plasmid DNA site at the downstream end of the gene editing cassette. 
Therefore, expression of this additional single-guide RNA led not only to the 
genomic barcoding event, but also to self-destruction of the plasmid DNA. Plasmid 
self-destruction could have been used as an alternative way to counter-select plasmid 
DNA in the presented CRISPR knockout experiments. Such an alternative plasmid 
elimination strategy would circumvent selective stress associated with 5-fluorouracil 
toxicity, which can alter the composition of a heterogenous mutant pool (i.e., cells 
which lose plasmid material faster have a competitive advantage over cells which are 
slower at losing their plasmid DNA). Moreover, the self-destruction mechanism can 




Insufficient plasmid copy numbers could have also been an issue in the gene deletion 
screens. Since efficient single-gene knockouts were observed in the proof-of-concept 
experiments, plasmids levels were not expected to be a limiting factor in the genome 
editing system, which harboured a two micron plasmid origin of replication leading 
to 10-40 plasmid copies per cell (Futcher and Cox, 1984). However, it might be 
possible that for some genomic loci it was in fact limiting. Repair of double-stranded 
breaks using an exogenous repair template (as opposed to, e.g., a sister chromatid 
template) requires a physical search for the donor DNA. For example, in budding 
yeast and other eukaryotes various proteins help in relocating damaged genomic loci 
to nuclear compartments which better assist in DNA repair (Seeber and Gasser, 
2017). Therefore, increasing availability of the donor template may lead to increased 
genome editing efficiencies. Recently, Bao et al. boosted intracellular levels of their 
two micron CRISPR-Cas9 plasmid (to ~200 copies) by using a truncated auxotrophic 
marker promoter and later demonstrated successful genome-wide S. cerevisiae 
editing using this enhanced plasmid vector (Bao et al., 2018). The aforementioned 
MAGESTIC system, on the other hand, used an engineered LexA-Fkh1p fusion 
protein to recruit the plasmid-encoded repair templates to the double-stranded 
breaks. MAGESTIC plasmid vectors harboured several LexA DNA-binding sites, 
proximal to the donor DNA, to which the LexA portion of the fusion protein was 
able to bind. The Fkh1p side of the fusion construct interacted with proteins which 
accumulate at double-stranded breaks. These proteins are phosphorylated on 
particular threonine residues, to which the Fkh1p part binds, thus recruiting 
MAGESTIC donors to the cleavage sites, which led to a more than 5-fold increase in 
the editing efficiency. 
 
In general, in genome editing experiments the non-homologous end joining (NHEJ) 
and the homology-directed repair (HDR) pathways are two major competing DNA 
repair routes. In this project, introduction of custom genomic alterations was 
achieved through the preferred HDR mechanism. NHEJ repair of DNA breaks could 
have however impeded introduction of these to some extent. In the proof-of-concept 
studies led to ~80% editing efficiencies. However, these could have been further 
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enhanced by inactivating NHEJ. Roy et al. achieved enhanced editing efficiencies 
using this strategy. The NEJ1 gene encoding a protein involved in regulating non-
homologous end joining was deleted, which led to nearly 100% editing efficiency 
(Roy et al., 2018). Nonetheless, like the aforementioned genomic landing pad 
engineering, the NEJ1 knockout might be an undesirable modification of the original 
genotype in certain applications.
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The presented CRISPR-Cas9 experiments concerned themselves with demonstrating 
successful essential gene knockouts using a reference list of 1,156 characterised 
essential genes (Giaever et al., 2002). However, accurate assessment of gene 
essentiality has to consider the cellular environment context (Zhang and Ren, 2015). 
Therefore, this reference list could have been further filtered to ensure that it 
corresponds to the investigated experimental conditions. Nevertheless, proper 
function of some essential genes is critical, largely irrespective of the environmental 
context. For instance, ACT1 is an essential gene encoding actin, a conserved 
structural protein which controls proper cell polarisation, endocytosis and is involved 
in a number of other processes fundamental for the cell (Wertman, Drubin and 
Botstein, 1992). ACT1 sequencing reads were therefore further scrutinised. Mean 
read count, corresponding to all 4 ACT1 barcodes, however did not reveal a strong 
depletion (an average of 159 reads, i.e., 15% less than the non-essential mutant 
population sample mean). 
 
Aside from the genome editing issues, confirmation of essential gene knockouts is 
challenging too. In the proof-of-concept experiments, it was concluded that a poor 
recovery of cells following transfection of the CRISPR system implied successful 
essential gene knockouts. However, it is also plausible that it was caused by 
inefficient mutagenesis, which is known to lead to burdening Cas protein cleavage 
cycles (Cagney et al., 2006). Therefore, in these initial studies, an example essential 
gene knockout, the lethal effect of which can be suppressed by a second mutation, 
could have been investigated instead. The essential gene deletion could have thus 
taken place in the presence and in the absence of genetic suppression, leading to 
more conclusive results. 
 
To further investigate correctness of our genome editing, a novel NGS sequencing 
library preparation protocol was proposed, capable of confirming correct genomic 
barcode integrations in an unbiased manner. This alternative method relied on 
capturing and sequencing nucleic acid sequences neighbouring the barcoding 
cassettes and its application was expected to help detecting any incorrect barcode 
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insertions as well as any remaining plasmid vector background following the 
chemical counter-selection experiments. 
 
This approach resembles some of the existing methodologies, e.g., inverse PCR or 
GUIDE-Seq (Tsai et al., 2014). However, these methodologies were incompatible 
with the barcoding cassettes used due to wrong primer-binding site orientation and 
lack of an internal restriction site, and were more prone to sequence amplification 
errors, respectively. In the initial experiments, feasibility of the proposed approach 
was demonstrated using a pre-amplified genomic DNA region as the extension 
template, but amplification signal was absent when unfragmented genomic DNA 
material was used as the extension template. Further optimisation of the first protocol 
step (i.e., the single-stranded DNA extension), in particular of the starting DNA 
template amount, could lead to improvement of these first results, since much greater 
molar amounts of the amplicon DNA were used owing to its much shorter length as 
compared to the genomic nucleic acid material. Moreover, genomic DNA sonication 
or enzymatic fragmentation could further help in obtaining NGS-compatible DNA 

















5.1 Work Contributions 
 
Most of the work presented in this chapter was conducted during an industrial 
placement at a Thermo Fisher Scientific DNA manufacturing facility (GeneArt; 
Regensburg, Germany). 
 
Under supervision of Dr. Axel Trefzer and Dr. Michael Liss, I developed the Monte 
Carlo simulation software, conducted the proof-of-concept simulation studies and 
built a machine learning model to predict DNA sequence-specific manufacturing 
turnaround times. Dr. Phillip Kuhn provided additional guidance regarding process 
duration modelling as well as specifications for the software usage. The example 
manufacturing process information was obtained from Peter Poltnigg and Michaela 
Deinert, who also provided additional support in estimating parameters of the 
constructed example manufacturing process model. Tatiana Konovalova prepared the 
GeneArt Strings data mining dataset, which was used to train the machine learning 








As DNA fabrication is becoming to an increasing extent high-throughput, 
development of tools for rational analysis of the expected DNA manufacturing costs 
and turnaround times is of growing importance. The costs of setting up and running 
high-throughput DNA production pipelines are substantial and therefore call for 
predictive methodologies capable of estimating DNA fabrication expenses and 
durations, as well as guiding researchers towards the most promising process 
optimisation targets (Chambers, Kitney and Freemont, 2016). However, decisions 
concerning setup, automation and planning of experimental procedures are often 
based on personal experience rather than data. Therefore, DNA manufacturing 
facilities could benefit from analytical methodologies used in other high-throughput 
industries (Jahangirian et al., 2010; Cameron, Bashor and Collins, 2014). 
 
However, to make these methodologies relevant to DNA fabrication the underlying 
DNA sequences should be considered. Different nucleic acid sequences are 
associated with unique levels of manufacturing complexity. Extreme GC content, 
stable secondary structure, DNA repeats and homopolymers are among the most 
problematic nucleic acid sequence features and often lead to manufacturing failures, 
alongside human error and equipment-related issues (Oberortner et al., 2016). If 
possible, DNA characteristics should therefore be taken into account to ensure 
accurate prediction of the expected manufacturing costs and turnaround times as well 
as to assist in formulating DNA sequence constraint policies to recognise and reject 
DNA orders that are too challenging to complete within a given time frame. 
 
This chapter therefore presents development and application of a probabilistic 
simulation framework to predict DNA manufacturing turnaround times and estimate 
the most significant manufacturing process parameters at one of the main synthetic 
DNA production facilities. To further improve predictions of the DNA production 
times, a classification model was built and used to estimate success probabilities of 
one of the investigated manufacturing steps, based on the underlying DNA sequence 
GC content and length. The proposed probabilistic simulation approach is evaluated 
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against real data from an example DNA manufacturing process. A statistical model 
of the example DNA fabrication process was built, using information obtained from 
the facility’s personnel and manufacturing execution system, and simulation 
experiments were conducted using Python scripts to predict turnaround times in 




Mathematical models of complex manufacturing processes can be too difficult to 
analyze using analytical approaches. Numerical methods, such as probabilistic 
Monte Carlo simulations, provide an alternative to computing analytical solutions of 
statistical models. Monte Carlo simulation studies use random number sampling 
from pre-defined distribution functions and statistical modelling to instead mimic 
behavior of such complex systems and estimate analytical solutions of their models 
(Fig 5.1). 
 
5.3.1 The Probabilistic Simulation Methodology 
 
Easy-to-use Monte Carlo simulation tools were therefore built to make 
computational analyses of the manufacturing turnaround times accessible to non-
experts (Python code in Appendix 4.3). The tools constructed rely on a mathematical 
description of a given manufacturing process using a standard Microsoft Excel 
spreadsheet (Supp. Table 4.2.1 in Appendix 4.2), which is later analysed by Python 
simulation algorithms. The standardised spreadsheet requires users to define 
manufacturing steps and their order, as well as their failure probabilities and the 




Figure 5.1 DNA Manufacturing Process Modelling Approach 
The modelling work performed throughout this doctoral thesis project sought to develop tools for 
DNA-specific DNA manufacturing duration and costs simulation studies (process turnaround time 
simulation example shown above). In order to infer DNA-specific time and cost predictions, (1) 
statistical models have to be built and predict success of individual manufacturing steps, based on 
different DNA features (found to have significant impact on the success rates), and (2) a 
manufacturing step duration / cost simulation framework has to be developed. Success rates predicted 
in the first stage can be thus fed into the simulation analysis. The simulation framework developed 
throughout this thesis project allows the user to define the manufacturing process model, which will 
be later subjected to the simulation analysis. Each manufacturing step is thus assigned a statistical 
distribution which best reflects real life step durations / costs, and which will be used as a sampling 
distribution during the simulation studies (each simulation experiment samples one number from the 
sampling distribution; many simulation experiments are typically performed). Truncated normal 
distributions were chosen as the default sampling distributions (to avoid sampling extreme and 
negative time / cost values) and the user gets to define their parameters – minimum and maximum 
values, mean and standard deviation.  
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The tools developed use truncated normal distributions to model durations of 
consecutive DNA manufacturing steps. Truncated normal distributions are derived 
from the normal distribution and harbour two additional parameters defining strict 
minimal and maximal values (Supp. Fig. 4.1.1 in Appendix 4.1). These limit 
parameters can be used to prevent sampling of negative numbers, which is 
particularly probable for normal distributions with means close to zero and high 
standard deviations. Normal distribution is a common modelling choice for many 
phenomena. Various phenomena can be viewed as a composite of various 
independent probabilistic events, outcomes of which are described by independent 
random variables. According to the Central Limit Theorem and its variants, 
summation of these variables commonly tends towards a normal distribution, leading 
to the aforementioned observation (Brookes, 1955). In this work, the choice of 
truncated normal distributions in particular stemmed from an additional observation - 
that biological manufacturing step durations rarely exceed certain maximum values 
and are never negative values. For instance, duration of a polymerase chain reaction 
depends on a variable target amplicon length, impacting duration of the DNA 
extension phase. While PCR amplicon lengths are normally distributed, during gene 
synthesis they are frequently also bound by some minimum and maximum lengths, 
reflecting precise manufacturing needs. Additionally, PCR duration cannot fall 
below the minimum viable PCR protocol duration. Another example are bio-
manufacturing steps involving microbial growth, e.g., if a certain bacterial incubation 
period is exceeded, cells will enter death phase and degradation of antibiotics will 
occur for experiments using antibiotic selection, leading to undesired bacterial 
growth (e.g., satellite colonies) (Hou and Poole, 1969). Too short incubation times, 
on the other hand, can lead to failure in obtaining microbial colonies or enough cells 
to extract sufficient quantities of plasmid DNA (Sezonov, Joseleau-Petit and D’Ari, 
2007). Companies thus typically define minimum and maximum microbial 
outgrowth durations, in order to minimise manufacturing process failures.  
 
Uniform, gamma distributions are two alternative statistical distributions allowing 
modelling non-negative values, as well as values bound by certain minimum to 
maximum ranges (uniform distribution), however none of them combines the ability 
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to model normally distributed event durations as well as minimum and maximum 
duration-bound events, thus leading to the final choice of truncated normal 
distributions for sampling random event durations. Simulation studies using 
truncated normal probability density functions should however carefully define the 
desired maximum and minimum value parameters. Namely, pre-setting the 
maximum and minimum value range in the tail regions of the Gaussian curve leads 
to non-normally distributed random variables and can additionally lead to slow 
random variates sampling (Botev and L’Ecuyer, 2017). 
 
To account for staff availabilities, simulation software considers working schedules 
of people involved in running the DNA manufacturing operations. Specification of 
their working hours and weekdays as well as the simulated manufacturing start date 
and time is therefore required. The decision on starting a particular manufacturing 
step is guided by several factors. First, a computational algorithm checks whether a 
simulated process time and date fall within the working hours. Second, it evaluates 
whether a given step is likely to finish prior to the end of the working rota by 
calculating the 95th percentile of its duration distribution. If at least one of these 
conditions is not satisfied, the algorithm advances in time until both conditions are 
met. Some biological experiments as well as process steps harnessing automated 
procedures often do not require human supervision once set up. For instance, 
incubation of bacterial liquid cultures and media plates (following DNA transfection) 
can be performed overnight. Therefore, the modelling framework sought to 
distinguish such process steps by enforcing specification of their supervision 
requirements (i.e., can a process step run overnight). Consequently, special rules are 
applied to manufacturing steps, in that the simulation algorithm does not require their 
termination prior to the end the working schedule. Manufacturing steps to be started 
on the last working day are a special case for which the algorithm simulates a wait 
time equal to the sum of the remaining time of the last working day and duration of 
the non-working week period (e.g., a weekend). Such a modelling rule was imposed 
to prevent an excessive wait time, which in a real manufacturing setting could, e.g., 




Following specification of a given process model, simulation algorithms parse the 
spreadsheet document, generate random durations of manufacturing steps and control 
their progression in the simulated process run time, so that it conforms with the pre-
defined time constraints. A large number of computer simulations must be performed 
until the distribution of the simulated turnaround times converges. According to the 
law of large numbers (Sedor, 2015), the distribution profile thus obtained reflects the 
true probability density function of the turnaround time, under the assumptions of the 
probabilistic DNA manufacturing model. The number of simulation loops can 
therefore be specified by the user, based on the output simulation data, to ensure 
convergence. 
 
The main process simulation tool returns three types of data automatically (Fig. 5.3, 
5.4 and 5.5 and Supp. Fig. 4.1.1 and 4.1.2 in Appendix 4.1). First, a histogram of 
the simulated process turnaround times is returned, along with a cumulative 
distribution plot. A default 90th percentile cutoff is drawn on both plots to indicate 
process duration with a 90% likelihood of process completion. In addition to these 
plots, a text file is returned, which stores simulated process durations of every 
simulation experiment performed to allow for any other custom data processing. The 
second output includes data describing simulated manufacturing step start and end 
times. First, a timeline plot is returned, which represents overlaid simulated step 
durations in process run time. An alternative version of the simulation tool returns a 
stack plot, which instead represents percentage of simulated process step instances 
being completed in a particular time interval. A raw data file, describing simulated 
manufacturing step start and end timestamps, is also returned. The last output 
comprises plots illustrating all input truncated normal distributions used to model a 
given process, to provide researchers with a graphical representation of their chosen 
sampling probability density functions. 
 
Aside from estimating distribution functions of process turnaround times, indicating 
the most significant process optimisation targets is yet another piece of information 
which is valuable throughout any process improvement efforts. Therefore, the 
simulation toolkit includes an additional computational tool which uses output of the 
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main simulation tool (i.e., the simulated process durations text file) and conducts a 
one-factor-at-a-time (OFAT) sensitivity analysis to indicate process model 
parameters (e.g., mean duration of gel electrophoresis) which have the most 
significant impact on the DNA manufacturing turnaround time. A one-factor-at-a-
time method was used to compute sensitivities of a given process model to all of its 
parameters. One by one, each parameter of the model is thus increased by 1%, other 
parameters remaining unchanged. The resulting modified model is simulated n times, 
with n being the number of simulation loops computed in the initial simulation study. 
Expected process duration of the original model is later subtracted from the modified 
model’s expected turnaround time, with the mathematical difference indicating how 
sensitive a given manufacturing process model is to a certain parameter. Results of 
this analysis are returned as a bar chart depicting sensitivities to the 20 most 
significant parameters (Fig. 5.6). 
 
5.3.2 Modelling of an Example Industrial DNA Fabrication Process 
 
An example Thermo Fisher Scientific DNA manufacturing process was studied to 
test the function of the Monte Carlo simulation tools (Figure 5.2 illustrates the 
process model and the original DNA manufacturing process; also shown in Supp. 
Fig. 4.1.6 in Appendix 4.1). This process builds DNA fragments up to ~3 kb-long, 
which are later cloned in a plasmid vector. The target constructs are assembled from 
2-3 sub-fragments, the size of which ranges from 240 bp to 1.1 kb. The sub-fragment 
pieces are in turn made from oligonucleotides, which are assembled using a 
polymerase chain assembly method (Fig. 5.2 A). To alleviate DNA synthesis errors, 
two rounds of sub-fragment and full-length fragment error correction are performed, 
after which the resulting populations of digested nucleic acid strands are stitched 
together enzymatically (Sequeira et al., 2016). Following the double DNA 
correction, full-length DNA fragments are cloned into a plasmid DNA vector using a 
PCR-based protocol. Once transfected into E. coli, 8 bacterial colonies are picked 
and a colony PCR verification of the plasmid insert region is performed. Two clones 
exhibiting the correct amplification signal are later further assessed by DNA 
sequencing. Next-generation sequencing is the predominant DNA validation method. 
The remaining DNA orders are assessed using Sanger sequencing, due to, e.g., 
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customer requirements for Sanger sequencing chromatogram files. Together with the 
last two DNA verification steps, the construction process harbours several additional 
control procedures following the gene synthesis, error correction and bacterial 
transformation manufacturing steps (Fig. 5.2 and Supp. Fig 4.1.6 in Appendix 4.1). 
For each of these control points, a specific rescue path is defined, which indicates 
alternative manufacturing protocols to be tested and experiments to be repeated in 
order to salvage failed DNA construction steps. 
 
To build a mathematical model of the example process, probability distributions of 
its underlying manufacturing steps as well as failure rates at the quality control steps 
had to be estimated. Mean durations of most of the construction steps, except for the 
DNA design, oligonucleotide synthesis and DNA sequencing steps, were estimated 
by the personnel in charge of different experimental stages. Step durations were 
assumed to follow a normal distribution with maximal and minimal bounds. The 
remaining parameters of the step duration distributions, i.e., their variances and value 
limits, were assumed as well. A manufacturing data mining approach was taken to 
estimate turnaround time distributions and their parameters of the DNA design, 
oligonucleotide synthesis and DNA sequencing manufacturing stages. Timestamp 
data from the company's Manufacturing Execution System (MES), which logs start 
and termination of different manufacturing tasks, was analysed. Manufacturing stage 
duration distributions were inferred and Monte Carlo simulation experiments were 
used to recapitulate the observed distributions as well as deduce the underlying 
manufacturing sub-stages and their failure probabilities. This approach however led 
to predicted DNA manufacturing times which significantly differed from company’s 
own observation. It was thus concluded that the MES data, which relies on curation 
by human operators, was not an ideal source of information. Details of this research 
are described in Supp. Fig. 4.1.3 and 4.1.4 in Appendix 4.1. Thus, in the rest of this 
chapter durations of the DNA design, oligonucleotide synthesis and DNA 
sequencing manufacturing stages were assigned arbitrary durations, based on 
personal experience, although these could easily be replaced by data-based 




Information obtained from these studies was then used to simulate the constructed 
process model and compare its output with real manufacturing data. Due to 
significant discrepancies observed between the two manufacturing duration 
distributions, turnaround time distributions of the DNA design, oligonucleotide 
synthesis and DNA sequencing manufacturing steps, and their parameters were 
assumed instead (Supp. Fig. 4.1.3 and 4.1.4 in Appendix 4.1 and Supp. Table 
4.2.2 in Appendix 4.2). 
 
Failure rates at the individual biological sample control steps were likewise retrieved 
from the MES system. For the DNA sub-fragment gene synthesis, the obtained 
failure rate originated from the product of the underlying single sub-fragment 
construction failure probabilities. For the multiple bacterial clone assessment steps, 
on the other hand, i.e., the colony PCR and DNA sequencing steps, the acquired 
success rates referred to the likelihood of obtaining a sufficient number of correct 
bacterial clones (colony PCR – at least two, DNA sequencing – at least one). Upon 
manufacturing failure, rescue routes have to be initialised. The process model 
simplified some of these DNA sample salvage procedures. For instance, duration 
distributions of analogous sample rescue protocols and their failure probabilities 
were assumed to be the same as those of the original experiments (Figure 5.2 and 
Supp. Fig. 4.1.6 in Appendix 4.1).  
 
Information on non-working weekdays was obtained from the company’s personnel. 
Staff working schedules, on the other hand, were based on both true (the technicians’ 
schedule) and assumed operational schedules (the IT team schedule). Information on 
manufacturing steps running overnight was based on communications with company 
staff, except for the insert sequencing step, which was assumed to run past working 
hours. As most of the example process DNA sequencing validation is done with 
NGS, it was also assumed that NGS was the only DNA sequencing procedure used 
to validate the finished DNA constructs. To model process turnaround times, given 
the time constraints stated beforehand, the simulation manufacturing start date and 
time had to be decided as well. The chosen simulation start date and time matched 
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Figure 5.2 Case Study DNA Manufacturing Workflow 
(A) The example DNA production pipeline manufactures ~3 kb DNA fragments from 2-3 sub-fragment DNA blocks, which are assembled from single-stranded oligonucleotides. 
Full-length fragment DNA is cloned into a plasmid vector (left panel). Graphical representation of the process model constructed (right panel), depicting all manufacturing rescue 
paths. (B) The original manufacturing process (reference for modelling simplifications / assumptions in A).
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5.3.3 Proof-of-concept Monte Carlo Simulation Studies 
 
The mathematical model of the example process (Supp. Table 4.2.1 in Appendix 
4.2) was next subjected to the probabilistic simulation analysis to estimate the 
expected turnaround time of the DNA construction process as well as to infer the 
most significant process parameters. Results of the numerical analysis were 
compared with the observed manufacturing turnaround times (data collected 
throughout the first 5 months of 2018). However, to do that weekend data had to be 
first removed from the simulation results, as the real manufacturing data dataset 
described the manufacturing turnaround times in business days.  
 
The Monte Carlo simulation experiments (1,000 simulation experiments performed) 
estimated that the expected manufacturing process duration totals 6 days, which 
equaled the observed mean duration. Both simulated and observed turnaround time 
distributions were non-Gaussian multimodal distributions with asymmetrical modes, 
which can be attributed to discrete manufacturing routes of different DNA orders, 
i.e., including none or different combinations of rescue procedures (Fig 5.3). The 
observed production time distribution however harboured a longer tail, describing 
probabilities of manufacturing procedures taking the most time to complete. This 
difference was reflected by 90% quantile values (simulated data – 10 days, observed 
data – 11 days), which differed by 1 day. Presence of distribution tails in both of the 
investigated datasets can be attributed to the elevated failure likelihood of the final 
DNA sequencing step (i.e., 12%), which corresponds to the success rate of at least 1 
correct construct out of 2 and possibly stems from the fact that none of the preceding 
verification procedures assess correctness of the DNA sequences at a single 
nucleotide resolution (i.e., mainly gel electrophoresis assessments). In the future, 
failure rate of the last validation step could be alleviated by introduction of 
intermediate DNA sequencing steps or by sequencing more DNA constructs.  
 
Two types of timeline plots were generated to illustrate completion of the simulated 
manufacturing steps in time (Fig 5.4 and 5.5). Both graphical representations 
indicated simulation instances which included execution of the manufacturing rescue 
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paths. Both graphs also reflected the imposed time constraints, i.e., the simulated 
DNA fabrication did not take place on weekends and run beyond the working hours, 






Figure 5.3 Comparison of the 
Simulated Process Durations and 
the Observed Duration Data 
Observed and simulated process 
durations datasets are illustrated with 
histogram and cumulative 
distribution plots. 1,000 Monte Carlo 
simulation experiments were carried 
out to obtain the simulated process 
durations dataset. The simulated and 
observed mean process turnaround 
times (in days) are equal. Minor 
discrepancies were observed between 
the 90th percentiles, i.e., 10 and 11 
days, respectively, and reflected a 
lighter distribution tail in the 
simulated dataset. Both of the 
investigated distributions harboured 
several modes, or maxima, which 





Figure 5.4 Simulation Instances in the Simulated Process Run Time - Stack Plot  
For every simulation experiment, start and end times of the consecutive manufacturing steps were recorded. The stack plot illustrates percentage of simulated manufacturing steps 
taking place at a certain time. No manufacturing steps took place during the pre-defined free weekdays (here, the weekend) and outside of the pre-defined working hours, except for 





Figure 5.5 Simulation Instances in the Simulated Process Run Time - Timeline Plot 
Individual simulated manufacturing step durations were overlaid in the timeline plot. Colour strength of the horizontal step duration bars correlates with the number of simulated 
steps taking place at a certain simulated process time. Non-working hours and days were shaded light grey. No manufacturing steps took place during the pre-defined free weekdays 
and outside of the staff working hours, except for the overnight steps, e.g., the incubation of media plates. Therefore, the simulated manufacturing processes conform with the pre-
defined time constraints. 
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To investigate the most significant process model parameters, sensitivities of the 
process model to all of its parameters were calculated. The sensitivity analysis tool 
estimated that the most significant model parameter is the minimal duration of 
plasmid insert sequencing (Fig 5.6). Insert sequencing is one of the longest steps (~5 
hours duration) in the DNA manufacturing pipeline, therefore it was expected that a 
slight increase in its duration will have a significant impact on the total 
manufacturing process duration. However, some of the results were surprising. For 
instance, considering the oligo synthesis step’s duration distribution with small 
variance, it is surprising that its minimum duration was highlighted as an important 
parameter instead of its mean, which increase would have moved more probability 
density towards the longer step durations. More simulation experiments (> 100) 
should therefore be performed in order to minimise analysis’ stochasticity and 
improve its accuracy. Performing such simulation analysis is expected to take more 




Figure 5.6 Sensitivity Analysis of the Process Model 
A one-factor-at-a-time sensitivity analysis was conducted to identify the most significant parameters 
of the example process model. In every model sensitivity experiment, one of the model parameters 
(e.g., mean duration of oligo synthesis) was increased by 1% and the resulting new process model was 
simulated the same number of times as the original model. Expected process turnaround time of the 
initial model was next subtracted from the expected process duration of the new model, yielding a 
measure of model’s sensitivity to a given parameter (i.e., the parameter sensitivity). Model 
sensitivities to 20 most significant parameters are illustrated by the bar chart and their calculations 
were based on a hundred simulation experiments. According to the analysis performed, minimal 
duration of insert sequencing is the most significant model parameter.  
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5.3.4 Classification Model for Predicting Sequence-specific Turnaround Times 
 
As mentioned earlier, several nucleic acid sequence characteristics are known to 
cause problems throughout the DNA manufacturing process (Oberortner et al., 
2016). Thus, the second goal of the project was to build a predictive tool capable of 
estimating manufacturing failure probabilities of different DNA sequences based on 
the nucleic acid sequence features which are known to have a negative impact on the 
DNA fabrication failure rates. To accomplish that, data mining studies were 
conducted to find such problematic DNA sequence characteristics. Information 
obtained from these studies was later used to build a supervised machine learning 
model able to predict DNA sequence-specific manufacturing failure probabilities. 
Output of this model was also harnessed to estimate DNA sequence-specific 
turnaround times of the example manufacturing process (Table 5.1) 
 
The first data mining attempts used a DNA sequence dataset obtained from an 
academic project aiming at PCR amplification and cloning of standardised yeast 
transcription unit DNA parts, using Golden Gate assembly (Guo et al., 2015). 
However, no significant difference was observed between the successful and failed 
DNA sequence datasets when impact of several nucleic acid sequence features on 
DNA amplification was studied (e.g., impact of the amplicon minimal free energies) 
(Supp. Fig. 4.1.5 in Appendix 4.1). This data was also not directly relatable to the 
example manufacturing process. 
 
Therefore, a more relevant industrial dataset was acquired, which comprised 
manufacturing data of GeneArt Strings (from 2017-2018), i.e., one of the Thermo 
Fisher Scientific synthetic DNA products. As in the example process sub-fragment 
DNA constructs, GeneArt Strings are built from single-stranded oligonucleotides. 
Thus, data comprising their gene synthesis failures can be better related to the 
example manufacturing process and harnessed to predict its DNA sequence-specific 
sub-fragment construction failure probabilities. The acquired dataset harboured 
nucleic acid sequence information on ~17,000 DNA orders and their corresponding 
gene synthesis failure rates. Size of the DNA sequences obtained did not exceed 
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maximal length of the example process sub-fragments and therefore corresponded to 
a single round of oligonucleotide assembly. Customer orders were classified either as 
‘easy’, ‘difficult’ or ‘very difficult’. The first class referred to orders which never 
failed the gene synthesis step, while the latter two classes concerned orders which 
involved at least one gene synthesis failure. Two problematic DNA sequence 
features were investigated, i.e., the DNA sequence length and its global GC content 
(Oberortner et al., 2016). For both of them, significant differences were observed 
between the successful and failed DNA construct distributions. Moreover, a ~50% 
decrease in the gene synthesis success rate was observed for DNA sequences with 





Figure 5.7 Impact of DNA Sequence Features on Failure of Gene Synthesis 
Data mining studies were conducted to identify how global GC content and DNA sequence length 
impact failure of oligonucleotide assemblies. GeneArt Strings manufacturing data was analysed. 
“Easy” assemblies refer to oligonucleotide assemblies which did not have to be repeated. “Difficult” 
and “very difficult” assemblies had to be repeated (at least once). Histograms of the “easy”, “difficult” 
and “very difficult” are overlaid. A statistically significant difference (as judged by a two-sample 
Kolmogorov-Smirnov test) was observed between the successful and failed sample (the “difficult” 
and “very difficult” datasets) GC content and DNA sequence length data. A decrease in the 




The GC content and DNA sequence length data was next used to build a predictive 
classification machine learning model, predicting gene synthesis success rates (based 
on these two DNA sequence features). Various machine learning algorithms were 
considered, e.g., logistic regression, k-nearest neighbours (k-NN) and support vector 
machine (SVM) algorithms. Despite its ability to generate predictions readily 
interpretable as class probabilities, the logistic regression algorithm was ruled out 
early on due to its inability to work well with non-linearly distributed data, 
necessitating modelling of non-linear decision boundaries. The k-NN algorithm was 
another alternative, able to model non-linearly distributed data. However, the k-NN 
algorithm is known to be sensitive to outliers and therefore was not chosen. Kernel 
SVM algorithms (e.g., the RBF kernel SVM) work well with outliers, and thus do 
not require any data pre-processing, are able to model non-linear data structures and, 
additionally, work well with small high-dimensionality datasets, which makes the 
resulting SVM models scalable in terms of adding additional features to the machine 
learning analysis (King, Feng and Sutherland, 1995). 
 
A support vector classifier (SVC) was thus trained and used to predict gene synthesis 
success rates (Fig. 5.8). Its optimal parameters (C and gamma) were found using a 
hyperparameter tuning tool from the scikit-learn Python machine learning package, 
evaluating all possible combinations of pre-defined model parameters by cross 
validation. Cross-validation is a standard statistical technique, which evaluates the 
ability of a given model to infer predictions on one part of the dataset after being 
trained using its other part. A classification method with a higher cross-validation 
score is therefore better adapted to the problem at hand and does not suffer from 
problems such as over- or -under-fitting the data (Kohavi, 1995). The C parameter is 
a regularisation parameter, which describes the impact of misclassification on the 
algorithm objective function. For instance, an SVM model with a large C value will 
try to avoid misclassification at a sacrifice of a smaller data points’ distance from the 
classification hyperplane. A small C value SVM model on the other hand will allow 
more misclassification to find a hyperplane with the largest minimum margin. The 
gamma parameter describes the standard deviation of the Gaussian radial basis 
function (RBF), namely equals to the inverse of its standard deviation. Thus, small 
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gamma parameter values lead to a large RBF standard deviation, which points the 
machine learning algorithm towards considering a large number of local data points 
with similar importance (even if they are far away from each other) when making the 
local data classification decision. A small RBF standard deviation (large values of 
the gamma parameter) on the other hand points the RBF kernel SVM algorithm 
towards considering a small number of local data points, when taking the local 
classification decision, where two data points are only considered similarly important 
when close to each other (Syarif, Prugel-Bennett and Wills, 2016).  
 
To evaluate impact of the predicted success probabilities on the expected DNA 
manufacturing turnaround time estimations, a set of example GC content and length 
DNA sequence features was used to predict success rates of the example process 
sub-fragment gene syntheses using the SVC model. In order to obtain success 
probabilities of all oligonucleotide assemblies combined, involved in a given DNA 
fragment construction, the underlying sub-fragment success rates were next 
multiplied and the corresponding failure rates were used in simulating the process 
model. As anticipated, optimal sub-fragment GC contents and lengths led to the 
shortest expected turnaround times (accounting for both business and non-business 
days), while extreme DNA sequence features led to longer expected DNA 




Figure 5.8 Classification Model to Predict Success Probability of Gene Synthesis 
The GeneArt Strings GC content and DNA sequence length data was used to train a predictive model, using a support vector machine (SVM) algorithm. The constructed model was 
able to predict success probabilities of oligonucleotide assemblies, based on the underlying DNA GC content and length. GeneArt Strings oligonucleotide assemblies follow an 
analogous experimental procedure to the example process sub-fragment assemblies and therefore can be related to the process case study. A hyperparameter tuning computational 
tool was used to choose the best classification model (i.e., with the highest mean cross-validation score). Hyperparameters (C and gamma) and the cross-validation score of the best 
machine learning model are indicated. Predicted (left plot) and observed (right plot) DNA assembly success rates are illustrated with heat maps.  
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Table 5.1 DNA Sequence-specific Manufacturing Turnaround Time Estimations 
fragment ID 
sub-fragment A 
GC content and 
length 
sub-fragment B 









of success expected manufacturing turnaround time 
fragment 1 40%, 500 bp 40%, 500 bp 0.940 0.940 0.884 7 days 23 hours 
fragment 2 70%, 500 bp 70%, 500 bp 0.909 0.909 0.826 8 days 9 hours 
fragment 3 70%, 500 bp 40%, 150 bp 0.909 0.673 0.612 8 days 16 hours 
fragment 4 70%, 150 bp 40%, 150 bp 0.638 0.673 0.429 8 days 20 hours 










The developed Monte Carlo simulation tools are capable of accurately estimating 
DNA manufacturing process turnaround times, with results of the example 
simulation studies being comparable to the observed production durations (although 
minor discrepancies between the simulated and real data were also present). 
Furthermore, the software developed is capable of estimating the most significant 
manufacturing parameters, which can be expected to be the most promising process 
optimisation targets. Methods to conduct DNA sequence-specific simulation studies 
were also developed and allowed computation of customised gene synthesis success 
rate predictions, which were later used to estimate DNA sequence-specific 
manufacturing turnaround time distributions. Several modelling methods could 
however be improved and some limitations of the analyses performed have to be 
considered when interpreting results of the simulation studies. 
 
First, construction of the example manufacturing process model was based on 
estimating and assuming the underlying manufacturing step distribution functions 
and their parameters based on the information obtained from the company’s 
personnel. However, data describing real manufacturing step durations would have 
been more supportive in defining the input distribution functions. I tried to obtain 
such data by mining the manufacturing step start and end timestamp records (stored 
in the company’s MES system). However, these attempts did not lead to improved 
manufacturing turnaround time estimations, possibly due to data artefacts present in 
the timestamp datasets (Supp. Fig. 4.1.3 in Appendix 4.1). More accurate variance 
estimations could have also been obtained, e.g., by collecting additional 10% and 
90% quantile estimations from the staff, which can be used to calculate standard 
deviations, given known distribution means (Cook, 2010). 
 
Second, simplification of the biological sample rescue manufacturing routes in the 
constructed statistical model could have contributed to the observed minor data 
discrepancies. For example, some manufacturing rescue paths of the example DNA 
fabrication process involved different experimental protocols (Supp. Fig. 4.1.6 in 
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Appendix 4.1), durations of which could have differed from those of the original 
procedures. However, such rescue scenarios were not accounted for in the example 
process model. The simulation tools also do not support modelling of multiple rescue 
options, which are possible in the example manufacturing process (i.e., the colony 
PCR step), and therefore sample control steps involving these had to have their 
rescue paths simplified. 
 
Level of modelling detail could have also had an impact on the simulation results. In 
principle, manufacturing steps can be decomposed into a large number of sub-steps. 
Therefore, decisions regarding how granular a particular process model is are 
subjective and often guided by a certain level of detail required to assess some 
possible targets for process optimisation. However, despite the freedom to choose the 
required level of detail, some manufacturing stages can be difficult to decompose 
into more fine-grained steps. In this project, the oligonucleotide and DNA fragment 
design step posed such difficulties. Modelling duration of the design procedure was 
needed to benchmark simulation results against the observed data, referring to 
complete customer DNA order lifecycles, i.e., from the time of the order placement 
until the time of its shipment. However, deconvolution of the DNA design steps 
exclusive to the example DNA production process was challenging, as the design 
procedure involves simultaneous evaluation of multiple possible manufacturing 
routes to meet various customer, manufacturing and DNA sequence constraints. 
Therefore, modelling assumptions were made regarding the DNA sequence design 
step. 
 
Modelling tools developed by this project allowed certain properties to be assigned 
to the manufacturing steps (e.g., the “overnight” attribute). However, an additional 
attribute could have been considered to make it possible to “chain” some of the 
consecutive manufacturing steps. Such a step characteristic could, e.g., prevent 
setting up bacterial transformations, if there is not enough time to plate the 
transfected cells, while maintaining the desired level of modelling detail. 
Furthermore, it could be used to investigate the impact of automation and integration 




Biological sample batching is another important aspect of DNA manufacturing. In 
high-throughput DNA manufacturing facilities DNA fabrication often takes place in 
large sample batches, comprising 96 samples or more, which makes it difficult to 
model such processes with single sample resolution. Such resolution could be useful, 
e.g., in conducting accurate manufacturing cost simulation studies, which account for 
repetitions of fractions of sample batches only. However, the modelling approach 
presented in this manuscript does not support investigation of such scenarios. 
 
The simulation software developed in this project also does not account for 
manufacturing steps which happen in parallel. While this limitation does not pose 
major issues for simulating manufacturing turnaround times of the example 
manufacturing process, it makes it difficult to accurately model costs of the sub-
fragment gene synthesis manufacturing stage. For instance, for three example 
parallel sub-fragment gene synthesis manufacturing steps, A, B and C, for which 
manufacturing costs are independent and distributed identically, however, which 
gene synthesis success rates differ, example repetition of step A only is associated 
with approximately one third of the costs of running the parallel A, B, C sub-process. 
In the case of modelling manufacturing step durations, duration of step A repetition 
could be similar to the parallel A, B, C sub-process duration, which makes modelling 
of production turnaround times easier as compared to the simulation analysis of 
manufacturing costs. 
 
Last but not least, incorporation of the DNA sequence information into the process 
simulation studies sought to make the manufacturing turnaround time estimations 
more relevant to the production of complex nucleic acid sequences. A classification 
model was therefore built to tailor gene synthesis failure probabilities to specific sets 
of sub-fragment DNA sequences and accounted for two problematic DNA sequence 
features, i.e., extreme GC content and DNA sequence length. Nevertheless, 
information about several additional DNA sequence features could have been used to 
train the model in an effort to improve its predictive power. For instance, DNA 
repeats are known to pose problems throughout the gene synthesis process and 
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therefore information about their abundance could have improved accuracy of the 
predictions made (Oberortner et al., 2016). Moreover, information about the DNA 
sequence length could have been used to improve modelling of the DNA 
amplification steps, duration of which is DNA sequence length-dependent and would 
therefore become deterministic. This would lead to less randomness in the simulation 
data and therefore less variance in the predicted turnaround times, yielding more 















Scientific discovery, technological innovation and development of rapid prototyping 
methodologies are three factors which drive the progress of engineering disciplines. 
For instance, invention of the steam engine or the power loom are examples of 
technological innovations which sparked the first Industrial Revolution, leading to 
mechanisation of various manufacturing processes (Ó Gráda, 2016). More recently, 
further standardisation and automation of different operations have been making it 
possible to rapidly Design, Build and Test mechanical and electrical systems using 
standardised engineering components, computer-aided design (CAD) and rapid 
prototyping methods (e.g., 3D printing) (Deming, 2000; Gross et al., 2014). The 
latest advances in machine learning and data science on the other hand have been 
providing means to additionally Learn from the consecutive Design, Build and Test 
cycle iterations, thus allowing researchers to capitalise on the knowledge gained 
throughout the engineering process (LeCun, Bengio and Hinton, 2015). 
 
Today, biology is maturing into an engineering discipline thanks to the same 
enabling factors. Namely, the improving DNA reading, writing and editing 
technologies and laboratory automation solutions are the main driving forces of this 
transition, facilitating rapid construction and prototyping of novel biological systems 
(Check Hayden, 2014; Kosuri and Church, 2014; Libbrecht and Noble, 2015; Chao 
et al., 2017; Shendure et al., 2017; Clore, 2018). This doctoral thesis project 
therefore aimed at harnessing this technological progress to further assist in 
accelerating biological research and rationalizing function of living organisms. 
 
In order to do that, work presented in this thesis sought to address several remaining 
challenges which are limiting aspects of the genetic engineering Design, Build, Test 
and Learn cycle: first, the demand for cheaper and faster DNA fabrication; second, 
the need for efficient genome-scale DNA editing tools for rapid screening of 
engineered microbes; third, the need for predictive methodologies able to improve 
planning of high-throughput DNA manufacturing. 
 
In the first results chapter of this thesis, application of an automated acoustic 
dispensing technology was proposed. The experimental work presented showed that 
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it is possible to assemble DNA in volumes orders of magnitude lower than 
previously, leading to substantial reductions in reagent costs. Currently, a growing 
number of high-throughput industrial and academic facilities harnesses acoustic 
dispensing robots to miniaturise their DNA manufacturing assays (Shapland et al., 
2015; Chao et al., 2017). Moreover, since its publication, the miniaturised DNA 
fabrication approach developed has been already adopted by automated biofoundries, 
seeking to increase their DNA manufacturing capacities in a cost-efficient manner 
(Johnson et al., 2016; Chao et al., 2017). One limitation of applying acoustic 
dispensing in DNA fabrication is however the high initial cost of purchasing an 
acoustic liquid handler, which makes this type of technology accessible mostly to 
larger synthetic DNA manufacturing facilities rather than individual research 
laboratories. Droplet microfluidics provides an alternative solution to miniaturisation 
of biological assays and is becoming more accessible to researchers as 3D printing 
services and devices are becoming commodities (Gach et al., 2017). To date, Gibson 
and Golden Gate assembly protocols have been downscaled using this technology. 
For instance, Patrick et al. miniaturised a two-fragment Golden Gate reaction down 
to 490 nL, while Khilko et al. assembled 12 oligonucleotides using 600 nL Gibson 
assembly and performed an additional nanolitre DNA error correction reaction 
(Patrick et al., 2015; Khilko et al., 2018). Design and operation of microfluidic 
instruments however still requires relevant expertise and therefore this technology 
has not been yet widely applied by individual research laboratories (Gach et al., 
2017). 
 
In the second results chapter, development of a genetic tool for rapid prototyping of 
wild-type and synthetic S. cerevisiae strains was described. This section detailed 
efforts to build a genome-scale gene deletion library based on the state-of-the-art 
CRISPR DNA editing technology. Completion of this work holds promise for 
functional genetic screens, in search for essential gene sets ensuring yeast survival 
under different environmental conditions. Moreover, application of the proposed 
gene deletion approach to synthetic budding yeast strains might facilitate 
identification of genetic defects as well as novel genetic interactions caused by 
refactoring of their genetic code (Shen et al., 2017).  
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Last but not least, in the last results chapter, probabilistic Monte Carlo simulation 
software was developed to estimate speed of DNA manufacturing, and thus help plan 
DNA fabrication in high-throughput DNA synthesis facilities. Benchmarking the 
DNA order turnaround time predictions against real manufacturing data from a 
commercial DNA provider revealed accurate estimates of DNA production times. 
Moreover, a machine learning classification method was established to estimate 
nucleic acid sequence-specific customer order turnaround times which accounted for 
difficulties in synthesizing DNA fragments with extreme GC contents and lengths 
(Oberortner et al., 2016). The computational studies presented therefore demonstrate 
the potential of business intelligence strategies to be used for analysis of high-
throughput DNA production pipelines, e.g., those of automated biofoundries. 
 
In conclusion, results of this project show that current limitations of the synthetic 
biology Design, Build, Test and Learn cycle can be tackled with a range of 
interdisciplinary approaches, including methodologies derived from industrial 
process engineering (Mourtzis, Doukas and Bernidaki, 2014). Application of 
automation technologies constitutes the common denominator of the work presented 
in this thesis manuscript, as these technologies have proven their potential in 
establishing robust and reliable high-throughput DNA synthesis procedures. 
However, this thesis also stresses the importance of harnessing high-throughput data 
for learning purposes, using computer-aided manufacturing software to collect 










Appendix 1.1 Supplementary Tables 
 
Supp. Table 1.1.1 PCR Primers 
ID direction DNA sequence (5’ – 3’) application reference DNA template 
YCp2391* forward GAGATCCAGTTCGATGTAACC 
amplification of the 
nanolitre Gibson 
Assembly fragment (1) 
pPC025* 
YCp2392* reverse AGGATGTCCCAAGCGAAC 
amplification of the 
nanolitre Gibson 
Assembly fragment (1) 
pPC025* 
YCp2393* forward TTACCAAAGGTGGTCCGCTG 
amplification of the 
nanolitre Gibson 
Assembly fragment (2) 
pPC025* 
YCp2394* reverse TCAGTTGGGTGCACGAGTG 
amplification of the 
nanolitre Gibson 
Assembly fragment (2) 
pPC025* 
YCp2395* forward AGCGTGGGTCTCGGGCTACTAGTAGTTGATCTAATTATGGAATACC pMBP1 promoter part amplification 
BY4741 
genomic DNA 
YCp2396* reverse GTGCTGGGTCTCACATCGCTTGTGTTTCTGGGATTTACGTTGTGTC pMBP1 promoter part amplification 
BY4741 
genomic DNA 
YCp2214* forward GATCCTTTGATTTTCTACCG nanolitre PCR experiments HcKan_P* 
YCp2215* reverse CTCGATAACTCAAAAAATACG nanolitre PCR experiments HcKan_P 
PKp001 forward TGCGCATGTTTCGGCGTTCGAAACTTCTCCGCAGTGAAAGATAAATGATC 
DNA insert cloning into 




PKp002 reverse GTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC 
DNA insert cloning into 




PKp003 forward AGCAACTCCAATGACCACG 
Sanger sequencing 






ID direction DNA sequence (5’ – 3’) application reference DNA template 
PKp004 reverse GTGACGCAAGCATCAATGG 
Sanger sequencing 




P5 forward AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT Illumina NGS sequencing 
DNA w/ Illumina 
primer-binding 
sites 
P7-B1 reverse CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTT CCGATCT 
Illumina NGS sequencing 
(primer w/ a sequencing 
index) 
DNA w/ Illumina 
primer-binding 
sites 
P7-B2 reverse CAAGCAGAAGACGGCATACGAGATACATCGGTGACTGGAGTTCAGACGTGTGCTCTT CCGATCT 
Illumina NGS sequencing 
(primer w/ a sequencing 
index) 
DNA w/ Illumina 
primer-binding 
sites 
P7-B3 reverse CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACTGGAGTTCAGACGTGTGCTCTT CCGATCT 
Illumina NGS sequencing 
(primer w/ a sequencing 
index) 
DNA w/ Illumina 
primer-binding 
sites 
P7-B4 reverse CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACGTGTGCTCTT CCGATCT 
Illumina NGS sequencing 
(primer w/ a sequencing 
index) 
DNA w/ Illumina 
primer-binding 
sites 
P7-B5 reverse CAAGCAGAAGACGGCATACGAGATCACTGTGTGACTGGAGTTCAGACGTGTGCTCTT CCGATCT 
Illumina NGS sequencing 
(primer w/ a sequencing 
index) 
DNA w/ Illumina 
primer-binding 
sites 
P7-B6 reverse CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCAGACGTGTGCTCTT CCGATCT 
Illumina NGS sequencing 
(primer w/ a sequencing 
index) 
DNA w/ Illumina 
primer-binding 
sites 
P7-B7 reverse CAAGCAGAAGACGGCATACGAGATCAGATCGTGACTGGAGTTCAGACGTGTGCTCTT CCGATCT 
Illumina NGS sequencing 
(primer w/ a sequencing 
index) 
DNA w/ Illumina 
primer-binding 
sites 
P7-B8 reverse CAAGCAGAAGACGGCATACGAGATTAGCTTGTGACTGGAGTTCAGACGTGTGCTCTT CCGATCT 
Illumina NGS sequencing 
(primer w/ a sequencing 
index) 
DNA w/ Illumina 
primer-binding 
sites 
P7-B9 reverse CAAGCAGAAGACGGCATACGAGATGATCAGGTGACTGGAGTTCAGACGTGTGCTCTT CCGATCT 
Illumina NGS sequencing 
(primer w/ a sequencing 
index) 





ID direction DNA sequence (5’ – 3’) application reference DNA template 
P7-B10 reverse CAAGCAGAAGACGGCATACGAGATATCACGGTGACTGGAGTTCAGACGTGTGCTCTT CCGATCT 
Illumina NGS sequencing 
(primer w/ a sequencing 
index) 
DNA w/ Illumina 
primer-binding 
sites 
 PKp005 forward AGCAACTCCAATGACCACG amplification of the barcoded genomic frag. 
BY4741 
genomic material 
PKp006 reverse GTGACGCAAGCATCAATGG amplification of the barcoded genomic frag. 
BY4741 
genomic material 






























5 nL 20 nL 40 nL 80 nL 2,500 nL 
fragment 2  
(86 ng/µL) 7.5 nL 42.5 nL 85 nL 170 nL 2,500 nL 


















master mix 17.5 nL 82.5 nL 167.5 nL 332.5 nL 2,500 nL 
pMBP1 
(20 ng/µL) 30 nL 150 nL 300 nL 600 nL 4,500 nL 
HcKan_P 
(10 ng/µL) 2.5 nL 17.5 nL 32.5 nL 67.5 nL 500 nL 





Supp. Table 1.1.4 Nanolitre PCR Reactions 












10 µM primer 
(YCp2214) 2.5 nL 12.5 nL 25 nL 37.5 nL 50 nL 500 nL 
10 µM primer 
(YCp2215) 2.5 nL 12.5 nL 25 nL 37.5 nL 50 nL 500 nL 
DNA template 5 nL 25 nL 50 nL 75 nL 100 nL 1,000 nL 
GoTaq Green 
Master Mix 25 nL 125 nL 250 nL 375 nL 500 nL 5,000 nL 
nuclease-free 
water 15 nL 75 nL 150 nL 225 nL 300 nL 3,000 nL 












Appendix 2.1 Supplementary Tables 
 
Supp. Table 2.1.1 DNA Assembly Reagent Costs 



















100ML µL 100,000 50.1 0.000501 
Deoxynucleotide 
Mix, PCR-
Grade, 400 µL 
Agilent 





















Aldrich N1511-1G grams 1 85.1 85.1000 








NEB M0208L units 10,000 195.2 0.01952 
T4 DNA Ligase NEB M0202M units 100,000 166.4 0.00166 
BsaI-HF NEB R3535L units 5,000 169.6 0.03392 
BSA, Molecular 





Supp. Table 2.1.2 DNA Assembly Reagent Costs - Gibson Method 
reagent name reaction volume (nL) reagent cost (£) 
UltraPure 1 M Tris-HCI 
Buffer, pH 7.5 
50 2.369× 10)k 
250 1.1845× 10)r 
500 0.000002369 
1,000 0.000004738 
20,000 (positive control) 0.00009476 
Magnesium chloride solution, 
for molecular biology, 1.00 
M±0.01 M 
50 2.505× 10)k 
250 1.2525× 10)r 
500 0.000002505 
1,000 0.00000501 
20,000 (positive control) 0.0001002 
Deoxynucleotide Mix, PCR-





20,000 (positive control) 0.05004 
DL-Dithiothreitol, for 
molecular biology, =98% 
(TLC), =99% (titration) 
50 6.68997× 10r 
250 3.34498× 10)= 
500 6.68997× 10)= 
1,000 0.000133799 







20,000 (positive control) 0.0000716 
ß-Nicotinamide adenine 
dinucleotide hydrate, =99% 
50 2.82715× 10)r 
250 1.41357× 10)= 
500 2.82715× 10)= 
1,000 5.6543× 10)= 






20,000 (positive control) 0.0026112 






20,000 (positive control) 0.2504 






20,000 (positive control) 1.5616 









Supp. Table 2.1.3 DNA Assembly Reagent Costs – Golden Gate Method 
reagent name reaction volume (nL) reagent cost (£) 











7,500 (positive control) 0.0848 
BSA, Molecular Biology 
Grade 




7,500 (positive control) 0.009044 









Appendix 2.2 Supplementary Figures 
 
Supp. Figure 2.2.1 Sanger Sequencing Verification of DNA Assembly Junctions 
(A) DNA junctions of Golden Gate assemblies; There are two junctions, upstream and downstream of 
the cloned pMBP1 yeast promoter. (B) DNA junctions of Gibson assemblies; There are two junctions, 
one inside the bla gene open reading frame (conferring resistance to ampicillin and carbenicillin 
antibiotics) and the second one inside the red fluorescent protein (RFP) reading frame, allowing 




Appendix 2.3 Supplementary Calculations 
 
This section details computations of the number of expected experimental trials 
required until a successful DNA assembly. Calculations of the expected DNA 
fabrication reagent costs are subsequently shown. 
 
The number of DNA fabrication trials until a DNA construct is made is a 







For both Gibson and Golden Gate assemblies, the observed success rate of DNA 
assembly was 1 successful DNA fabrication experiment (at least 1 correct clone 







The expected reagent costs of Golden Gate and Gibson assemblies are a multiple of 
the number of expected experimental trials and reagents costs per one reaction. 
 






× 1	British	pence = 3	British	pence 
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Synthetic biology is a nascent interdisciplinary research 
field that leverages rational design approaches based on 
engineering principles.1,2 Synthetic biology distinguishes 
itself from traditional genetic engineering in several ways: 
(1) synthetic biology takes advantage of de novo DNA syn-
thesis technologies, rather than relying on the existing natu-
ral templates; (2) synthetic biologists use standardized 
genetic parts not only to facilitate the assembly of novel 
sequences, but also to more predictably construct the bio-
logical system based on the characterization of individual 
parts3; and (3) similar to other engineering disciplines, com-
puter-assisted designers (CADs) and mathematical model-
ing are instrumental in synthetic biology to effectively help 
synthetic biologists navigate the design space.4
Although synthetic biology is still in an early stage, several 
breakthroughs in the past decade have already demonstrated its 
great potential for society; for instance, Keasling’s group used 
a synthetic biology approach to engineer the baker’s yeast 
Saccharomyces cerevisiae to produce artemisinin, an impor-
tant antimalarial drug.5 Lu and Collins engineered bacterio-
phage for an antibiotic therapy6 and, more recently, also 
developed a paper-based cell-free methodology to rapidly 
detect Ebola viruses.7
The enabling technology for synthetic biology is the 
development of a suite of advanced DNA synthesis and 
assembly methods, such as Golden Gate assembly,8 Gibson 
assembly,9 circular polymerase extension cloning (CPEC),10 
transformation-assisted recombination (TAR) cloning,11 
and PaperClip assembly12 (for a comprehensive review on 
DNA assembly methods, refer to Ellis et al.13). Collectively, 
these technologies open up the possibility to redesign and 
resynthesize DNA at the genome scale. Poliovirus cDNA 
was synthesized without a natural template in 2002 by Cello 
et al.14 Itaya’s group pioneered the combination of two 
genomes in one cell in vivo.15 The J. Craig Venter Institute 
chemically resynthesized a bacterial genome16 and devel-
oped the genome transplantation technology to reboot the 
cell with the synthetic bacterial genome.17 Together with 
several other groups across the world, our group is part of 
the international synthetic yeast consortium (www.syntheti 
cyeast.org), which aims to redesign and resynthesize the 
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Smart DNA Fabrication Using Sound 
Waves: Applying Acoustic Dispensing 
Technologies to Synthetic Biology
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Abstract
Acoustic droplet ejection (ADE) technology uses focused acoustic energy to transfer nanoliter-scale liquid droplets with 
high precision and accuracy. This noncontact, tipless, low-volume dispensing technology minimizes the possibility of cross-
contamination and potentially reduces the costs of reagents and consumables. To date, acoustic dispensers have mainly 
been used in screening libraries of compounds. In this paper, we describe the first application of this powerful technology 
to the rapidly developing field of synthetic biology, for DNA synthesis and assembly at the nanoliter scale using a Labcyte 
Echo 550 acoustic dispenser. We were able to successfully downscale PCRs and the popular one-pot DNA assembly 
methods, Golden Gate and Gibson assemblies, from the microliter to the nanoliter scale with high assembly efficiency, 
which effectively cut the reagent cost by 20- to 100-fold. We envision that acoustic dispensing will become an instrumental 
technology in synthetic biology, in particular in the era of DNA foundries.
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world’s first eukaryotic genome. We recently reported the 
completion of the first synthetic yeast chromosome arm18 
and the first fully synthetic eukaryotic chromosome.19 As a 
safety measurement and responsible innovation in synthetic 
biology, efficient biocontainment technologies have been 
developed to restrict the viability of engineered microbes to 
prevent the dual use of synthetic biology technologies.20
Traditional liquid handling technology has enabled 
increased throughput of many Life Sciences (Lowell, MA) 
protocols and assays by (1) increasing operational speeds, (2) 
reducing working volumes (down to a microliter range), and 
(3) reducing the need for a generally error-prone human han-
dling, and ultimately contributed to substantial workflow cost 
savings. Despite an already big “leap forward,” the demand 
for further protocol miniaturization continues to increase, in 
particular in ultra-high-throughput screening (uHTS).21 
Traditional tips/nozzles-based robotic platforms struggle to 
precisely dispense liquid droplets below the microliter thresh-
old. Pin tools can be used to transfer nanoliter to microliter 
liquid from source plates to destination plates; however, 
because they are contact based, the pin tools usually require 
washing and drying between transfers to avoid cross-contam-
ination. Also, the delivery volume of pin tools is difficult to 
control, as it is due to a combination of many factors, such as 
the shape of the pin, the diameter of the pin, the coating of the 
pin, and the speed of dipping and removing of the pin. Finally, 
pin tools are usually made in 96, 384, and 1536 formats, 
which limits their flexibility of usage, e.g., in setting up differ-
ent reaction volumes in the same plate. Another technology 
allowing reaction miniaturization is the microfluidic chip 
technology.22 Kong and others have successfully used micro-
fluidic chips to synthesize DNA sequences up to 1 kb,23 and 
Tewhey et al. used microfluidic chips to run 1.5 million PCRs 
in parallel.24 The main disadvantage of the microfluidic chip 
approach is that the master molds and the control layer need to 
be custom designed and fabricated for different reactions; 
however, the de novo DNA synthesis using microfluidic chips 
is very complementary with the miniaturized assembly meth-
ods described in this paper.
First described in 1927, the acoustic droplet ejection 
(ADE) phenomenon utilizes acoustic energy to rapidly 
move low-volume nanoliter to picoliter droplets without 
any physical contact.25 Before it reached the laboratory set-
ting in the 2000s, the drop-on-demand technology was first 
exploited in a number of other fields, including the ink-jet 
printing industry. Today, Labcyte, Inc. (Sunnyvale, CA) is 
pioneering the acoustic dispensing technology for Life 
Sciences, with its Echo series robotic platforms being able 
to transfer multiple 2.5 or 25 nL droplets from the 384- and 
1536-well sources to the various (inverted) destination 
plates. Unlike traditional robotic liquid transfer methods, 
laboratory acoustic dispensing has been shown to be highly 
precise at the nanoliter volume range (as demonstrated by 
its low coefficients of variation), therefore enabling the 
desired further miniaturization of current protocols and 
assays. The acoustic dispenser is flexible enough to set up 
any-to-any configurations between the source plate and the 
destination plate, and the reaction volumes can vary from 
well to well in the same reaction plate.
Here, for the first time, we report yet another exciting 
acoustic dispensing application: nanoliter-scale DNA assem-
bly. The majority of assembly expenses are enzymes, includ-
ing DNA polymerases, Therefore, downscaling the reaction 
volume from the microliter to the nanoliter scale while main-
taining high assembly efficiency, will make DNA synthesis 
and assembly more accessible to synthetic biologists.
Materials and Methods
Echo PCR
Conventional endpoint PCR is instrumental in making syn-
thetic DNA. To test the minimal volume of regular PCR 
using Echo, we set up PCRs of various volumes. The plas-
mid HcKan_P vector (120 ng/µl) was used as the DNA tem-
plate, and a pair of primers YCp2214 and YCp2215 were 
designed to amplify a targeted DNA fragment of 1378 bp 
(Fig. 1A; all primers used in this paper are listed in Suppl. 
Table S1). The GoTaq Green Master Mix (Promega, 
Madison, WI) was used in the PCR. Five reaction volumes 
ranging from 50 to 1000 nL were set up (Table 1), and each 
reaction was performed in four replicates. All PCRs were 
set up using the following cycling conditions: preheat the 
PCR machine and then put in the PCR plate, 2 min at 95 °C, 
32 cycles of 10 s at 95 °C, 30 s at 50 °C and 2 min at 72 °C, 
7 min at 72 °C, and hold at 4° C. GoTaq Green Master Mix 
(35 µL) and double-distilled water (ddH2O; 30 µL) were 
added separately to source plate 1, which was an Echo 384-
well polypropylene plate (Labcyte). YCp2214 and YCp2215 
(10 µL each) and template DNA (10 µL) were added sepa-
rately to source plate 2, which was an Echo 384-well low-
dead-volume plate (Labcyte). The destination plate used in 
this paper was MicroAmp EnduraPlate (Life Technologies, 
Carlsbad, CA).
Gibson DNA Assembly
First described in 2009, the Gibson DNA assembly method9 
belongs to a group of overlap-directed DNA assembly tech-
niques such as CPEC,10 SLiCE,26 and SLIC27 assemblies. The 
Gibson assembly method is one of the most used in synthetic 
biology, and it can assemble DNA sequences up to small 
genome sizes from overlapping DNA fragments in an isother-
mal one-pot reaction. The advantage of Gibson assembly is 
that it is sequence independent and generates scarless final 
assembled DNA products. Typically, the Gibson assembly 
requires about a 40 bp homologous region between two adja-
cent DNA fragments, and these homologous regions are usu-
ally added to the fragments by a high-fidelity PCR. Briefly, the 
assembly reaction takes place in a cocktail of enzymes (termed 
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Gibson master mix) at 50 °C for 60 min: (1) First, T5 exonu-
lease chews back the DNA in a 5′ to 3′ direction from the 
homologous terminal ends to reveal reverse complementary 
single-stranded sequences between two adjacent fragments. 
(2) While the 5′ to 3′ DNA digestion proceeds, a high-fidelity 
DNA polymerase fills in the single-stranded DNA region. (3) 
Finally, Taq DNA ligase seals the nicked DNA strands, which 
yields the final assembled product.
Gibson Reaction Setup by Echo. Two pairs of primers 
(YCp2391 and YCp2392 for fragment 1, YCp2393 and 
YCp2394 for fragment 2) were designed to amplify two frag-
ments with 40 bp end homology from a red fluorescent pro-
tein (RFP)–containing plasmid pPC025, thus allowing 
subsequent Gibson reassembly of the plasmid. The two 
homologous junctions were placed within the ampicillin 
resistance gene and the RFP open reading frame (ORF) to 
reduce the overall false positive rate and to allow phenotypic 
screening for successful assembly isolates, respectively. In 
contrast to Golden Gate assembly (see below), here RFP 
serves as a positive screen for correct assemblies. PCR prod-
ucts were gel purified using the QIAquick gel extraction kit 
(Qiagen, Valencia, CA). The standard 15 µL Gibson assem-
bly master mix was prepared as described in the original Gib-
son assembly paper.9 Gibson master mix (40 µL) was added 
to source plate 1, which is an Echo 384 polypropylene plate 
(Labcyte). Each DNA fragment (10 µL) was added to source 
plate 2, which is an Echo 384 low-dead-volume plate (Lab-
cyte). One-pot Gibson assembly was incubated at 50 °C for 
60 min in a preheated PCR thermal cycler (Table 2).
Golden Gate Assembly
The Golden Gate DNA assembly method utilizes a combina-
tion of a TypeIIS restriction enzyme and a ligase to assemble 
the DNA fragments.8 TypeIIS enzymes (e.g., BsaI and BsmBI 
enzymes) are endonucleases that cut outside their recognition 
sites, creating 4 bp DNA overhangs. By carefully designing 
the 4 bp overhangs, one can use the Golden Gate reaction to 
directionally assemble DNA fragments. The Golden Gate 
DNA assembly reaction starts with a given TypeIIS endonu-
clease DNA digestion, leaving behind staggered cuts in the 
backbone and the fragment DNA. The design-imposed DNA 
complementarity allows annealing of the resulting “sticky 
ends,” creating the desired plasmid construct. In the final 
reaction step, the T4 DNA ligase repairs the nicks to com-
plete the DNA construction phase.
Golden Gate Reaction Setup by Echo. The HcKan_P plasmid 
(2.8 kb, diluted to 10 ng/µl) was used as the acceptor vector. 
This plasmid carries a KanR selectable marker, along with 
a RFP cassette flanked by a pair of outward-facing BsaI 
Table 1. PCR Setup.
Reagent/nl Echo Echo Echo Echo Echo Manual
Primer YCp2214 2.5 12.5 25.0 37.5 50.0 500.0
Primer YCp2215 2.5 12.5 25.0 37.5 50.0 500.0
Template DNA 5.0 25.0 50.0 75.0 100.0 1000.0
ddH2O 15.0 75.0 150.0 225.0 300.0 3000.0
GoTaq Green Master Mix 25.0 125.0 250.0 375.0 500.0 5000.0
Total 50 nL 250 nL 500 nL 750 nL 1000 nL 10,000 nL
Figure 1. PCR setup by Echo.  
(A) A pair of primers was designed 
to amplify a fragment of 1.3 kb, and 
PCRs of various volumes were set 
up by the Echo machine. (B) Gel 
electrophoresis confirms that PCR 
can work at the 250 nL scale.
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sites. We amplified the promoter pMBP1 (500 bp) directly 
from yeast BY4741 (MATa, leu2∆0 met15∆0 ura3∆0 
his3∆1) genomic DNA with primers YCp2395 and 
YCp2396 and added a pair of inward-facing BsaI sites to 
flank the promoter part (Fig. 2A). The PCR product was 
purified using a PureLink PCR purification kit (Life Tech-
nologies) and diluted to 20 ng/µl. The 4 bp overhangs were 
designed in such a way that the promoter can be efficiently 
assembled into the acceptor vector. Bacteria carrying the 
residual RFP plasmid will give a bright red pigment, which 
would facilitate the visual identification of correct assem-
bled clones (white colonies; see Fig. 2C).
The Golden Gate master mix was made of 35 µL T4 
ligase (2000 U/µl, New England Biolabs, NEB), 35 µL 
BsaI-HF (NEB), 52.5 µL 10× T4 buffer (NEB), and 25 µL 
200× BSA (NEB). Golden Gate assembly reactions were set 
up using the following cycling conditions: 15 cycles of 5 
min at 37 °C and 10 min at 16 °C, 5 min at 50 °C, 10 min at 
80 °C, and hold at 4 °C. Five reaction volumes arranging from 
50 to 1000 nL were set up (Table 3), and each reaction was 
performed in triplicate. A manual positive control reaction 
of 7.5 µL was also set up to confirm the fidelity of the 
reagents. Golden Gate master mix (30 µL) was added to 
source plate 1, which is an Echo 384 polypropylene plate 
(Labcyte). pMBP1 PCR product (10 µL) and HcKan_P vec-
tor (10 µL) were added to source plate 2, which is an Echo 
384 low-dead-volume plate (Labcyte).
Bacterial Transformation
As the assembly reactions set up by Echo were at the nanoli-
ter scale, it is difficult to take out the assembled DNA using 
pipets and transform them into bacterial competent cells. 
Instead, bacterial competent cells were added to each well 
containing an assembled product. Competent Escherichia 
coli (20 µL; MAX Efficiency DH5α, Life Technologies) was 
added to each well of the reaction plate. The PCR plate was 
incubated on ice for 20 min and then placed in a heat block at 
42 °C for 45 s. The plate was placed back on ice to incubate 
for 5 min, before adding 200 µL of room temperate super 
Optimal Catabolite repression (SOC) medium to each well. 
The plate was incubated at 37 °C with shaking at 200 rpm for 
1 h. A multichannel pipet was used to slowly drip 40 µL of 
each transformation mixture onto an omnitray containing 
selective solid agar medium (LB—Kan). Alternatively, 100 
µL of transformation mixture was plated on individual petri 
dishes with selective solid agar medium (Golden Gate assem-
bly, LB—Kan; Gibson assembly, LB—Amp). Plates were 
incubated overnight at 37 °C until single colonies appeared.
Gel Electrophoresis
Gel electrophoresis was performed to analyze the PCR 
products (120 V, 30 min; 1% w/v agarose in Tris-acetate-
EDTA (TAE) buffer with 1× SYBR Safe DNA stain). Each 
PCR product was first diluted with ddH2O to a final volume 
of 5 µL when the PCR volume was smaller than 5 µL.
Sanger Sequencing
A BigDye Terminator v3.1 Cycle Sequencing Kit (Life 
Technologies) was used to verify the DNA assembly clones 
according to the manufacturer’s instructions, and the Sanger 
sequencing reactions were carried out by Edinburgh 
Genomics.
Results and Discussion
We used the Echo machine to set up PCRs in total volumes 
ranging from 50 nL to 1 µL (Fig. 1 and Table 1). Starting 
from 250 nL, a band of the correct size could be detected in 
the gel electrophoresis. Because we diluted the PCR prod-
uct to 5 µL in order to run the gel electrophoresis, it is pos-
sible that PCRs at 50 nL scale were successful, but the gel 
electrophoresis was not sensitive enough to detect the sig-
nal. Alternatively, it would be possible to use the Caliper 
Labchip GX instrument that can detect DNA concentrations 
as low as 5 ng/µL. Downsizing the PCR from 50 µL or 
higher to 250 nL already effectively cuts the reagent cost by 
200-fold. Miniaturized PCR is ideal for diagnostic purposes 
such as fast genotyping and colony-screening PCR, but it is 
less suitable for applications requiring use of the PCR prod-
uct for downstream procedures, such as cloning, because 
the yield of double-stranded DNA may not be sufficient.
Gibson assembly worked extremely well in this experi-
ment. Correct assembly was observed from as low as the 
250 nL reaction volumes, and at 500 and 1000 nL the 
assembly efficiencies are comparable with or better than the 
manual control of the 20 µL reaction, but with a significant 
standard deviation. This allows us to cut the reagent cost by 
20-fold or more. Even more encouraging, we observed no 
background (Fig. 2C) and 100% correct assembly through 
Table 2. Gibson Assembly Reactions.
Reagent/nl Echo Echo Echo Echo Manual
Gibson master mix 37.5 187.5 375.0 750.0 15,000.0
Fragment 1 (113.8 ng/µl) 5.0 20.0 40.0 80.0 2,500.0
Fragment 2 (86.8 ng/µl) 7.5 42.5 85.0 170.0 2,500.0
Total 50 nL 250 nL 500 nL 1000 nL 20,000 nL
Kanigowska et al. 53
Figure 2. Gibson assembly reaction setup by Echo. (A) The pPC025 plasmid was split into two overlapping fragments at the 
middle of the ampicillin resistance gene and the RFP ORF. Two fragments were generated with 40 bp overlap at both ends and then 
assembled by the Gibson assembly reaction. (B) Gel electrophoresis confirming the successful PCR amplification of both fragments. 
(C) Successful Gibson assembly product gives rise to red bacterial colonies. The assembly efficiency was so high that no background 
colonies (white) were observed. Negative control reactions, which had only one fragment in the reactions, yielded no colonies.  
(D) Sequencing verification of both assembly junctions shows 100% assembly accuracy. (E) Cost-effectiveness and assembly efficiency 
comparison of different reaction volumes for Gibson assembly.
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Sanger sequencing across the assembly junctions (six red 
colonies were sequenced; Fig. 2D), and this will be highly 
beneficial for future automation plans, as it will greatly 
reduce the colony screening effort.
With Golden Gate assembly, we successfully assembled 
DNA at a 50 nL reaction volume (typically 15 µL reactions 
when performed manually), and at the 250 and 500 nL scales 
the assembly efficiencies are higher than those of the manual 
control. This leads to at least a 30-fold reduction in reagent use 
when performing Golden Gate reactions using Echo. We did 
observe vector background in the assembly (red colonies, as 
shown in Fig. 3C). There are several ways we can overcome 
this problem. First, instead of using RFP for screening, we can 
use the toxic ccdB gene, which cannot give rise to background 
colonies in a nonpermissive transformation host. Second, we 
can add a higher concentration of the BsaI enzyme in the 
Golden Gate master mix to further digest the residual acceptor 
vector. Finally, we may be able to reduce the background by 
extending the BsaI digestion step in the incubation.
With further optimization, it should be possible to down-
size the reaction volume even further. For instance, in this 
paper, individual components were shot off to the destination 
well one by one (in the case of 50 nL PCRs, only 1 droplet of 
primer was shot), and it is possible that some components 
were not sent into the reaction pool due to slight misalign-
ment of the acoustic dispenser, meaning the reactants simply 
didn’t mix. In this case, it would be of advantage to premix as 
many components as possible and then shoot more droplets 
altogether. We also suggest dispensing the master mix using 
a bulk dispenser or liquid handler, so that the destination well 
has a larger liquid surface to uptake the incoming droplet and 
minimize chances for the droplets hitting the well wall. It is 
always a good practice to centrifuge the PCR plate when 
appropriate before putting it into the PCR thermal cycler to 
start the reaction. To prevent the nanoliter droplet from evap-
orating before the chemical reaction starts, we always preheat 
the PCR machine before putting in the reaction plate. Finally, 
it is more economical to use low-dead-volume plates as the 
source plate for expensive reagents such as enzymes and 
polymerases.
In the world of laboratory automation, efficiency and 
robustness are as important as cost saving. With this in 
mind, we overlaid the number of correct assemblies (effi-
ciency) with standard deviation (robustness) in the same 
plot with the cost of reactions for the Gibson assembly (Fig. 
2E) and the Golden Gate assembly (Fig. 3E). The intersec-
tions of the two curves indicate the “sweet spots” for choos-
ing desired reaction volumes, which are of high efficiency, 
low standard deviation, and relatively low cost. It should be 
noted that our cost calculation did not take into account the 
dead volume of reagents, and logically it can be assumed 
that the dead-volume cost per reaction would decrease as 
more reactions are set up by Echo in one experiment. 
Whenever possible, low-dead-volume plates should be used 
for expensive reagents to save cost. Conversely, we did not 
include the tip cost in the manual control experiments, 
which increase substantially when the number of reactions 
is scaled up. Continuously monitoring DNA assembly effi-
ciency along with the assembly cost is critical to successful 
operation of a large DNA synthesis and assembly automa-
tion facility, such as the UK DNA foundries.
The acoustic dispensing has great potential in automat-
ing other molecular biology operations. We also used the 
Echo to purify single colonies from bacterial and yeast 
cultures, which is traditionally challenging to automate. 
As Echo is capable of dispensing nanoliter droplets with 
high precision, it is also ideal for generating high-density 
assembly libraries through combinatorial assembly meth-
ods. In conclusion, the work described here is the first 
report on use of the acoustic dispenser in the area of syn-
thetic biology, and we envision that this technology will 
be instrumental in lab automation, in particular in the era 
of DNA foundries.
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Appendix 3.1 Supplementary Tables 
 
Supp. Table 3.1.1 crRNAs Used in Single-gene Deletion Experiments 












(YOR128C) TAACTTCGTTGTAAAGAATA AGG 50.0 47.5 
CAN1 
(YEL063C) CACAAACACACCACAGACGT GGG 50.0 71.8 
SEN34 




Supp. Table 3.1.2 Sanger Sequencing of Sample CRISPR Pool Bacterial Clones’ Plasmid DNA 
clone 
number 
plasmid insertion length (bp) comments 
1 167 correct full oligonucleotide length insertion 
2 167 correct full oligonucleotide length insertion 
3 171 correct full oligonucleotide length insertion 
4 23 truncated oligonucleotide insertion 
5 170 correct full oligonucleotide length insertion 
6 168 correct full oligonucleotide length insertion 
7 167 correct full oligonucleotide length insertion 
8 169 correct full oligonucleotide length insertion 
9 166 correct full oligonucleotide length insertion 
10 106 truncated oligonucleotide insertion 
11 0 no alignment 
12 169 correct full oligonucleotide length insertion 
13 170 correct full oligonucleotide length insertion 
14 169 correct full oligonucleotide length insertion 
15 53 truncated oligonucleotide insertion 
16 166 correct full oligonucleotide length insertion 
17 0 no alignment 
18 166 correct full oligonucleotide length insertion 
19 171 correct full oligonucleotide length insertion 
20 170 correct full oligonucleotide length insertion 
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Supp. Table 3.1.3 Conserved and Non-conserved Regions Targeted 
chromosome number region coordinates (bp) control type 
IV 620666-621411 non-conserved 
XV 481945-482019 non-conserved 
II 28859-28918 non-conserved 
V 281218-281493 non-conserved 
XIV 495207-495385 non-conserved 
II 95942-95973 non-conserved 
XI 224685-224725 non-conserved 
II 60247-60653 non-conserved 
IV 582499-582789 non-conserved 
VII 478967-479395 non-conserved 
II 431106-431124 non-conserved 
XV 851843-851940 non-conserved 
XVI 14840-15051 non-conserved 
XV 329302-329403 non-conserved 
VIII 266917-266951 non-conserved 
XII 1064955-1065023 non-conserved 
XVI 920702-921212 non-conserved 
XII 84174-84264 non-conserved 
XII 981702-982094 non-conserved 
XIII 317097-317163 non-conserved 
XV 592809-592873 non-conserved 
IX 226079-226430 non-conserved 
XVI 620053-620317 non-conserved 
IV 722103-722354 non-conserved 
II 45731-45922 non-conserved 
XIV 495207-495385 non-conserved 
III 308313-308558 non-conserved 
III 289404-289616 non-conserved 
IV 1477200-1477237 non-conserved 
I 203149-203310 non-conserved 
III 123232-123575 non-conserved 
XIV 569941-570023 non-conserved 
XIII 759228-759271 non-conserved 
XI 527363-527670 non-conserved 
III 116734-117312 non-conserved 
XII 137875-137938 non-conserved 
VIII 423698-423722 non-conserved 
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chromosome number region coordinates (bp) control type 
II 143042-143160 non-conserved 
IV 217209-217306 non-conserved 
II 589120-589237 non-conserved 
XV 80015-80191 non-conserved 
V 61058-61141 non-conserved 
XIV 210183-210231 non-conserved 
II 658393-658598 non-conserved 
XV 908667-908898 non-conserved 
XII 337415-337459 non-conserved 
VIII 423673-423697 non-conserved 
XII 283734-283870 non-conserved 
X 462555-462719 non-conserved 
XII 449807-449876 non-conserved 
XVI 829071-829168 non-conserved 
II 334024-334149 non-conserved 
XI 666437-666548 non-conserved 
XV 31818-31847 non-conserved 
XI 418186-418305 non-conserved 
XVI 921683-921858 non-conserved 
VII 751103-751225 non-conserved 
VI 226771-226851 non-conserved 
XIII 77771-78272 non-conserved 
X 703207-703395 non-conserved 
XII 130725-130760 non-conserved 
XII 554147-554307 non-conserved 
XVI 85543-85580 non-conserved 
II 536452-536555 non-conserved 
XVI 572342-572407 non-conserved 
V 260857-260931 non-conserved 
XIV 525385-525535 non-conserved 
IV 1206555-1206674 non-conserved 
X 726899-726934 non-conserved 
VI 256998-257462 non-conserved 
XV 903780-903837 non-conserved 
XI 527363-527670 non-conserved 
VII 478967-479395 non-conserved 
VIII 184836-184873 non-conserved 
IV 741842-741854 non-conserved 
IX 142032-142548 non-conserved 
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chromosome number region coordinates (bp) control type 
III 127011-127143 non-conserved 
M 494-550 non-conserved 
XIII 124357-124496 non-conserved 
XVI 47105-47171 non-conserved 
V 498852-499077 non-conserved 
XV 167439-168003 non-conserved 
II 565531-565546 non-conserved 
XI 462997-463199 non-conserved 
XIV 356727-356792 non-conserved 
XII 1001725-1001926 non-conserved 
V 422867-422956 non-conserved 
VII 599208-599242 non-conserved 
XIV 632377-632565 non-conserved 
III 78290-78345 non-conserved 
V 570137-570322 non-conserved 
IV 158870-159350 non-conserved 
XVI 880725-881010 non-conserved 
VII 433580-433721 non-conserved 
XI 21080-21165 non-conserved 
XVI 627769-627858 non-conserved 
XVI 261318-261335 non-conserved 
II 668553-668661 non-conserved 
X 543766-544060 non-conserved 
IX 36558-36664 non-conserved 
XI 151239-151621 non-conserved 
XV 384977-385116 non-conserved 
XIII 512201-512744 non-conserved 
VIII 297098-297150 non-conserved 
IV 507787-507836 non-conserved 
IX 432714-432904 non-conserved 
VI 104471-104503 non-conserved 
IV 1447327-1447705 non-conserved 
XV 968475-968992 non-conserved 
IV 147931-147952 non-conserved 
VII 788319-788529 non-conserved 
XII 1041367-1041515 non-conserved 
XI 392404-392433 non-conserved 
X 623279-623349 non-conserved 
XII 391945-392710 non-conserved 
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chromosome number region coordinates (bp) control type 
VII 1065663-1067146 non-conserved 
XV 28048-28162 non-conserved 
XI 134217-134240 non-conserved 
XIII 318483-318496 non-conserved 
VII 547996-548034 non-conserved 
XIII 809026-809051 non-conserved 
IV 829059-829139 non-conserved 
XIII 135348-135374 non-conserved 
XV 21312-21426 non-conserved 
XIV 63333-63411 non-conserved 
XI 200576-200833 non-conserved 
XV 458793-458890 non-conserved 
XIII 503324-503739 non-conserved 
XII 898895-899023 non-conserved 
XIV 495123-495205 non-conserved 
IX 35651-35900 non-conserved 
IX 428006-428307 non-conserved 
XIV 439284-439353 non-conserved 
XI 221281-221342 non-conserved 
VII 23365-23449 non-conserved 
XIV 392497-392514 non-conserved 
II 720723-721240 non-conserved 
XIV 499057-499415 non-conserved 
XVI 339440-339552 non-conserved 
XIV 185556-185585 non-conserved 
XV 989298-989352 non-conserved 
VII 270776-270802 non-conserved 
XII 949196-949516 non-conserved 
XII 377465-377480 non-conserved 
X 445062-445193 non-conserved 
VIII 255890-256214 non-conserved 
XIII 922445-922541 non-conserved 
XVI 22017-22580 non-conserved 
XII 201622-201735 non-conserved 
IX 142032-142548 non-conserved 
XIII 917052-917577 non-conserved 
XVI 128284-128314 non-conserved 
XIII 793657-793720 non-conserved 
IV 1334154-1334344 non-conserved 
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chromosome number region coordinates (bp) control type 
XII 783956-784166 non-conserved 
II 498801-498837 non-conserved 
IV 509560-509669 non-conserved 
XII 289479-289532 non-conserved 
VII 726593-726821 non-conserved 
XVI 860460-860621 non-conserved 
XI 137104-137850 non-conserved 
V 257963-258034 non-conserved 
XI 229881-229987 non-conserved 
VIII 14579-14899 non-conserved 
XIII 463216-463291 non-conserved 
XIV 746565-746791 non-conserved 
III 126731-126909 non-conserved 
VII 414029-414100 non-conserved 
XIII 789103-789220 non-conserved 
IV 765552-765704 non-conserved 
X 223575-223782 non-conserved 
X 374589-374846 non-conserved 
II 40528-40579 non-conserved 
XV 468094-468210 non-conserved 
VIII 483969-484026 non-conserved 
XV 343082-343431 non-conserved 
II 808361-808598 non-conserved 
IV 1493991-1494009 non-conserved 
IV 454905-455028 non-conserved 
XV 312734-312755 non-conserved 
VII 508702-508891 non-conserved 
XVI 183057-183198 non-conserved 
X 745262-745340 non-conserved 
VIII 242024-242347 non-conserved 
X 719065-719183 non-conserved 
XIV 330980-331210 non-conserved 
VII 478967-479395 non-conserved 
I 13226-13361 non-conserved 
IV 1189572-1189838 non-conserved 
XV 960397-960730 non-conserved 
XI 108911-109116 non-conserved 
XIII 10029-10196 non-conserved 
XVI 272816-273002 non-conserved 
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chromosome number region coordinates (bp) control type 
IV 19689-19981 non-conserved 
II 555447-555664 non-conserved 
II 196222-196559 non-conserved 
XII 1041676-1041797 non-conserved 
XII 368125-368242 non-conserved 
VII 35235-35405 non-conserved 
XIII 91727-91980 non-conserved 
XV 818559-818570 non-conserved 
XVI 129738-129795 non-conserved 
XVI 246374-246579 non-conserved 
V 254429-254544 non-conserved 
IV 1182755-1182823 non-conserved 
VII 16395-17053 non-conserved 
III 122464-122483 non-conserved 
VII 810962-811065 non-conserved 
XV 216345-216430 non-conserved 
XV 40168-40299 non-conserved 
I 229752-229892 non-conserved 
VII 962062-962159 non-conserved 
XIV 546430-546468 non-conserved 
IV 1005338-1005367 non-conserved 
VII 1069616-1069864 non-conserved 
IX 316469-316603 non-conserved 
XVI 775846-776015 non-conserved 
V 53497-53589 non-conserved 
XIV 355507-355949 non-conserved 
XVI 929803-930343 non-conserved 
XIII 634562-634687 non-conserved 
IV 25877-25937 non-conserved 
II 714637-714744 non-conserved 
II 415424-415644 non-conserved 
VI 113986-114652 non-conserved 
XVI 568997-569134 non-conserved 
XV 170507-170558 non-conserved 
XIV 405814-405897 non-conserved 
IV 477362-477724 non-conserved 
XII 898363-898406 non-conserved 
XI 304399-304484 non-conserved 
XV 1078213-1078478 non-conserved 
 
 209 
chromosome number region coordinates (bp) control type 
IX 93119-93297 non-conserved 
IV 443725-443855 non-conserved 
VII 1083912-1083968 non-conserved 
IV 1013965-1014151 non-conserved 
IV 158870-159350 non-conserved 
X 724098-724273 non-conserved 
XVI 488294-488542 non-conserved 
IX 99158-99344 non-conserved 
VI 181208-181402 non-conserved 
XVI 645550-645589 non-conserved 
VII 508642-508703 non-conserved 
XV 487521-487571 non-conserved 
XIII 923147-923388 non-conserved 
XII 292176-292342 non-conserved 
VI 258038-258299 non-conserved 
XII 949196-949516 non-conserved 
X 615332-615574 non-conserved 
II 581389-581417 non-conserved 
VII 377325-377342 non-conserved 
IV 569955-570410 non-conserved 
VII 413350-413454 non-conserved 
XI 207921-207951 non-conserved 
VII 257007-257230 non-conserved 
I 87147-87179 non-conserved 
XIV 250316-250816 non-conserved 
IX 7372-7509 non-conserved 
II 527860-527879 non-conserved 
IV 1362189-1362307 non-conserved 
VIII 412521-412795 non-conserved 
X 339488-339519 non-conserved 
XIII 512201-512744 non-conserved 
VII 202386-202602 non-conserved 
IX 289137-289224 non-conserved 
XII 980987-981056 non-conserved 
VI 245339-245990 non-conserved 
II 558199-558265 non-conserved 
V 468261-468361 non-conserved 
XIV 479569-479587 non-conserved 
IX 439609-439667 non-conserved 
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chromosome number region coordinates (bp) control type 
XI 325521-325650 non-conserved 
III 273666-274101 non-conserved 
VII 56058-56233 non-conserved 
II 45338-45459 non-conserved 
I 158806-158964 non-conserved 
XIII 31733-32134 non-conserved 
XV 80015-80191 non-conserved 
XVI 209971-209983 non-conserved 
IV 475990-476554 non-conserved 
X 521740-521781 non-conserved 
IV 926935-926984 non-conserved 
IV 1169013-1169168 non-conserved 
XI 457055-457182 non-conserved 
XII 823480-823511 non-conserved 
XIII 296745-296874 non-conserved 
XIV 441113-441274 non-conserved 
XIII 795565-795645 non-conserved 
XVI 857320-857396 non-conserved 
VII 589747-589805 non-conserved 
XVI 834505-834559 non-conserved 
XII 581939-582004 non-conserved 
X 617540-617907 non-conserved 
XIV 374961-375115 non-conserved 
VII 74965-75137 non-conserved 
II 785701-786131 non-conserved 
I 181-261 non-conserved 
VII 787932-788171 non-conserved 
XIV 274080-274209 non-conserved 
X 227933-228081 non-conserved 
XIV 135812-135938 non-conserved 
XV 701313-701392 non-conserved 
II 575999-576132 non-conserved 
IV 715380-715452 non-conserved 
VI 207087-207318 non-conserved 
IV 1341992-1342065 non-conserved 
VII 857838-858144 non-conserved 
VIII 498860-498889 non-conserved 
IV 591950-592218 non-conserved 
XII 407195-407257 non-conserved 
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chromosome number region coordinates (bp) control type 
IV 1050383-1050420 non-conserved 
V 53604-53736 non-conserved 
XVI 544159-544465 non-conserved 
VII 767000-767342 non-conserved 
VI 260381-260480 non-conserved 
XIII 411288-411349 non-conserved 
III 8669-8761 non-conserved 
VIII 455706-455746 non-conserved 
XV 702585-702680 non-conserved 
XV 665146-665335 non-conserved 
XIV 87457-87499 non-conserved 
XI 615066-615127 non-conserved 
VI 174001-174015 non-conserved 
XIV 663914-663947 non-conserved 
VI 169470-169732 non-conserved 
IX 249136-249162 non-conserved 
XIV 63104-63257 non-conserved 
IV 1494446-1494510 non-conserved 
VII 10274-10637 non-conserved 
IV 50680-50982 non-conserved 
XII 20577-21002 non-conserved 
XV 837228-837468 non-conserved 
X 154937-154983 non-conserved 
V 570137-570322 non-conserved 
XII 84089-84139 non-conserved 
XIV 59937-60021 non-conserved 
III 78618-78945 non-conserved 
IV 1162461-1162733 non-conserved 
XI 270825-271775 non-conserved 
XVI 14840-15051 non-conserved 
X 639431-639544 non-conserved 
II 604781-604802 non-conserved 
XI 21080-21165 non-conserved 
XI 374357-374503 non-conserved 
VII 857838-858144 non-conserved 
XIII 547633-547712 non-conserved 
I 212162-212354 non-conserved 
IV 1116833-1116961 non-conserved 
II 496893-496981 non-conserved 
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chromosome number region coordinates (bp) control type 
XVI 287254-287512 non-conserved 
IV 103503-103547 non-conserved 
VI 11125-11255 non-conserved 
IX 27820-28625 non-conserved 
IV 2954-3017 non-conserved 
VIII 501144-501930 non-conserved 
IV 48633-48679 non-conserved 
XI 567367-567702 non-conserved 
VIII 282383-282477 non-conserved 
IV 117484-117531 non-conserved 
V 106786-107006 non-conserved 
III 178321-178451 non-conserved 
XIII 601254-601560 non-conserved 
VII 421267-421299 non-conserved 
XIII 651227-651588 non-conserved 
V 362374-362580 non-conserved 
II 592921-593068 non-conserved 
V 258316-258735 non-conserved 
IV 964893-964929 non-conserved 
VIII 258173-258237 non-conserved 
XII 510592-510715 non-conserved 
XIV 723114-723205 non-conserved 
XII 928066-928291 non-conserved 
V 504151-504825 non-conserved 
XIII 133054-133119 non-conserved 
V 39746-39758 non-conserved 
VIII 522032-524787 non-conserved 
XV 619357-619398 non-conserved 
V 263884-264012 non-conserved 
VII 959060-959232 non-conserved 
VII 107915-107974 non-conserved 
VI 255447-255495 non-conserved 
XII 84174-84264 non-conserved 
XVI 129808-129880 non-conserved 
XIV 553119-553334 non-conserved 
XV 304256-304413 non-conserved 
IV 407760-408138 non-conserved 
XI 361980-362326 non-conserved 
IV 524918-525039 non-conserved 
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chromosome number region coordinates (bp) control type 
IV 141724-141836 non-conserved 
V 541174-541552 non-conserved 
XVI 264479-264600 non-conserved 
V 552228-552407 non-conserved 
X 177792-177916 non-conserved 
XII 390701-390752 non-conserved 
VII 17314-17659 non-conserved 
XV 766795-766867 non-conserved 
XIII 574016-574469 non-conserved 
V 132720-132827 non-conserved 
IV 620666-621411 non-conserved 
XII 48914-49245 non-conserved 
XIII 221335-221394 non-conserved 
IV 80606-82437 non-conserved 
X 417045-417121 non-conserved 
II 410669-410822 non-conserved 
VIII 516628-517275 non-conserved 
I 220498-220814 non-conserved 
VII 1011458-1011604 non-conserved 
IV 544754-544875 non-conserved 
IV 1005217-1005332 non-conserved 
I 119970-120091 non-conserved 
V 56296-56421 non-conserved 
VI 26101-26811 non-conserved 
XVI 582993-583060 non-conserved 
VIII 1873-1975 non-conserved 
XV 40168-40299 non-conserved 
VII 534916-534991 non-conserved 
XVI 822303-822371 non-conserved 
XIV 65142-65273 non-conserved 
X 538424-538542 non-conserved 
I 199087-199140 non-conserved 
II 186637-186842 non-conserved 
M 43795-44046 non-conserved 
III 133234-133273 non-conserved 
VI 222962-223040 non-conserved 
X 727018-727118 non-conserved 
I 222103-222378 non-conserved 
XIII 512201-512744 non-conserved 
 
 214 
chromosome number region coordinates (bp) control type 
XVI 281771-281926 non-conserved 
V 221690-221713 non-conserved 
IV 292141-292358 non-conserved 
XVI 454991-455040 non-conserved 
II 288720-289139 non-conserved 
IV 1166558-1166632 non-conserved 
I 215708-215877 non-conserved 
XIV 335181-335202 non-conserved 
X 397116-397353 non-conserved 
XII 1064955-1065023 non-conserved 
II 476805-477235 non-conserved 
XIV 777046-777318 non-conserved 
XIV 745789-745854 non-conserved 
V 423598-423914 non-conserved 
IV 1140956-1141111 non-conserved 
XII 20397-20578 non-conserved 
XII 539634-539709 non-conserved 
XIV 349766-349813 non-conserved 
XV 891606-891690 non-conserved 
XVI 627503-627525 non-conserved 
VII 1069616-1069864 non-conserved 
VII 634252-634302 non-conserved 
XI 302062-302332 non-conserved 
VII 318080-318707 non-conserved 
III 316255-316330 non-conserved 
IV 1506101-1506587 non-conserved 
IV 68930-68995 non-conserved 
VI 221643-221712 non-conserved 
IX 130084-130099 non-conserved 
VI 82059-82344 non-conserved 
IV 1090264-1090414 non-conserved 
XIII 396591-396906 non-conserved 
V 242655-242996 non-conserved 
VII 990636-991077 non-conserved 
I 82134-82600 non-conserved 
IV 132784-132817 non-conserved 
II 36728-36753 non-conserved 
XI 645918-645934 non-conserved 
XV 581492-581736 non-conserved 
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chromosome number region coordinates (bp) control type 
IV 1362189-1362307 non-conserved 
IV 1270898-1270922 non-conserved 
XIV 784024-784073 non-conserved 
VII 581738-581770 non-conserved 
VIII 48356-48374 non-conserved 
II 720605-720653 non-conserved 
XVI 98892-99215 non-conserved 
VIII 335840-336192 non-conserved 
XII 872729-872762 non-conserved 
IV 1447179-1447326 non-conserved 
XV 463904-464438 non-conserved 
VII 323584-323696 non-conserved 
XII 786160-786210 non-conserved 
VIII 370603-370720 non-conserved 
XIII 325480-325627 non-conserved 
XII 822870-822911 non-conserved 
IV 1365912-1366222 non-conserved 
XV 681159-681350 non-conserved 
IX 27820-28625 non-conserved 
XI 666547-666653 non-conserved 
IV 1031583-1031750 non-conserved 
III 273666-274101 non-conserved 
V 362374-362580 non-conserved 
VII 122133-122255 non-conserved 
XIII 619748-619841 non-conserved 
VIII 123858-123984 non-conserved 
VII 905860-905923 non-conserved 
XIII 225366-225536 non-conserved 
XII 874793-874944 non-conserved 
XI 506453-506515 non-conserved 
XIII 731636-732154 non-conserved 
IX 426715-426811 non-conserved 
IV 320528-320666 non-conserved 
V 554027-554629 non-conserved 
XV 303088-303230 non-conserved 
XII 792684-792889 non-conserved 
VII 1007362-1007406 non-conserved 
IV 477362-477724 non-conserved 
XVI 825129-825148 non-conserved 
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chromosome number region coordinates (bp) control type 
IX 278140-278183 non-conserved 
V 363849-364064 non-conserved 
XII 877549-877740 non-conserved 
IV 1383640-1383798 non-conserved 
II 269759-269892 non-conserved 
II 288225-288532 non-conserved 
VII 788540-788798 non-conserved 
IV 494486-494572 non-conserved 
VII 1078916-1079517 non-conserved 
XIII 551323-551429 non-conserved 
VII 330857-330965 non-conserved 
IV 1005145-1005165 non-conserved 
XI 638393-638753 non-conserved 
II 801930-802564 non-conserved 
XIV 635543-635817 non-conserved 
X 94711-94850 non-conserved 
XV 238515-238617 non-conserved 
XV 170507-170558 non-conserved 
XVI 205091-205136 non-conserved 
VIII 123591-123702 non-conserved 
XI 352625-352888 non-conserved 
V 264649-264799 non-conserved 
XIII 432435-432573 non-conserved 
II 349931-350096 non-conserved 
XIII 119521-119546 non-conserved 
V 504151-504825 non-conserved 
XVI 739729-739872 non-conserved 
XIII 689011-689081 non-conserved 
IV 859303-859336 non-conserved 
II 151359-151491 non-conserved 
XVI 793805-793909 non-conserved 
XVI 843200-843260 non-conserved 
XVI 173052-173149 non-conserved 
X 639431-639544 non-conserved 
VIII 131595-131900 non-conserved 
XI 260201-260507 non-conserved 
VII 522840-523435 non-conserved 
VII 951626-951888 non-conserved 
IV 80606-82437 non-conserved 
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chromosome number region coordinates (bp) control type 
XV 123762-123860 non-conserved 
XVI 321954-322069 non-conserved 
XVI 227578-227624 non-conserved 
XV 310150-310172 non-conserved 
VII 22201-22302 non-conserved 
I 210984-211021 non-conserved 
XIII 91727-91980 non-conserved 
IV 321835-322009 non-conserved 
VIII 138282-138402 non-conserved 
VII 1083912-1083968 non-conserved 
XI 67470-67553 non-conserved 
X 629169-629237 non-conserved 
IV 436924-437011 non-conserved 
II 414818-415197 non-conserved 
VII 180611-180644 non-conserved 
VII 842639-842744 non-conserved 
VI 90790-90860 non-conserved 
IV 130610-130646 non-conserved 
IV 699828-700017 non-conserved 
IV 321835-322009 non-conserved 
XVI 525066-525597 non-conserved 
IV 1466157-1466229 non-conserved 
VII 700303-700604 non-conserved 
XII 708767-708794 non-conserved 
XIII 271692-271816 non-conserved 
IV 410811-410823 non-conserved 
VI 153125-153211 non-conserved 
XVI 418028-418123 non-conserved 
V 271311-271433 non-conserved 
VI 255646-255661 non-conserved 
X 30365-30611 non-conserved 
VI 207087-207318 non-conserved 
V 512362-512523 non-conserved 
XII 931979-932204 non-conserved 
XI 389316-389378 non-conserved 
XV 892171-892314 non-conserved 
VII 770479-770567 non-conserved 
IX 21322-22053 non-conserved 
M 56095-56170 non-conserved 
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chromosome number region coordinates (bp) control type 
IV 83144-83546 non-conserved 
XIV 186886-187019 non-conserved 
XI 262030-262273 non-conserved 
V 396389-396608 non-conserved 
XV 161372-161519 non-conserved 
IX 10850-11254 non-conserved 
V 362374-362580 non-conserved 
II 555447-555664 non-conserved 
II 203267-203323 non-conserved 
IV 829059-829139 non-conserved 
XII 745103-745430 non-conserved 
VII 584336-584645 non-conserved 
XVI 163803-163920 non-conserved 
IV 387176-387324 non-conserved 
IV 1523037-1523147 non-conserved 
V 53604-53736 non-conserved 
IV 506976-506995 non-conserved 
XIV 778952-779269 non-conserved 
XV 773628-773756 conserved 
XI 255096-255189 conserved 
XIV 559247-559360 conserved 
X 337773-337879 conserved 
XV 773755-773854 conserved 
VII 1028796-1028905 conserved 
XV 217033-217124 conserved 
V 483171-483269 conserved 
XV 16899-17006 conserved 
XVI 572490-572644 conserved 
XIII 662107-662289 conserved 
XV 947657-947887 conserved 
XIII 434492-434588 conserved 
XV 725193-725327 conserved 
XIII 20562-20687 conserved 
III 2571-2700 conserved 
XI 100380-100669 conserved 
IV 1517850-1518260 conserved 
IV 1165026-1165164 conserved 
XIII 408822-408915 conserved 
VII 856632-856750 conserved 
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chromosome number region coordinates (bp) control type 
XVI 592144-592313 conserved 
II 336896-337058 conserved 
IV 1516676-1517060 conserved 
V 140077-140230 conserved 
II 363626-363743 conserved 
VIII 484655-484767 conserved 
XIV 447517-447609 conserved 
V 88949-89093 conserved 
II 364403-364520 conserved 
VII 371385-371493 conserved 
IV 867926-868083 conserved 
VII 993761-993912 conserved 
IV 1005424-1005523 conserved 
VII 1000608-1000717 conserved 
IV 1514076-1514221 conserved 
IV 811949-812044 conserved 
V 89657-89749 conserved 
VIII 98120-98257 conserved 
XI 164571-164684 conserved 
II 145318-145493 conserved 
IV 1514799-1515064 conserved 
II 145077-145319 conserved 
VIII 244492-244620 conserved 
VII 1029004-1029123 conserved 
XI 171364-171474 conserved 
V 88278-88554 conserved 
XVI 520613-520745 conserved 
XIV 335953-336063 conserved 
IV 848354-848509 conserved 
V 9202-9296 conserved 
III 3820-3999 conserved 
IV 927058-927166 conserved 
XII 645994-646140 conserved 
XIV 634737-634995 conserved 
XI 338928-339027 conserved 
XV 947986-948171 conserved 
IV 1515154-1515293 conserved 
XVI 585905-586003 conserved 
II 164167-164306 conserved 
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XVI 497847-497972 conserved 
II 165829-165921 conserved 
XII 510876-510974 conserved 
V 87683-87861 conserved 
VIII 67564-67669 conserved 
XIV 642506-642605 conserved 
XVI 412821-412967 conserved 
XVI 863278-863369 conserved 
VII 483108-483235 conserved 
XV 104019-104113 conserved 
X 180384-180502 conserved 
XVI 863435-863677 conserved 
VII 1029793-1029891 conserved 
XII 447675-447920 conserved 
XV 17086-17188 conserved 
V 338652-338844 conserved 
V 139919-140033 conserved 
I 227106-227214 conserved 
XV 948274-948620 conserved 
IV 1515400-1515658 conserved 
XIII 624310-624414 conserved 
XVI 551786-551896 conserved 
XII 826282-826401 conserved 
XIV 263504-263609 conserved 
VIII 190297-190441 conserved 
XVI 862340-862560 conserved 
XVI 829273-829434 conserved 
V 339119-339385 conserved 
XIV 107190-107299 conserved 
XIV 662052-662152 conserved 
XIII 445289-445393 conserved 
XVI 874978-875103 conserved 
VIII 509163-509256 conserved 
XV 947285-947455 conserved 
XV 946688-946810 conserved 
IV 416953-417053 conserved 
XV 978345-978506 conserved 
II 364171-364362 conserved 
IV 1515670-1515811 conserved 
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XIV 87553-87653 conserved 
VIII 56506-56597 conserved 
XII 212230-212323 conserved 
II 482485-482817 conserved 
VII 857640-857732 conserved 
IV 49150-49258 conserved 
XIII 661992-662095 conserved 
IV 411442-411639 conserved 
II 342578-342676 conserved 
XII 825281-825426 conserved 
VII 993904-993996 conserved 
X 393288-393557 conserved 
VI 164211-164351 conserved 
VIII 4803-4928 conserved 
X 526030-526153 conserved 
IV 867571-867678 conserved 
VII 398396-398498 conserved 
IV 915929-916023 conserved 
XVI 412073-412252 conserved 
XII 492926-493115 conserved 
VII 277865-278388 conserved 
XVI 67124-67223 conserved 
III 2700-2822 conserved 
II 408772-408873 conserved 
IV 1519098-1519267 conserved 
IV 1515832-1515949 conserved 
II 740720-740825 conserved 
XV 768174-768265 conserved 
VIII 119813-119926 conserved 
VII 150698-150795 conserved 
II 482950-483424 conserved 
VIII 470673-470780 conserved 
XIII 445103-445205 conserved 
XI 336322-336427 conserved 
III 293033-293177 conserved 
VI 4686-4813 conserved 
IV 173512-173769 conserved 
II 36811-36914 conserved 
IV 889097-889216 conserved 
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XVI 464052-464168 conserved 
VII 610118-610237 conserved 
VII 1011826-1011933 conserved 
XIII 306111-306222 conserved 
VII 610251-610342 conserved 
XVI 412282-412394 conserved 
VIII 2238-2595 conserved 
XVI 280027-280181 conserved 
V 107010-107101 conserved 
VI 164564-164742 conserved 
VI 261312-261463 conserved 
V 201772-201911 conserved 
XIII 810589-810721 conserved 
XII 921681-921778 conserved 
XVI 863171-863264 conserved 
IV 1071542-1071636 conserved 
XII 825500-825606 conserved 
IV 461402-461495 conserved 
XI 381974-382070 conserved 
XIII 439011-439108 conserved 
II 680107-680241 conserved 
XII 416819-416936 conserved 
XIV 447421-447513 conserved 
XIV 692062-692159 conserved 
XII 286619-286729 conserved 
VII 884069-884164 conserved 
IV 1459419-1459536 conserved 
VI 54947-55043 conserved 
XIV 174438-174591 conserved 
XV 947455-947546 conserved 
XV 128034-128174 conserved 
XII 341163-341263 conserved 
IV 1514330-1514521 conserved 
XIV 452140-452246 conserved 
X 521786-521878 conserved 
IX 93422-93514 conserved 
XI 175051-175301 conserved 
X 623143-623234 conserved 
XI 159092-159212 conserved 
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XII 441289-441466 conserved 
XVI 297911-298031 conserved 




Appendix 3.2 Supplementary Figures 
 
Supp. Figure 2.2.1 Sanger Sequencing Verification of Single-gene CRISPR Deletion Experiments 
(A) ADE2 deletion experiments introducing an 8 bp frameshift-triggering mutation, deleting the Cas9::sgRNA recognition sequences (i.e., the protospacer and protospacer-adjacent 
motif sequences); Plasmid DNA from > 15 red yeast colonies (putative ADE2 mutants) was sequenced and the sequencing results confirmed successful non-essential gene deletions. 
Test (plasmid HDR donor) and positive control (dsDNA HDR donor) experiments were DNA sequencing-verified. (B) ADE2 deletion experiments introducing the 8 bp deletions and 









Appendix 4.1 Supplementary Figures 
 
Supp. Figure 4.1.1 Automatically-
generated Plot of Input 
Manufacturing Step Duration 
Distributions 
Probability density functions of the 
input truncated normal distributions, 
with their mean, standard deviation, 
minimum and maximum bound 
parameters indicated, are one of the 
automatically-generated plots returned 
by the Monte Carlo simulation tool.  
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Supp. Figure 4.1.2 Automatically-generated Simulation Results Files 
Two simulation results files are returned by the Monte Carlo simulation tool. The “process_durations.txt” file stores all simulated process durations (in minutes), while the 
“step_start_and_end_datetimes.txt” file stores information on all simulated start and end times of the individual model manufacturing steps. Data from the “process_durations.txt” 




Supp. Figure 4.1.3 Manufacturing Timestamp Data Mining and Simulation-aided Fitting of 
Turnaround Time Distributions 
(A) To estimate turnaround time distributions of DNA design and the oligo synthesis and NGS 
manufacturing stages, start and end timestamps of these manufacturing phases were retrieved from the 
company’s manufacturing execution system, which stores information on individual DNA orders. The 
time difference between the end and start times was computed to yield durations of the investigated 
production phases. Durations corresponding to non-working days (i.e., weekends) were subtracted 
from this data. Distributions of the turnaround times obtained are illustrated. All three distributions are 
multimodal and thus not Gaussian. For the oligo synthesis and NGS validation manufacturing stages, 
this data suggests different manufacturing rescue routes involved in the underlying DNA orders. 
Possible data collection artefacts were observed in the last two turnaround time distributions, e.g., 
DNA orders with oligo syntheses and NGS validations shorter than 5 min. (B) The oligo synthesis and 
NGS turnaround time distributions were recapitulated with Monte Carlo simulation experiments. The 
two manufacturing stages were split into a number of manufacturing steps. Their number was based 
on the number of distribution modes. Durations of these steps were next modelled with normal 
distributions (which complied with the modelling framework developed). Parameters of the step 
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duration distributions, as well as their failure probabilities, were adjusted through simulation 
experiments so that the output manufacturing stage distributions resembled the observed duration 
data. Fitting of a mathematical distribution to the DNA design duration data was not successful and 




Supp. Figure 4.1.4 Using the Simulation-estimated Turnaround Time Distributions to Simulate 
the Example Process Model 
(A) Results of simulation experiments based on data including assumptions regarding durations of 
DNA design, oligonucleotide synthesis and NGS (B) Results of simulation experiments based on the 
simulation-estimated turnaround time distributions of the DNA oligonucleotide synthesis and NGS 
manufacturing stages; The DNA design stage was not considered by the alternative process model as 
it appeared to take a negligible amount of time (according to the timestamp-derived turnaround time 
distribution). In order to use the simulation-derived distribution data, the corresponding 
manufacturing steps were assigned an additional attribute called “run whenever”, which allowed them 
to be unconstrained by the pre-defined working schedules as information on staff availabilities was 
not applicable to modelling of these manufacturing steps. A larger difference between the simulated 
and observed mean production times (2 days) was observed. Similarly to the observed data 
distribution, distribution of the simulated DNA manufacturing times was multimodal, however with a 
much heavier tail. Due to these discrepancies, timestamp data-derived distributions were thus not used 




Supp. Figure 4.1.5 Impact of DNA Sequence Features on Failure of DNA Amplification  
Data regarding DNA amplification failures and the underlying DNA sequences (500 bp-long) was 
obtained from the YeastFab project database (Guo et al., 2015). Impact of different global and local 
nucleic acid sequence features on the amplification failure was investigated. No significant difference 
(as judged by a two-sample Kolmogorov-Smirnov test) was observed between distributions of the 
successful and failed DNA amplifications for the global features. Similarly, no significant difference 
was observed when the local features were investigated in 100 bp DNA windows. Mean GC content 
and minimum free energy are indicated by the plotted lines. Shaded areas represent the corresponding 





Supp. Figure 4.1.6 Diagram of the Example DNA Manufacturing Workflow 
Diagram of the case study DNA manufacturing workflow; Manufacturing rescue paths are indicated 
and include manufacturing steps with multiple rescue options (i.e., the colony PCR step); Several 
manufacturing success rates were not recorded by the MES system. 
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Appendix 4.2 Supplementary Tables 
 
Supp. Table 4.2.1 Model of the Example DNA Manufacturing Process 
step 

























0 completed N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
1 fragment and oligo design 120 360 240 30 truncated normal IT 2 0 N/A no 
2 oligo synthesis 240 480 360 30 truncated normal technicians 3 0 N/A no 
3 polymerase chain assembly 30 40 32 5 truncated normal technicians 4 0 N/A no 
4 PCR 30.5 100 63 5 truncated normal technicians 5 0 N/A no 
5 gel electrophoresis QC 30 45 34 5 truncated normal technicians 6 2 3 no 
6 PCR purification 45 60 48 10 truncated normal technicians 7 0 N/A no 
7 DNA dilution 13 30 25 5 truncated normal technicians 8 0 N/A no 
8 error correction 20 30 23 5 truncated normal technicians 9 0 N/A no 
9 sub-fragment fusion 91 120 96 5 truncated normal technicians 10 0 N/A no 
10 gel electrophoresis QC 2 30 45 34 5 truncated normal technicians 11 6 8 no 
11 PCR purification 2 45 60 48 10 truncated normal technicians 12 0 N/A no 
12 DNA dilution 2 20 40 23 10 truncated normal technicians 13 0 N/A no 
13 fragment refinement 20 30 23 5 truncated normal technicians 14 0 N/A no 
14 assembly into a vector 71 90 76 5 truncated normal technicians 15 0 N/A no 
15 bacterial transformation 76 90 80 10 truncated normal technicians 16 0 N/A no 
16 incubation of media plates 720 1080 840 60 truncated normal technicians 17 1 15 yes 
17 colony picking 10 20 15 5 truncated normal technicians 18 0 N/A no 
18 colony PCR 50 90 62 5 truncated normal technicians 19 0 N/A no 
19 gel electrophoresis QC 3 30 45 34 5 truncated normal technicians 20 2 8 no 
20 liquid culture incubation 720 1080 840 60 truncated normal technicians 21 0 N/A yes 
21 plasmid midiprep 45 90 60 10 truncated normal technicians 22 0 N/A no 
22 insert sequencing library prep. 180 300 240 30 truncated normal technicians 23 0 N/A no 
23 insert sequencing 330 390 360 15 truncated normal technicians 24 0 N/A yes 




Supp. Table 4.2.2 Process Model – Incorporating Timestamp Data-derived Distribution Estimations 
step 




























0 completed N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
1 oligo synthesis 0 5000000 1700 250 truncated normal N/A 5 60 2 N/A yes 
2 oligo synthesis rescue 1 0 5000000 1200 200 truncated normal N/A 5 60 3 N/A yes 
3 oligo synthesis rescue 2 0 5000000 1300 1 truncated normal N/A 5 20 4 N/A yes 
4 oligo synthesis rescue 3 0 5000000 2500 1 truncated normal N/A 5 0 5 N/A yes 
5 PCA 30 40 32 5 truncated normal technicians 6 0 N/A no no 
6 PCR 30.5 100 63 5 truncated normal technicians 7 0 N/A no no 
7 gel electrophoresis QC 30 45 34 5 truncated normal technicians 8 2 3 no no 
8 PCR purification 45 60 48 10 truncated normal technicians 9 0 N/A no no 
9 DNA dilution 13 30 25 5 truncated normal technicians 10 0 N/A no no 
10 error correction 20 30 23 5 truncated normal technicians 11 0 N/A no no 
11 sub-fragment fusion 91 120 96 5 truncated normal technicians 12 0 N/A no no 
12 gel electrophoresis QC 2 30 45 34 5 truncated normal technicians 13 6 10 no no 
13 PCR purification 2 45 60 48 10 truncated normal technicians 14 0 N/A no no 
14 DNA dilution 2 20 40 23 10 truncated normal technicians 15 0 N/A no no 
15 fragment refinement 20 30 23 5 truncated normal technicians 16 0 N/A no no 
16 assembly into a vector 71 90 76 5 truncated normal technicians 17 0 N/A no no 
17 bacterial transformation 76 90 80 10 truncated normal technicians 18 0 N/A no no 
18 incubation of plates 720 1080 840 60 truncated normal technicians 19 1 16 yes no 
19 colony picking 10 20 15 5 truncated normal technicians 20 0 N/A no no 
20 colony PCR 50 90 62 5 truncated normal technicians 21 0 N/A no no 
21 gel electrophoresis QC 3 30 45 34 5 truncated normal technicians 22 2 10 no no 
22 liquid culture incubation 720 1080 840 60 truncated normal technicians 23 0 N/A yes no 
23 plasmid midiprep 45 90 60 10 truncated normal technicians 24 0 N/A no no 
24 NGS 0 5000000 1400 200 truncated normal N/A 0 85 25 N/A yes 
25 NGS rescue 1 0 5000000 1400 150 truncated normal N/A 0 35 26 N/A yes 
26 NGS rescue 2 0 5000000 1500 1 truncated normal N/A 0 15 27 N/A yes 
27 NGS rescue 3 0 5000000 1500 1 truncated normal N/A 0 0 0 N/A yes 
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Appendix 4.3 Supplementary Code 
 
4.3.1 Monte Carlo Simulation Tool 
 
import pandas as pd 
import numpy as np 
import math 
import operator 
from collections import defaultdict 
import datetime as dt 
import matplotlib.pyplot as plt 
import matplotlib.dates as mdates 
from mpl_toolkits.axes_grid.anchored_artists import AnchoredText 
import seaborn as sns 
from scipy.stats import truncnorm 
 
from subroutines_v2 import (simulate_model_n_times_w_time_constraints) 
 





def mc_simulation(file_name, nloops): 
    """Returns and saves 3 figures, a .txt file with n simulated process durations and a .txt file with n simulated step start and end datetimes""" 
 
    model = pd.read_excel(file_name, sheet_name="process_model") #file name has to be in parentheses 
 
    start_date_and_time = pd.read_excel(file_name, sheet_name="start_datetime") 
    start_datetime = dt.datetime.strptime( 
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        start_date_and_time.iloc[0].start_datetime, "%Y.%m.%d.%H.%M" 
    ) 
 
    working_hours = pd.read_excel(file_name, sheet_name="working_hours") 
    free_weekdays = pd.read_excel(file_name, sheet_name="free_weekdays") 
 
    model["step_number"] = model.step_number.astype(int) 
    model["next_step"] = model.next_step.astype(int) 
    model["next_rescue_step"] = model.next_rescue_step.astype(int) 
 
    step_datetimes, process_durations = simulate_model_n_times_w_time_constraints(model, start_datetime, working_hours, free_weekdays, nloops) 
 
    model_steps = [] 
 
    for key, value in step_datetimes.items(): 
        for i in range(len(value)): 
            model_steps.append(key) 
 
    start_datetimes = [] 
 
    for key, value in step_datetimes.items(): 
        for item in value: 
            start_datetimes.append(dt.datetime.strptime(item[0], "%Y-%m-%d %H:%M")) 
 
    end_datetimes = [] 
 
    for key, value in step_datetimes.items(): 
        for item in value: 
            end_datetimes.append(dt.datetime.strptime(item[1], "%Y-%m-%d %H:%M")) 
 




    fig1 = plot_process_durations_pdf_cdf(process_durations, nloops) 
    fig2 = plot_simulated_model_steps_in_process_runtime(model, 
                                                         nloops, 
                                                         start_datetime, 
                                                         model_steps, 
                                                         start_datetimes, 
                                                         end_datetimes, 
                                                         max_end_datetime) 
    fig3 = plot_input_pdfs(model) 
 
    with open("process_durations.txt", "w") as output: 
        output.write(";".join([str(d) for d in process_durations])) 
 
    with open("step_start_and_end_datetimes.txt", "w") as output: 
        output.write(str(step_datetimes)) 
 
    fig1.savefig("fig1_process_durations_pdf_cdf.pdf", format="pdf", bbox_inches="tight") 
    fig2.savefig("fig2_simulated_model_steps_in_process_runtime.png", format="png", bbox_inches="tight", dpi=1000) 
    fig3.savefig("fig3_input_pdfs.pdf", format="pdf", bbox_inches="tight") 
 





4.3.2 Subroutines of the Simulation Tool 
 
import pandas as pd 
import numpy as np 
import math 
import operator 
from collections import defaultdict 
import datetime as dt 
import matplotlib.pyplot as plt 
import matplotlib.dates as mdates 
from mpl_toolkits.axes_grid.anchored_artists import AnchoredText 
import seaborn as sns 
from scipy.stats import truncnorm 
 
def random_step_duration(model_step): 
    """Returns a random number sampled from a truncated normal distribution""" 
 
    mean = model_step.mean_duration 
    stdev = model_step.standard_deviation 
    minimum = model_step.minimum_duration 
    maximum = model_step.maximum_duration 
    a, b = (minimum - mean)/stdev, (maximum - mean)/stdev 
    return truncnorm.rvs(a, b, loc=mean, scale=stdev) 
 
def step_is_failing(model_step): 
    """Returns True if model_step failing""" 
 
    failure_probability = model_step.step_failure_probability 





    """Returns model_step 95th percentile""" 
 
    mean = model_step.mean_duration 
    stdev = model_step.standard_deviation 
    minimum = model_step.minimum_duration 
    maximum = model_step.maximum_duration 
    a, b = (minimum - mean)/stdev, (maximum - mean)/stdev 
    return truncnorm(a, b, loc=mean, scale=stdev).ppf(0.95) 
 
def compute_percentile(results_list, n): 
    """Return simulation result_list nth percentile""" 
 
    return np.percentile( 
        np.asarray(results_list), 
        n 
    ) 
 
def can_start_at_t(model_step, t, human_start, human_end, free_days): 
    """Returns True if model_step can be executed at time t""" 
 
    weekday_dict = { 
        "Mon": 0, 
        "Tue": 1, 
        "Wed": 2, 
        "Thu": 3, 
        "Fri": 4, 
        "Sat": 5, 
        "Sun": 6 
    } 
 
    if t.strftime('%a') in free_days: #is it weekend? 
 
 243 
        return False 
 
    if not (human_start < t.time() < human_end): #is process current time within working hours? 
        return False 
 
    step_end = t + dt.timedelta(minutes=step_p95(model_step)) #can we finish a step before end of working hours? 
 
    if model_step.runs_overnight == "no": 
        next_evening = t.replace(hour=human_end.hour, 
                                 minute=human_end.minute) 
        return step_end < next_evening 
 
    else: 
        next_last_day_evening = t + dt.timedelta(days=max(0, (weekday_dict[free_days[0]] - 1) - t.weekday()))  
        next_last_day_evening = next_last_day_evening.replace(hour=human_end.hour, 
                                                              minute=human_end.minute) 
        return step_end < next_last_day_evening #don't do overnight steps on the last working day 
 
def simulate_model_w_time_constraints(model, start_datetime, working_hours, free_weekdays): 
    """Returns a dictionary with step_name keys and their values, 
    as tuples of string start and end date and time results; 
    and a total process turnaround time (in min)""" 
 
    step_number = 1 
    current_datetime = start_datetime 
    simulation_result = {} 
 
    while (step_number != 0): 
 




        #human working schedule for model_step 
        human_working_schedule = working_hours[working_hours.team_name == model_step.team_resource] 
        human_start = dt.time(hour=int(human_working_schedule.start_hour), 
                              minute=int(human_working_schedule.start_minute)) 
        human_end = dt.time(hour=int(human_working_schedule.end_hour), 
                            minute=int(human_working_schedule.end_hour)) 
 
        #free weekdays 
        free_days = list(free_weekdays.free_weekdays.values) 
 
        #can model_step start at current_datetime? if not, keep checking every 1 min and wait until it can start 
        while not can_start_at_t(model_step, current_datetime, human_start, human_end, free_days): 
            current_datetime = current_datetime + dt.timedelta(minutes=1) 
 
        #now, model_step can be executed (save its start and end datetimes) 
        step_start = "%d-%d-%d %d:%d" % ( 
            current_datetime.year, 
            current_datetime.month, 
            current_datetime.day, 
            current_datetime.hour, 
            current_datetime.minute) 
 
        current_datetime += dt.timedelta(minutes=random_step_duration(model_step)) 
 
        step_end = "%d-%d-%d %d:%d" % ( 
            current_datetime.year, 
            current_datetime.month, 
            current_datetime.day, 
            current_datetime.hour, 




        simulation_result[model_step.step_name] = (step_start, step_end) 
 
        #did it fail? 
        if step_is_failing(model_step): 
            step_number = model_step.next_rescue_step 
        else: 
            step_number = model_step.next_step 
 
    return simulation_result, (current_datetime - start_datetime).total_seconds()/60 #total turnaround time in minutes 
 
def simulate_model_n_times_w_time_constraints(model, start_datetime, working_hours, free_weekdays, ntimes): 
    """Returns a dictionary of model_step keys and values - lists of n (start, end datetime) tuples; 
    and a list of n total process durations (in min)""" 
 
    simulation_results = [ 
        simulate_model_w_time_constraints(model, start_datetime, working_hours, free_weekdays) for i in range(ntimes)] 
 
    step_datetimes = { 
        key: [dictionary[key] for dictionary in [item[0] for item in simulation_results]] 
        for key in [item[0] for item in simulation_results][0] 
    } 
    process_durations = [item[1] for item in simulation_results] 
    return step_datetimes, process_durations 
 
def compute_process_sensitivity(model, start_datetime, working_hours, free_weekdays, process_durations, nloops): 
    """Returns an absolute value-sorted dictionary with sensitivity analysis results (values) for each model parameter (key)""" 
 
    model_parameters_dictionary = {} 
 




        failure_probability_df = model.set_value(i, "step_failure_probability", 1.01*row.step_failure_probability) 
        mean_duration_df = model.set_value(i, "mean_duration", 1.01*row.mean_duration) 
        min_duration_df = model.set_value(i, "minimum_duration", 1.01*row.minimum_duration) 
        max_duration_df = model.set_value(i, "maximum_duration", 1.01*row.maximum_duration) 
        standard_deviation_df = model.set_value(i, "standard_deviation", 1.01*row.standard_deviation) 
 
        if i != 0: 
            if row.step_failure_probability != 0: 
                failure_probability_dict = { 
                    (row.step_name, "failure probability"): 
                    np.mean(simulate_model_n_times_w_time_constraints(failure_probability_df,  
                                                                      start_datetime,  
                                                                      working_hours,  
                                                                      free_weekdays, nloops)[1])-np.mean(process_durations) 
                } 
                mean_duration_dict = { 
                    (row.step_name, "mean duration"): 
                    np.mean(simulate_model_n_times_w_time_constraints(mean_duration_df,  
                                                                      start_datetime,  
                                                                      working_hours,  
                                                                      free_weekdays, nloops)[1])-np.mean(process_durations) 
                } 
                min_duration_dict = { 
                    (row.step_name, "min duration"): 
                    np.mean(simulate_model_n_times_w_time_constraints(min_duration_df,  
                                                                      start_datetime,  
                                                                      working_hours,  
                                                                      free_weekdays, nloops)[1])-np.mean(process_durations) 
                } 
                max_duration_dict = { 
                    (row.step_name, "max duration"): 
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                    np.mean(simulate_model_n_times_w_time_constraints(max_duration_df,  
                                                                      start_datetime,  
                                                                      working_hours,  
                                                                      free_weekdays, nloops)[1])-np.mean(process_durations) 
                } 
                standard_deviation_dict = { 
                    (row.step_name, "max duration"): 
                    np.mean(simulate_model_n_times_w_time_constraints(standard_deviation_df,  
                                                                      start_datetime,  
                                                                      working_hours,  
                                                                      free_weekdays, nloops)[1])-np.mean(process_durations) 
                } 
 
                model_parameters_dictionary.update(failure_probability_dict) 
                model_parameters_dictionary.update(mean_duration_dict) 
                model_parameters_dictionary.update(min_duration_dict) 
                model_parameters_dictionary.update(max_duration_dict) 
                model_parameters_dictionary.update(standard_deviation_dict) 
 
            else: 
                mean_duration_dict = { 
                    (row.step_name, "mean duration"): 
                    np.mean(simulate_model_n_times_w_time_constraints(mean_duration_df,  
                                                                      start_datetime,  
                                                                      working_hours,  
                                                                      free_weekdays, nloops)[1])-np.mean(process_durations) 
                } 
                min_duration_dict = { 
                    (row.step_name, "min duration"): 
                    np.mean(simulate_model_n_times_w_time_constraints(min_duration_df,  
                                                                      start_datetime,  
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                                                                      working_hours,  
                                                                      free_weekdays, nloops)[1])-np.mean(process_durations) 
                } 
                max_duration_dict = { 
                    (row.step_name, "max duration"): 
                    np.mean(simulate_model_n_times_w_time_constraints(max_duration_df,  
                                                                      start_datetime,  
                                                                      working_hours,  
                                                                      free_weekdays, nloops)[1])-np.mean(process_durations) 
                } 
                standard_deviation_dict = { 
                    (row.step_name, "max duration"): 
                    np.mean(simulate_model_n_times_w_time_constraints(standard_deviation_df,  
                                                                      start_datetime,  
                                                                      working_hours,  
                                                                      free_weekdays, nloops)[1])-np.mean(process_durations) 
                } 
 
                model_parameters_dictionary.update(mean_duration_dict) 
                model_parameters_dictionary.update(min_duration_dict) 
                model_parameters_dictionary.update(max_duration_dict) 
                model_parameters_dictionary.update(standard_deviation_dict) 
        else: 
            pass 
 
    sorted_dict = sorted(model_parameters_dictionary.items(), key=lambda it: abs(it[1])) #list output 
    sorted_dict_keys = [sorted_dict[entry][0] for entry in range(len(sorted_dict))] 
    sorted_dict_values = [sorted_dict[entry][1] for entry in range(len(sorted_dict))] 
 




4.3.3 Sensitivity Analysis Tool 
 
import pandas as pd 
import numpy as np 
import math 
import operator 
from collections import defaultdict 
import datetime as dt 
import matplotlib.pyplot as plt 
import matplotlib.dates as mdates 
from mpl_toolkits.axes_grid.anchored_artists import AnchoredText 
import seaborn as sns 
from scipy.stats import truncnorm 
 
from subroutines_v2 import (compute_process_sensitivity) 
from plotting_v2 import (plot_top_parameters) 
 
def sensitivity_analysis(model_file_name, simulation_results_file_name): 
    """Returns a figure of process sensitivity to top 20 most significant model parameters""" 
 
    model = pd.read_excel(model_file_name, sheet_name="process_model") #file name has to be in parentheses 
 
    start_date_and_time = pd.read_excel(model_file_name, sheet_name="start_datetime") 
    start_datetime = dt.datetime.strptime( 
        start_date_and_time.iloc[0].start_datetime, "%Y.%m.%d.%H.%M" 
    ) 
 
    working_hours = pd.read_excel(model_file_name, sheet_name="working_hours") 
    free_weekdays = pd.read_excel(model_file_name, sheet_name="free_weekdays") 
 
    model["step_number"] = model.step_number.astype(int) 
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    model["next_step"] = model.next_step.astype(int) 
    model["next_rescue_step"] = model.next_rescue_step.astype(int) 
 
    with open(simulation_results_file_name, 'r') as f: 
        content = f.read() 
 
    process_durations = [float(v) for v in content.split(';')] 
    nloops = len(process_durations) 
 
    sorted_dict, sorted_dict_keys, sorted_dict_values = compute_process_sensitivity( 
        model, 
        start_datetime, 
        working_hours, 
        free_weekdays, 
        process_durations, 
        nloops 
    ) 
 
    fig = plot_top_parameters(sorted_dict, sorted_dict_keys, sorted_dict_values) 
    fig.savefig("fig1_sensitivity_analysis_results.pdf", format="pdf", bbox_inches="tight") 
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